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AGA   Appropriate for gestational age 
AGR   Absolute growth rate 
AGR10-28   Absolute growth rate for weight (neonatal) from day 10 to 28 
AGR30-60   Absolute growth rate for weight (juvenile) from day 30 to 60 
AGR60-90   Absolute growth rate for weight (adolescent) from day 60 to 90 
AKT   Product of the AKT protooncogene, serine/threonine-protein kinase or 
protein kinase B 
p-AKT/AKT  phosphorylated to non-phosphorylated AKT (or protein kinase B) 
AMPK   5' adenosine monophosphate-activated protein kinase 
p-AMPK/AMPK  phosphorylated to non-phosphorylated 5' adenosine monophosphate-
activated protein kinase 
ANOVA   Analysis of Variance (statistical test) 
ATP  Adenosine triphosphate 
AUCinsulin   Area under the curve for insulin 
AUCglucose   Area under the curve for glucose 
BMI   Body mass index 
CoA   Coenzyme A   
DOHaD  Developmental origins of health and disease 
dpm   Disintegrations per minute 
FADH2,   Flavin adenine dinucleotide (hydroquinone form) 
FAT/CD36  Fatty Acid Translocase/Cluster of Differentiation 36  
FFA   Free fatty acid concentration 
FGR   Fractional growth rate 
FGR10-28   Fractional growth rate for weight (neonatal) from day 10 to 28 
FGR30-60   Fractional growth rate for weight (juvenile) from day 30 to 60 
FGR60-90   Fractional growth rate for weight (adolescent) from day 60 to 90 
G0  Gestational age day 0 (day of mating) 
G0-G40  Gestational age day 0 to day 40 
G0-G60  Gestational age day 0 to day 60 
GIR   Glucose infusion rate 
GLUT 1/2/3  Glucose transporter 1/2/3 isoforms  
GLUT4  Glucose transporter 4 isoform 
HEC   Hyperinsulinaemic euglycaemic clamp 






IMVS   Institute of Medical and Veterinary Science 
IRS 1/2  Insulin receptor substrate isoforms 1 and 2 
IUGR   Intrauterine growth restriction (or retardation) 
IVGTT   Intravenous glucose tolerance test 
L0  Day 0 of lactation (day of birth) 
L0-L30  Day 0 to day 30 of lactation (day of birth to day of weaning) 
LBW  Low birth weight 
LPL  Lipoprotein lipase 
LS  Litter size 
MCR  Metabolic clearance rate  
meq   Milli equivalent 
mRNA   Messenger ribonucleic acid 
µU   Micro unit 
NAD+/NADH  Nicotinamide adenine dinucleotide (oxidised and reduced form) 
NCD  Non-communicable diseases 
n.d.  Not determined 
NSD   Not significantly different 
NIDDM   Non-insulin dependent diabetes mellitus 
OD  Outer diameter 
OGTT  Oral glucose tolerance test 
p70S6K  Ribosomal protein S6 kinase beta-1 
PI3K   Phosphatidylinositol-3-kinase 
PIP3  Phosphatidylinositol (3,4,5)-trisphosphate 
PKC   Protein kinase C 
PKC,   Protein kinase C zeta isoform 
RIA   Radioimmunoassay 
SD   Standard deviation 
SEM   Standard error of the mean 
SGA   Small for gestational age 
SPSS  Statistical Package for Social Sciences 
ssGIR   Steady state glucose infusion rate achieved during the second hour of the 
hyperinsulinaemic euglycaemic clamp 
T2DM  Type 2 Diabetes Mellitus 
%CV   Coefficient of variance 
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Intrauterine growth restriction (IUGR) and neonatal catch-up growth are risk factors 
for the development of metabolic disease in later life. Developmental programming of insulin 
resistance is hypothesised to underpin many of these disorders. Animal models are required to 
investigate the mechanisms underlying this programming of insulin resistance and metabolic 
disease. Therefore, the current study assessed the effects of spontaneous growth restriction due 
to natural variation in litter size in the guinea pig on programming of adult metabolic outcomes. 
Increasing litter size reduced birth weight, birth length and birth weight to length 
ratio while head dimensions at birth were relatively conserved, indicating head sparing and 
asymmetrical IUGR. Offspring from larger litters displayed faster neonatal fractional growth 
and faster absolute and fractional juvenile growth. Relative feed intake in juveniles was 
increased in offspring from larger litters, and increased neonatal growth also predicted 
hyperphagia in juveniles. Rapid neonatal growth also correlated with increased visceral 
adiposity in adult males, but not females, suggesting sex-specific programming of postnatal 
phenotype. Thus, the spontaneously IUGR guinea pig exhibits key features of human IUGR 
including neonatal catch-up growth, postnatal hyperphagia and increased fat deposition 
(Chapter 2). 
To enable further study of the effects of litter size and neonatal growth on insulin 
sensitivity, methodology for the hyperinsulinaemic euglycaemic clamp (HEC) was validated 
for use in the guinea pig. The dose-response curve for whole-body glucose uptake using 
recombinant human insulin was characterised and HECs with D-[3-3H]-glucose infusion were 
performed to characterise insulin sensitivities of whole body glucose uptake and partitioning of 
glucose metabolism in males and females at ~half maximal and near maximal insulin doses. 
Insulin infusion at 7.5 mU.min-1.kg-1 increased glucose utilisation and storage, while 
suppressing glucose production, while insulin at 30 mU.min-1.kg-1 also increased the rate of 




utilisation, storage and production during insulin stimulation were higher in female than male 
guinea pigs, but insulin sensitivity of these and whole body glucose uptake did not differ 
between sexes (Chapter 3).  
HEC was then used to assess whole body insulin sensitivity and partitioned glucose 
metabolism in young adult offspring from varying litter sizes. In males, insulin sensitivities of 
whole body glucose uptake and glucose utilisation correlated positively, while that of 
endogenous glucose production tended to correlate positively with birth weight, and these 
associations were independent of neonatal catch-up growth, adult adiposity and muscle mass. 
Whole body and partitioned glucose metabolism in young adult females were not related to 
birth weight, however, the insulin sensitivity of endogenous glucose production correlated 
negatively with neonatal catch-up growth independently of birth weight. These results suggest 
a contribution of intrinsic deficits in skeletal muscle and liver to sex-specific perinatal 
programming of insulin resistance in this species (Chapter 4).  
Overall, these studies demonstrate that increasing litter size in the guinea pig results 
in asymmetrical IUGR. The spontaneously growth restricted guinea pig exhibits sex-specific 
programming of postnatal growth, appetite, adiposity and insulin sensitivity, occurring 
primarily in males, not unlike that in humans and other animal models. This therefore provides 
a model for investigating the causal mechanisms and effects of ageing on the perinatal 
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 Scope of the Literature Review 
In epidemiological and geographical studies, intrauterine growth restriction (IUGR) 
and faster rates of neonatal growth, or “catch-up” growth, following perturbed growth in utero 
are risk factors for the development of numerous cardio-metabolic disease states later in life. 
This is an example of developmental programming of adult disease, the concept that events or 
exposures in early life can alter the developmental trajectory of the individual and alter their 
health and disease risk in later life. This literature review focuses on the relationship between 
IUGR and metabolic dysfunction, with specific emphasis on evidence for prenatal 
programming of insulin resistance, type 2 diabetes mellitus (T2DM), the metabolic syndrome, 
and obesity in later life in human studies and in experimental animal models. Neonatal 
accelerated or catch-up growth following IUGR in humans is an additional risk factor for 
impaired glucose homeostasis and obesity later in life and the evidence for effects of neonatal 
catch-up growth on the perinatal programming of metabolic dysfunction and obesity in humans 
and animal models is therefore also considered in this review. Because there is increasing 
evidence for sex-specific programming of metabolic disease in humans and in animal models 
with IUGR and neonatal catch-up growth, this review also assessed the evidence for sex-






 Concept of Developmental Origins of Health and Disease (DOHaD) 
According to the World Health Organisation Global Status Report on Non-
Communicable Disease 2010, non-communicable diseases (NCD) accounted for 63% of all 
deaths in 2008 with nearly 80% of deaths from NCDs coming from low and middle income 
countries1. With an ageing population the annual NCD death rate is likely to be the leading 
cause of death in all countries by 20301. These NCDs include cardiovascular disease, 
hypertension, stroke, metabolic diseases, hyperlipidaemia, central obesity, insulin resistance, 
glucose intolerance, T2DM, respiratory disease and some infection-related cancers1. Over the 
last several decades historical and epidemiological studies have consistently demonstrated that 
IUGR, as indicated by a low birth weight or being disproportionately short or thin for 
gestational age, is associated with an increased risk of developing NCDs later in life2-4. These 
findings led to the concept of the “Fetal Origins of Adult Disease”, also known as the “Thrifty 
Phenotype Hypothesis”5-7 or “Barker Hypothesis” as Professor David Barker was one of the 
principal pioneers of the field8. The hypothesis has since been expanded to the “Developmental 
Origins of Health and Disease” (DOHaD) hypothesis, as peri-conception environment, size at 
birth, accelerated growth trajectories after birth and subsequent exposures are now all 
recognised as contributing to the risk of NCDs8-13.  
The DOHaD hypothesis states that a fetus growing in a sub-optimal environment 
makes physiological and biochemical adaptions to survive14. This plasticity of fetal tissues 
induced by sub-optimal conditions in utero results in “programmed” changes, at a phenotypic 
level by the alteration of organs, tissues and cell signalling pathways 2, 3, 14. These adaptations 
through developmental plasticity ensure survival in the short-term; however, a mismatch 
between the in utero conditions and the individual’s postnatal life-course may expose 
dysfunction of key tissues involved in homeostatic control 2, 14-16. Therefore, the growing field 
of DOHaD investigates the programming of specific physiological and biochemical systems 





for gestational age2, 14, 17-19. Further, the hypothesis now also considers subsequent postnatal 
exposures, including how the accelerated neonatal growth following exposure to in utero 
constraint leads to increased risk of chronic disease states, such as stroke, cardiovascular disease 
and T2DM2, 3, 14.  
 
 Intrauterine Growth Retardation (IUGR) 
According to American Congress of Obstetricians and Gynecologists guidelines and 
the World Health Organization Report 2006, IUGR is defined as a fetus with a weight below 
the 10th percentile for any given gestational age20, 21. Similarly, an IUGR infant is born with a 
birth weight below the 10th percentile for gestational age. However, this definition, which is 
also used to define small size at birth for gestational age (SGA), can overestimate IUGR 
pregnancies as infants with incorrect estimates of gestational age and those infants who are 
proportionally small, but have not suffered an insult in an adverse in utero environment will be 
included22. Low birth weight (LBW = birth weight <2500 g) is also often used as a surrogate 
marker for exposure to a restricted in utero environment, particularly in historical human 
cohorts, but is even more limited because it does not differentiate effects of IUGR from those 
of gestational age. IUGR pregnancies have a prevalence of 5–8% in the general population, 
whilst IUGR is a contributing factor in 10-15% of all pregnancies with complications20.  
IUGR has been further classified into two sub-classes based on phenotype at birth - 
symmetrical (20-30%) and asymmetrical (70-80%) growth restriction22, 23. Symmetrical, type I 
or proportionate IUGR refers to a proportionate growth restriction of all organs of the fetus, 
perhaps suggesting mild growth restriction throughout gestation, as growth potential for these 
individuals is normal22. Asymmetrical, type II or disproportionate IUGR reflects more severe 
growth restriction predominantly in late gestation where fetal growth has exceeded placental 
capacity23. This asymmetrical growth is due to fetal adaptation to the mismatched nutrient 





adrenals at the expense of visceral organs such as the pancreas, liver and skeletal muscle as well 
as limiting long bone growth23, 24. Thus, the asymmetrical IUGR infant is indicated by being 
light, short or thin at birth, with the common phenomenon of brain sparing indicated by 
increased head circumference relative to birth weight and to abdominal circumference25, 26. 
These asymmetrical IUGR infants have a higher risk of morbidity and mortality after birth27 
throughout childhood28, 29 and later in life2, 3, 8. 
 
 Mechanisms and Risk Factors for Small Size at Birth or Clinical IUGR 
 
Although factors of fetal origin, such as intrauterine infections and congenital 
abnormalities (Table 1-1), can result in profound growth retardation, the incidences of these are 
rare at 7% and 10% of all IUGR births respectively23. Congenital malformations, genetic errors 
in metabolism or rhesus-induced anaemia account for only a small percentage of IUGR cases; 
however, approximately 30-40% of all fetuses with major structural disorders or chromosomal 
abnormalities have IUGR21, 30, 31. The sex of the fetus also influences size at birth with males 
approximately 4% heavier than females32.  
 
 
Growth in utero is largely determined by a complex interaction between the fetal 
genome and the availability of nutrients supplied to the fetus33. Although both the father and 
mother make equal contributions to the fetal genome, and hence growth potential, birth weight 
is largely determined by maternal constraints to fetal growth mediated by the in utero 
environment and maternal nutrient supply34-36. This is clearly illustrated by results of 
experiments crossing large Shire horses and Shetland ponies. Lower birth weight of Shetland-
Shire cross offspring born to Shetland mothers when compared to those born to Shire mothers, 





Maternal factors (Table 1-1) may account for approximately 50% of all cases of 
IUGR in developing countries22, with most ultimately leading to a reduction in supply of 
nutrients to the fetus36. Therefore, factors that reduce available maternal nutrient availability, 
such as malnutrition and multiple concepti, account for most of the IUGR cases in developed 
countries. Severe nutrient deficiency during pregnancy, as occurs in times of famine or 
seasonally in developing countries, results in reduced weight at birth, especially if nutrient 
deficiency occurs in later gestation where fetal demand for nutrients is at its greatest38-40. 
Exposure to the famine in Holland (Dutch Famine) during World War II in the first, second or 
third trimesters decreased birth weight by 0.2%, 6.6% and 8.1% respectively, demonstrating 
the impact of inadequate nutrition in later pregnancy38. Similarly, exposure to a low protein, 
low calorie (~ 300 calories/day) diet in utero during the Leningrad siege in 1942 reduced 
average birth weights by 18% and 16% in males and females respectively41. 
Multiple gestation pregnancy is associated with a higher risk of IUGR. In humans, 
appropriate for gestational age (AGA) twins and triplets have -24% and -35% lower mean birth 
weights compared to AGA singletons42. Even in singletons regarded as SGA, twins and triplets 
are on average -4.5% and -18% lighter42. Reductions of other measures of size at birth are 
observed in AGA twins and triplets in abdominal circumference and crown to heel length 
compared to AGA and SGA singletons, while head circumference remains relatively conserved 
across all groups42. In addition to the effects of maternal constraint, individual twins within 
monochorionic twin pregnancies are at risk of IUGR due to the unequal sharing of placental 
surface area, blood flow, and therefore nutrient supply20. The growth of twins in utero deviates 
from that observed in singletons at 32 weeks31 while that of triplets deviates at 26 weeks42 
suggesting that nutrient availability, transfer or placental sufficiency in multiple births is 
impaired in late gestation. These observations suggest that offspring from multiple births 





Maternal condition and phenotype before conception can also alter size at birth. Birth 
weight is reduced by 2.5% for every 10 kg decrease in maternal pre-pregnancy weight and by 
1-2% for every 10 cm decrease in maternal height, presumably due to maternal growth 
competing for nutrients or increased uterine constraint32. Other maternal factors that may 
contribute to small size at birth or IUGR are previous history of an IUGR pregnancy, maternal 
age less than 16 years, ethnicity and stress during pregnancy22, 25, 32, 33, 43. 
Smoking is estimated to account for 40% of growth-restricted newborns, with one 
study reporting a decrease in birth weight by 5% for each pack of 25 cigarettes smoked per day 
during gestation32. Other drug use, prescription, illicit drugs, or alcohol can also lead to a 
reduced weight at birth; however, in developed countries these do not have as great an effect as 
that of smoking22, 36 and the effects may be mediated in part by other factors such as low/poor 
nutrition or disruption of placental function33, 36. 
 
 
Uterine infections and diseases such as endometriosis limit the potential uterine 
endometrial implantation area and therefore subsequent placental function. Damage to the 
uterine endometrium can also disrupt placental function later in the pregnancy. 
The major extrinsic determinant of fetal growth is nutrient transfer by the placenta44. 
Placental factors (Table 1-1) contribute to most IUGR in developed countries where no 
pathological cause is identified21, 31, 45, 46. The placenta is the lifeline of the fetus, allowing 
oxygen, amino acids, glucose and other nutrients to be transferred from, and by-products of 
metabolism to be transferred to, the maternal circulation47. Placental growth and metabolism 
also utilises maternal nutrients, and hence is a further drain on maternal supplies48. In many 
mammalian species size at birth correlates positively with placental weight, therefore placental 





IUGR babies have a small placenta46, 50 and placental transfer of nutrients across the placenta 
is reduced in IUGR pregnancies46.  
Pregnancy-induced hypertension (preeclampsia) can reduce placental surface area 
and therefore these pregnancies are at up to 4-fold increased risk of IUGR33, 51-53. Preeclampsia 
reduces birth weight by approximately 5% in its milder forms but the effect can be as great as 
10-12% in more severe cases22, 32, 51, 52, and in early-onset preeclampsia, birth weight is reduced 
by up to 23%52. Preeclampsia induces asymmetrical IUGR, with reductions of 4.4% in birth 
weight but less substantial effects on crown-heel length (0.8%) and ponderal index (2.6%) 
reported in one study51. 
The placenta also produces hormones and growth factors that govern metabolism of 
mother and fetus during pregnancy49, 54. Disruption to the normal functioning of the placenta 
through exposure to challenges such as low oxygen, malnutrition or toxins, or through physical 
effects, such as lesions, infarcts, abnormal placentation, or placental abruption therefore also 
have an impact on production of placental growth factors and hormones49, 54. Hence, placental 
development and function are major determinants of fetal growth and resultant size at birth.  
 
 
Most environmental factors only account for a small proportion of all IUGR. These 
include high altitude, pollution (smoking, heavy metals and other toxins), hyperthermia, quality 
of drinking water and irradiation21, 31, 55. Secondary or passive smoking decreased birth weight 
by -7.0% compared to -6.3% for maternal smoking56, indicating that environmental smoke 
exposure has as significant an impact on fetal growth as maternal smoking itself. Psychosocial 
environmental factors such as family size, education and access to health care largely impact 





Table 1-1 Factors contributing to small size at birth in humans 
 
Fetal Factors Chromosomal abnormalities (Trisomy) 
 Congenital malformation 
 Genetic metabolic errors 
 Fetal infections 
 Sex of the fetus 
 Rhesus induced anaemia (hypoxia) 
  
Maternal Characteristics Race/ethnicity 
 Small/short stature 
 Pregnancy (parity, multiple conceptus, interval) 
 Low pre-pregnancy weight, body mass index 
 Overweight/Obesity at conception 
 Delivery at age <16 or >35 years 
  
Maternal Lifestyle Malnutrition (amino acids, lipids, iron, iodine) 
 Low pregnancy weight gain (2nd and 3rd trimesters) 
 Drug use (smoking, alcohol, illicit and prescription drugs) 
 Severe chronic disease, infection or anaemia 
 Socio-economic disadvantage 
 Emotional, physical stress 
  
Uterine Factors Abnormalities (fibroids, malformation) 
 Disease (intrauterine infection, endometriosis) 
  
Placental Factors Abnormal placentation 
 Small placental size 
 Low uteroplacental blood flow 
 Impaired placental transport of nutrients 
 Placental pathologies (infarcts, haematomas) 
 Antepartum haemorrhage 
 Pre-eclampsia  
  
Environmental Factors High altitude 
 Hyperthermia 
 Quality of drinking water 
 Pollutants (smoking, irradiation, heavy metals, toxicants) 
 Other (family size, education, health care support) 





 Catch-Up Growth 
 
Most infants undergo accelerated growth termed “catch-up” after IUGR which 
occurs in the first few months of life57-59. This accelerated growth is primarily a gain in fat mass 
rather than long bone growth. While most IUGR children catch-up to some degree, 
approximately 15% of infants do not undergo this accelerated growth and 50% of all IUGR 
infants have short stature as adults57. Children who fail to catch-up or “fail to thrive” after IUGR 
have increased perinatal morbidity and mortality60, and neurodevelopmental delay during 
childhood61-63, compared to those with catch-up growth, which may persist into adult life. 
Despite the advantageous effects of catch-up growth following IUGR, catch-up is a risk factor 




Recent studies in humans show that insulin sensitivity at 48 hours of age67 and at 1 
year of age68 is greater in IUGR/SGA children than infants born with appropriate size at birth. 
Furthermore, infant insulin sensitivity is positively associated with growth in terms of weight68, 
suggesting that increased insulin action may stimulate growth in this catch-up growth period. 
In neonatal lambs, insulin sensitivity during catch-up growth is positively associated with 
growth in terms of both birth weight, and long bones69. Insulin stimulates growth during early 
postnatal life, acting on both the chondritic growth plate in long bones and on skeletal muscles 
and other soft tissues70, 71. Therefore, high insulin sensitivity and/or secretion during early 








Down-regulation of thermogenesis has been suggested as a means by which catch-
up growth, especially that of fat, can occur with or without hyperphagia, by creating a “thrifty 
metabolism”72, 73. In the longer-term, however, this thrifty metabolism and increased fuel 
conservation lead to insulin resistance and associated disease72. 
 
 
The DOHaD hypothesis states that fetal development has plasticity and therefore 
organs of higher immediate importance, like the brain and adrenals, are conserved over organs 
of lower importance for immediate survival. This redistribution of blood flow and therefore 
nutrients is achieved by the endocrine signalling of cortisol and catecholamines24, both of which 
reduce size at birth when delivered to fetuses experimentally74, 75. The reduction of blood flow 
limits glucose utilisation and growth of somatic tissues while increasing glucose uptake in 
adipose tissue and hence promoting relatively faster growth of adipose depots than skeletal 
muscle64, 76. Further insulin resistance of skeletal muscle and relative insulin hyper-
responsiveness in fat redirects storage of excess fuels to adipose tissue after IUGR which leads 
to increased fat gain during catch-up72. Consistent with these differential effects of prior 
restriction between tissues, adipose tissue has a greater insulin sensitivity than skeletal muscle 








Catch-up growth often occurs when restricted nutrient availability, as occurs in 
IUGR, is followed by hyperphagia in a relatively nutrient-rich environment. Experimental 
IUGR alters the balance of orexigenic and anorexigenic neuropeptides in the brain which tend 
to increase feed intake later in life77, 78. Later, insulin and leptin resistance also follow IUGR 
which further impairs the negative feedback for feed intake. Although evidence for this is 
limited in humans79, offspring of small animal models of maternal undernutrition, obesity and 





Systematic reviews have implicated catch-up growth following IUGR as an 
additional risk factor for the development of hypertension81, cardiovascular disease66, obesity64 
and dysfunction in glucose homeostasis such as insulin resistance65, 82, especially in individuals 
then challenged with a high caloric/fat diet as occurs in developed countries. Poor growth in 
utero and catch-up growth appear to induce adverse cardio-metabolic outcomes in adulthood, 
including insulin resistance81, 83-89, via independent mechanisms65, 82, 90. Catch-up growth may 
also be a mechanism for gender-specific programming as early life factors contributed to more 







 Determinants of Glucose Homeostasis: glucose effectiveness, insulin 
secretion and insulin sensitivity 
Blood glucose concentrations are controlled by insulin secretion, insulin sensitivity 
of the target tissues, and by glucose effectiveness, the intrinsic action of glucose on its own 
metabolism91. In individuals with insulin resistance, the pancreas initially hyper-secretes insulin 
to compensate for the impaired responsiveness at the target tissue92, usually due to impaired 
post-receptor signalling. Hyperglycaemia and overt T2DM occur when the pancreas can no 
longer sustain this compensatory hypersecretion of insulin92. Humans with T2DM have reduced 
glucose effectiveness in addition to their insulin resistance and impaired insulin secretion which 
together impair glucose homeostasis93, 94.  
 
 
Glucose effectiveness is the ability of glucose to auto-regulate the suppression of 
endogenous glucose production and enhance glucose uptake to control its intrinsic metabolism 
under basal insulin conditions (independent of insulin’s actions)95, 96. Increased glucose 
availability under basal or steady insulin concentrations increases glucose storage in the liver 
by the induction of glucokinase and glycogen synthase while impairing enzymes of 
gluconeogenesis96. Additionally, GLUT4 translocation in skeletal muscle can be induced by 









Insulin is secreted by β-cells in the pancreas in response to a high nutrient 
concentration in blood (summarised in Figure 1-1). Insulin is contained in vesicles within the 
β-cell as a prohormone containing C-peptide. After a meal, circulating concentrations of 
nutrients including glucose, amino acids and free fatty acids are high and these are taken up 
into the β-cell to stimulate insulin and C-peptide secretion. The major stimulus for the release 
of insulin is increased concentrations of glucose in blood. In rodents, glucose enters the β-cell 
through the high capacity glucose transporter type 2 (GLUT2)97; however, other glucose 
transporters may also be involved, as fetal islets of GLUT2 knockout mice do not have impaired 
insulin secretion98. In the human pancreas, GLUT1 and GLUT3 are the main glucose 
transporters in the β-cell99. Once glucose is phosphorylated to glucose-6-phosphate, it is then 
metabolised down the glycolytic, citric acid cycle to produce the high redox potential molecules 
NADH and FADH2. These enter the electron transport system leading to an increase in the 
intracellular ATP/ADP ratio. Metabolism of amino and keto acids in the citric acid cycle and 
free fatty acids (FFA) via β-oxidation also increase ATP concentrations. The increase in ATP 
activates the prohormone convertase required for the cleavage of insulin from proinsulin. This 
relative increase in ATP also deactivates (closes) the ATP sensitive potassium channels, 
resulting in a depolarisation of the β-cell. This in turn activates voltage-gated calcium channels 
allowing extracellular Ca++ to enter the cell and act as a second messenger to initiate the 
exocytosis of insulin from its vesicles. Intracellular conversion of FFA to malonyl CoA may 
also act directly on protein kinase C and diacylglycerol, which in turn act to release Ca++ from 








Figure 1-1 Mechanisms of Stimulus-Secretion Coupling of Insulin in Humans 
 
GLUT 1/2/3, Glucose transporter 1/2/3 isoforms;    LPL, Lipoprotein lipase;  
NADH, Nicotinamide adenine dinucleotide (reduced form)  CoA Coenzyme A; 
FADH2, Flavin adenine dinucleotide (hydroquinone form)  FFA, Free Fatty Acids; 
ATP, Adenosine triphosphate;       Membrane Potential 
⊕ Stimulatory  ⊝	Inhibitory 






Other stimuli for insulin secretion are gastrointestinal hormones such as GLP-1101, 
acetylcholine102, 103, and drugs including the sulfonylureas104, 105. Acetylcholine and the 
sulfonylureas increase intracellular Ca++ to initiate exocytosis of insulin via differing 
mechanisms. Acetylcholine activates inositol triphosphate-dependent mobilization of 
intracellular Ca++ 99, 100 while the sulfonylureas inhibit the K+-ATP channels leading to 
activation of the voltage gated Ca++ channels and influx of Ca++ from extracellular fluid104, 105.  
Glucose supply from the diet varies substantially throughout 24-hours from low 
concentrations during periods of complete fasting to high concentrations during postprandial 
glucose loads. In the basal (fasted state) the brain is the primary user of glucose, with other 
tissues using alternative fuels such as lipids, amino acids and proteins. With high insulin 
concentrations, as occur after a meal, whole body glucose utilisation is increased with skeletal 
muscle contributing substantially to the rise in glucose utilisation106. Glucose concentrations in 
blood are controlled primarily by insulin. The diverse actions of insulin that range from growth 
and differentiation in fetal life to carbohydrate, lipid and protein metabolism in postnatal life, 
are made possible by the extensive post-receptor signalling cascades in insulin sensitive tissues 
(Figure 1-2). Insulin’s main actions are to inhibit endogenous glucose production by the liver 
and to stimulate glucose utilisation in peripheral tissues like skeletal muscle and adipose 









Figure 1-2 Summary of the Insulin Signalling Pathway 
 
IRS, Insulin Receptor Substrate;    PI3K, phosphatidylinositol 3-Kinase,  
PIP3, Trisphosphorylated inositol;    AKT, product of the AKT protooncogene;  
PKC, Protein Kinase C;     GSK3, Glycogen Synthase Kinase 3;  
FKHR, Forkhead in Human Rhabdomyosarcoma;  GLUT4, Glucose Transporter 4. 
p70S6K, Ribosomal protein S6 kinase beta-1 







When insulin binds to its tyrosine kinase receptor, the receptor dimerises to initiate 
the phosphorylation of the tyrosines on the intracellular domain of the receptor. This in turn, 
initiates the post-receptor insulin signalling pathway by the phosphorylation of the insulin 
receptor substrate (IRS), first the protein of insulin transduction signalling (Figure 1-2). IRS 
activates the p85a and p110 subunits of phosphatidylinositol 3-Kinase (PI3K) to activate 
Product of the AKT protooncogene (AKT) or protein kinase B (Figure 1-3). This initiates the 
translocation of GLUT4 to increase glucose uptake in insulin responsive tissues like skeletal 
muscle (major, Figure 1-3) and adipose tissue (minor, Figure 1-5). Phosphorylation of AKT 
activates other downstream cascade pathways increasing protein (skeletal muscle), and 
glycogen (skeletal muscle and liver) synthesis while suppressing endogenous glucose 
production by the liver (major, Figure 1-4) and kidney (minor).  
 
 
Insulin’s primary tissue targets are skeletal muscle, adipose tissue and the liver. In 
muscle, the primary action of insulin is to activate glucose, amino acid and fat uptake to increase 
utilisation for ATP production and storage of glucose as glycogen, protein synthesis, and 
intramuscular fat deposition. In adipose, insulin acts to store glucose, FFA and amino acids as 
fats and triglycerides. In liver, insulin acts to inhibit glucose production via gluconeogensis and 
glycogenolysis while stimulating glycogen synthesis. Insulin receptors are also found in the 
brain and in the kidney.  
 
 
Skeletal muscle is one of the major target tissues of insulin (Figure 1-3). Insulin’s 
main action in muscle is to increase the rate of glucose uptake by stimulating translocation of 





blood109. On binding to its receptor, insulin stimulates the formation of the second messenger 
phosphatidylinositol (3,4,5)-trisphosphate (PIP3) through the interaction of IRS and PI3K. PIP3 
initiates many phosphorylation cascades resulting in a net increase in glucose uptake and 
utilisation for energy and storage within the muscle cells (Figure 1-3). PIP3 activates protein 
kinase C (PKC) facilitating the translocation of intracellular vesicles containing GLUT4 to the 
cell membrane, where GLUT4 can facilitate glucose uptake into the cell. Insulin also influences 
metabolic processes within skeletal muscle through the up-regulation and/or activation of 
signalling pathways, through the dephosphorylation of key rate limiting enzymes involved in 
both storage of glucose as glycogen and utilisation of glucose for energy through glycolysis. In 
addition, other enzymes such as phosphoenolpyruvate carboxykinase (PEPCK), which is 
involved in the production of glucose-6-phosphate via gluconeogenesis, are inhibited by 
insulin. Insulin and the increased intracellular glucose-6-phosphate concentration also lead to 
activation of fatty acid synthesis and an increased intracellular pool of FFA. PIP3 also acts on 
lipoprotein lipases to cleave and facilitate the uptake of FFAs from circulating lipoproteins in 
the blood. In addition, other fatty acid transporters like fatty acid translocase/cluster of 
differentiation 36 (FAT/CD36) can be translocated to the cell membrane from intracellular 










Figure 1-3 Mechanism of Insulin Action in Skeletal Muscle 
 
IRS, Insulin Receptor Substrate;   PI3K, phosphatidylinositol 3-Kinase;  
PIP3, Trisphosphorylated inositol;   LPL, Lipoprotein Lipase;  
FFA, Free Fatty Acids;    ATP, Adenosine Triphosphate; 
G-6-P, Glucose-6-Phosphate;   GLUT4, Glucose Transporter 4. 









































Liver and kidney are the only two tissues that contain significant amounts of glucose-
6-phosphatase, the enzyme responsible for the conversion of glucose-6-phosphate to glucose111. 
Liver is also a major site of storage of glucose as glycogen. Therefore the liver is able to regulate 
the concentrations of blood glucose by its storage via glycogenesis and its release via 
gluconeogenesis and glycogenolysis97. 
Glucose transport into the liver is not controlled by insulin as the major glucose 
transporter in liver is GLUT2, and to a minor extent GLUT1, and these are not insulin 
responsive109. GLUT2 is a low affinity, but high capacity, glucose transporter making it well 
suited to a tissue such as the liver, where the role is to facilitate both uptake and efflux of glucose 
depending on hormonal and nutritional status97. Insulin increases storage of glucose as glycogen 
in the liver, by the activation of glycogen synthase and deactivation of glycogenolysis within 
the hepatocytes (Figure 1-4). Similar to skeletal muscle, insulin binding to its receptor 
stimulates the formation of the second messenger PIP3 through the interaction of the IRS and 
PI3K, which initiates many phosphorylation cascades resulting in a net increase in glucose 
storage and inhibition of glucose production by the hepatocytes. Insulin sensitive enzymes like 
fructose-1,6-phosphatase and PEPCK, the rate limiting enzyme in the gluconeogenesis 
pathway, are inhibited by insulin to reduce the conversion of amino acids to glucose-6-
phosphate111. By inhibiting glucose-6-phosphatase, insulin inhibits the formation of glucose 
and thus decreases hepatic glucose production. In addition, insulin stimulates fatty acid 
synthesis, converting glucose to FFAs, which are then mobilised to lipoproteins in the 











Figure 1-4 Mechanism of Insulin Action in the Liver 
 
IRS, Insulin Receptor Substrate;    PI3K, phosphatidylinositol 3-Kinase,  
PIP3, Trisphosphorylated inositol;    FFA, Free Fatty Acids;  
GLUT2/1 Glucose transporter isoforms 2 and 1 
⊕	Stimulated by the action of insulin.  ⊝	Inhibited by the action of insulin. 































Like the liver, the kidney contains glucose-6-phosphatase, the enzyme responsible 
for the conversion of glucose-6-phosphate to glucose, and is the main extra-hepatic site of 
gluconeogenesis111, 112. However, the kidney only produces a significant amount of glucose 
after prolonged starvation, providing about 10% of total blood glucose111, while others report 
figures from 5%-30% in the postprandial state112. Therefore, in physiological conditions the 
liver is the primary source of endogenous glucose production111. In addition, the production of 
glucose by the kidney is increased in the postprandial state when insulin and glucose 
concentrations are high, suggesting that, unlike the liver, insulin does not have a major role in 
suppressing glucose production in this tissue113.  
 
 
Insulin’s primary action in adipose tissue is to increase the rate of glucose uptake by 
the increased translocation of the insulin-sensitive GLUT4 to the cell surface109. Insulin also 
acts on lipoprotein lipases in the membrane, which increases the uptake of FFA into the cells. 
The increased intracellular glucose and FFA are stored as triglycerides in adipose cells (Figure 
1-5). The action of insulin on adipocytes leads to decreased circulating FFA, which in turn has 
an indirect effect on the liver to reduce hepatic glucose production97. 
 
 
The brain contains insulin receptors, with high concentrations reported in the 
olfactory bulbs, hypothalamus and hippocampus of the guinea pig, rat and human brain114-116. 
Insulin has many actions as a neuropeptide in the brain, including modulation of appetite, 
peripheral metabolism, and behaviour117, 118. Central administration of insulin into the 
ventricular space acts as a positive feedback for pancreatic insulin release119, 120. One important 





centrally-available insulin acts to suppress appetite and therefore reduces fat mass117. In rats, 
direct infusion of an antisense oligodeoxynucleotide targeting mRNA of the insulin receptor 
into the third ventricle of the brain specifically reduces hypothalamic insulin receptor number, 
causes hyperphagia and obesity and attenuates hepatic but not peripheral insulin sensitivity121. 
Therefore, insulin resistance of the brain may also act indirectly on the liver via increased 
glucose and FFA availability in the blood leading to the accumulation of further adipose tissue 
as well as the direct central actions on nutrient intake, obesity and impaired positive feedback 
on insulin secretion.  
 
 
Insulin action on glucose metabolism has two determinants; the amount of available 
insulin at the receptor (insulin secretion) and the sensitivity of the receptor and post-receptor 
events to initiate insulin’s actions in its target tissue (insulin sensitivity). Failure of both factors 
are known contributors to the risk of the development of T2DM122. Multiplication of insulin 
secretion and insulin sensitivity indices gives the insulin-stimulated glucose disposition index 
(DI) which is constant for individuals with the same degree of glucose tolerance. The DI can 
also be used to evaluate the efficacy of glucose homeostasis via assessment of an individual’s 
ability to increase β-cell insulin secretion as insulin sensitivity decreases123. The DI can 
determine if an individual has impaired insulin secretion relative to their insulin sensitivity, 









Figure 1-5 Mechanism of Insulin Action in Adipose Tissue 
 
IRS, Insulin Receptor Substrate;   PI3K, phosphatidylinositol 3-Kinase,  
PIP3, Trisphosphorylated inositol;   LPL, Lipoprotein Lipase;  
FFA, Free Fatty Acids;    GLUT4, Glucose Transporter 4;  
Acetyl CoA, Acetyl Coenzyme A.  


































 Failure of Glucose Homeostasis - Type 2 Diabetes Mellitus 
T2DM is an inter-organ disease where failure of insulin action (insulin resistance) at 
skeletal muscle, adipose tissue and liver, impaired insulin secretion from the pancreas and 
impaired glucose effectiveness are all involved in the loss of glucose homeostatic control107, 124, 
125. Although insulin resistance in skeletal muscle is the primary defect and may develop 
decades prior to the total failure of insulin secretion it is estimated that those with T2DM have 
a reduction in their insulin secretion output by up to 50%, independent of their current insulin 
resistance126, 127. Therefore, failure to maintain an appropriate insulin secretion response, 
relative to the sensitivity of the insulin target tissues, or the insulin disposition index, is crucial 
to the pathogenesis of T2DM122. 
Obesity due to a sedentary lifestyle and high caloric diets are the major risk factors 
for the metabolic syndrome of which T2DM is one of the primary components124, 128. FFA 
release from the increased adipose depots leads to an accumulation in skeletal muscle and liver 
which can down regulate insulin receptor numbers126. FFAs are an alternate fuel source for 
skeletal muscle and therefore high circulating FFAs impairs glucose utilisation by muscle128-
130. In addition, elevated FFAs induce apoptosis of β-cells which reduces the compensatory 
hyperinsulinaemia associated with insulin resistance128, 130, 131. FFAs further impair insulin 
sensitivity in skeletal muscle, adipose tissue and liver by impairing peripheral glucose uptake 
and inhibiting endogenous glucose production, stimulating hepatic gluconeogenesis flux rate 
and reducing glucose-induced glucose uptake in skeletal muscle, assessed during a 
hyperinsulinaemic-euglycaemic clamp132-135. In addition, adipokines such as resistin and TNF-
α, which are elevated in obesity, alter insulin signalling in target tissues perhaps via 
downregulation of tyrosine kinase activity107, 136, 137. Therefore, high adiposity especially central 
adiposity and FFA leads to a resultant systemic insulin resistance by reducing insulin secretion 





Due to chronic hyperglycaemia, even in the fasted state, glucose uptake is high into 
cells that express glucose transporters that are non-insulin dependent glucose transporters (not 
GLUT4) including, smooth muscle, cardiac muscle, macrophages, and endothelium138. This 
leads to increased levels of pyruvate entering the citric acid cycle and thus over-production of 
the high redox potential molecule NADH. This in turn elevates H2O2 and other reactive oxygen 
species in the mitochondria of these tissues138. Hyperglycaemia also increases advanced 
glycation end products as up to 35% of glucose is metabolised using alternate pathways such 
as the polyol pathway138. Once oxidised, these reactive oxygen species and advanced glycation 
end products further cause oxidative stress to tissues, contributing to the mitochondrial 
oxidative stress of T2DM and the associated vascular disease, poor endothelial function and 
low immune function138. 
 
  Measuring Indices of Glucose Homeostasis in vivo 
 
Probably the simplest way to directly assess insulin action in vivo is the insulin 
tolerance test (ITT)139, which involves a bolus intravenous (i.v.) injection of insulin to induce 
glucose disappearance from the blood139, 140. The ITT has been criticised as a clinical measure 
of insulin sensitivity due to the unpleasant symptoms of hypoglycaemia, as well as the potential 
for counter-regulatory effects of the hypothalamic-pituitary-adrenal axis via the release of 
cortisol and growth hormone to suppress glucose disappearance rates139. Importantly this 
method has been modified to include intraperitoneal injections of insulin enabling its use in 
small animals such as mouse, and results show good agreement with insulin sensitivity 







The hyperinsulinaemic-euglycaemic clamp (HEC) is considered the gold-standard 
method to assess insulin sensitivity in vivo. The method utilises a continuous infusion of insulin, 
either at a single or in a sequential series of infusion rates, with a variable glucose infusion rate 
(GIR) to maintain glucose levels at the basal (fasting) concentration measured prior to the 
insulin infusion. The GIR required at steady state to maintain euglycaemia during the insulin 
infusion (calculated using a previously published algorithm) provides an index of insulin 
sensitivity142.  
One advantage of the HEC over the insulin tolerance test as a method to measure 
response to insulin is that by maintaining plasma glucose concentrations during insulin 
stimulation the side effects of hypoglycaemia are alleviated142. In addition, the neuroendocrine 
homeostatic mechanisms that occur in response to hyperglycaemia are also reduced142. The 
HEC is an accurate measure to quantify insulin sensitivity and since only small blood samples 
are required for checking of euglycaemia it has been established and used extensively in a 
number of experimental animal models, including rats143-145 and mice146-148 and in non-human 
primates such as rhesus monkeys149-153 and baboons154. Continuous infusion of [3-3H]-glucose 
tracers prior to and during HEC allows assessment of rates of glucose utilisation, glycolysis and 
of storage, primarily by skeletal muscle, as well as the rate of endogenous glucose production, 
primarily by the liver, in the basal and insulin-stimulated states142, 145, 152. 
The main disadvantages of the HEC is that due to its complexity, it is a costly, labour 
and time intensive test155. When glucose tracers are used, larger blood volumes are required, 
which, when combined with the frequent blood samples required for monitoring blood glucose 
levels, can be a disadvantage for use in small animal models. In addition, surgical 
catheterisation is required therefore, experiments immediately following surgery may induce 
stress responses, or acute experiments are performed under anaesthesia both of which alter 







The hyperglycaemic clamp is similar to that of the HEC except that a bolus of glucose 
is infused acutely to achieve a rise in plasma glucose levels of 125 mg/dl above basal levels142. 
This raised glucose set point is then maintained by a variable glucose infusion throughout the 
clamp142. Because the glucose concentrations are constant during the clamp the amount of 
glucose infused is a measure of glucose metabolism142. The hyperglycaemic clamp can quantify 
the response and therefore the sensitivity of the β-cell to a rise in glucose, the early and late 
phases of insulin release can be measured independently and whole body glucose metabolism 
can be assessed142. The main disadvantages of the hyperglycaemic clamp are those of the HEC. 
The hyperglycaemic clamp like the HEC is a costly, labour and time intensive test as well as 
posing problems for small animal models as significant blood volumes may be required in 
assessing glucose metabolism over a time course142, 155.  
 
 
The glucose tolerance test (GTT) is a simple in vivo test used clinically to determine 
if an individual is glucose tolerant (x <7.8 mmol/l), intolerant (7.8 mmol/l > x < 11.1 mmol/l) 
or diabetic (x > 11.1 mmol/l) where x is the glucose concentration 2-hours post the glucose 
load157. Glucose is given as a bolus load, either intravenously (IVGTT) or orally (OGTT). 
Measurement of insulin concentrations during a GTT allows assessment of insulin secretion in 
response to a glucose challenge. This provides an index of pancreatic and therefore β-cell 
responsiveness to high circulating plasma glucose. The GTT operates on the principle that 







The OGTT is a simple test that involves administration of an oral glucose load, 
typically of 75 g in humans, following an overnight fast158. Blood samples are collected at 0 
(basal), 30, 60, and 120 minutes to determine profiles of glucose clearance and insulin 
responsiveness158. The glucose load is sometimes given as a meal, known as a meal tolerance 
test (MTT), which mimics more closely the physiological, postprandial condition155. The oral 
minimal model is a computation method that enables the estimation of insulin sensitivity, β-
cell function and hepatic insulin extraction based on the results from the OGTT158. A 
disadvantage of the OGTT and MTT is the assumption that there is low inter- and intra- 
individual variation in the absorption of glucose159. In addition, due to variations in oral glucose 
loading regimens used experimentally between species and within the same species 




The frequently sampled IVGTT typically involves a schedule of either fifteen 
samples to 180 minutes or twenty-six samples to 240 minutes after an i.v. bolus of glucose at 
0.3-0.5 g.kg-1164. The 15-sample schedule has become more accepted in large cohort 
experiments in humans164. The frequently sampled IVGTT utilises the glucose and insulin 
profiles over the 3 to 4-hour glucose tolerance test to indirectly calculate glucose effectiveness 
and insulin sensitivity using the minimal model technique as described by Bergman et al91, 159, 
165, 166. The main advantage of the IVGTT over the OGTT is it avoids the uncertainty of gastric 
emptying and thus reduces the effects of variable gastric/intestinal motility rates, and therefore 
glucose absorption rates, on outcome measures159. However, this test requires additional care 
due to the use of iv glucose and heparinised saline infusions as well as insertion of a catheter 







Fasting insulin concentration and the fasting glucose to insulin ratio are also utilised 
as measures of glucose homeostasis and insulin sensitivity in vivo91, 167. A general advantage of 
these indices is that they rely on measurement of glucose and insulin in a single blood sample 
following an overnight fast, hence they provide a simple, inexpensive assessment of insulin 
resistance especially in large clinical studies where direct measures such as the HEC may not 
be feasible. In the fasting state glucose is in homeostasis, with endogenous glucose production 
by the liver, and to a small degree by the kidney, balanced with whole-body glucose disposal. 
Therefore, the level of insulin secreted under fasting conditions reflects the sensitivity of the 
peripheral tissues for insulin dependent glucose disposal (mainly skeletal muscle). Calculation 
of fasting glucose to insulin ratio is also used as a measure of insulin resistance as it gives a 
measure of glucose control for a given insulin secretion. 
However, calculating insulin action indirectly using fasting concentrations does not 
differentiate low insulin secretion due to a relatively high insulin sensitivity of the tissues from 
individuals with failing β-cells and therefore reduced insulin secretion. Therefore, as glucose 
tolerance and insulin sensitivity decreases with ageing and the progression of β-cell exhaustion 
leads to diminished compensatory hyperinsulinemia the correlation of insulin sensitivity 
measured directly by HEC with that assessed by fasting insulin loses strength. Independent 
measures of both insulin secretion and sensitivity are required to determine relative secretion 
to sensitivity or insulin-stimulated glucose DI as calculated by the multiplication of insulin’s 







The homeostatic model assessment (HOMA) or the updated HOMA2 uses paired 
fasting insulin and glucose concentrations to calculate insulin sensitivity and insulin secretion 
through a computer derived simulation based on feedback mechanisms167, 168. The HOMA 
insulin resistance (HOMA-IR) model correlates reasonably well with insulin sensitivities 
derived from HEC in adults without severe impairment of glucose homeostasis167, 168. However, 
this correlation becomes skewed when selecting those with either high insulin sensitivity or 
with severe impairment such as in T2DM155.  
 
 
The quantitative insulin sensitivity check index (QUICKI) is a computer modelled 
calculation of insulin sensitivity using the inverse of the sum of the logarithms of basal glucose 
and log of insulin concentrations169. With ageing and in diabetic patients the glucose to insulin 
ratio begins to rise due to the loss of compensatory insulin secretion. Using the inverse of the 
sum of the logarithms reduces these standard errors of the high glucose to insulin ratio measures 
in these cohorts169.  
 
 Prenatal Programming of Glucose Metabolism in Humans 
 
Historical and geographical evidence provided the initial evidence for the prenatal 
origin of impaired glucose homeostasis and subsequent disease170, 171. Offspring subjected to 
the Dutch Winter famine in late gestation, when fetal growth is at its greatest, are small at birth 
and as adults have increased risk of impaired glucose tolerance, T2DM and the metabolic 
syndrome compared to those not affected by famine or exposed in early gestation only172. This 





later in life. These effects of famine on later glucose homeostasis have been supported by 
studies of other war-time and famine cohorts173.  
Geographical studies predominantly carried out in England and Wales have shown 
that areas of low socio-economic status, in industrial areas to the north of England and lower 
socio-economic status to the west, had the highest rates of cardiovascular disease in adults aged 
35-71 years in 1968-1978171. When compared to the infant death rate (1901-1910) in the same 
geographical zones, areas of higher rates of infantile death had higher rates of cardiovascular 
disease in later life171. This is consistent with correlation analysis of areas of high perinatal 
death rates today and mortality from stroke in the USA174, 175. This “Stroke Belt” occurs in the 
lower southern states, which are the lower socio-economic areas of the USA174, 175. 
These studies of famine and effects of socio-economic status on both perinatal 
outcomes and adult disease rates have given insight into the link between associations of early 
environment and diseases in later life171-175. Several studies since have assessed individual 
measures of size at birth in numerous cohorts around the world and have confirmed these 
associations across the normal spectra of size at birth. This has led to systematic reviews65, 176-
178 assessing the overall impact of small size at birth on later insulin sensitivity and glucose 
metabolism. Several systematic reviews have now shown that small size at birth is associated 
with increased risk of insulin resistance, T2DM and the metabolic syndrome later in life65, 176-
178.  
The systematic review carried out by Newsome et al in 2003176 showed that the link 
between low birth weight and a risk of impaired glucose homeostasis was consistent across 
multiple published studies, however, this review did not discriminate between small size at birth 
due to prematurity and that due to IUGR176.  
A systematic review by Harder et al in 2007 examined the shape of the association 
of birth weight and subsequent risk of T2DM178. Some previous studies report a linear 





protection against such risk. However, Harder et al (2007) report a J- or U-shaped relationship 
with both extremes in birth weight having increased risk of T2DM178 and this has also been 
supported in other systematic reviews177, 178. Most recently, Whincup et al 2008 confirmed that 
the adverse effects of low birth weight on risk of T2DM persisted even after correction for 
gestational age and current socioeconomic status177.  
These systematic reviews reveal that the associations of insulin resistance, glucose 
intolerance, T2DM or the metabolic syndrome with measures of small size at birth occur across 
the normal range in size at birth, and not only in IUGR individuals176-178. The systematic 
reviews by Whincup et al 2008 and Harder et al 2007 also give information on the shape of the 
resultant J or U-shaped relationship177, 178. This implies that being at the high extreme of birth 
weight is a risk factor rather than protective against metabolic disease. Exposure to maternal 
diabetes or obesity in utero are risk factors for the development of T2DM, obesity and the 
metabolic syndrome in childhood179-182, thus being large for gestational age due to nutrient 
excess in utero may also contribute to developmental programming of T2DM and metabolic 
dysfunction. 
Other hypotheses linking low birth weight to later adult disease propose a genetic 
link. As insulin is a potent growth factor in utero, genetically determined insulin resistance 
would be expected to result in both a reduced size at birth and a predisposition to T2DM later 
in life. However, although in Pima Indians, a population “genetically” prone to T2DM, LBW 
individuals are thinner at ages 5-29 years, they are more insulin resistant relative to their body 
size than those of normal birth weight181. Studies in twins have also given some insight as to 
the genotype versus phenotype contributions to T2DM, although the use of twins in such studies 
has received some criticism183. In monozygotic twins discordant for T2DM, the twin with adult 
T2DM had a lower birth weight compared to the one without184. In dizygotic twins where both 
twins have T2DM as adults the twin with the lowest birth weight had the highest fasting plasma 





solely account for the incidence of T2DM, and that intrauterine events, in part, program glucose 
metabolism in later life. Overall, these studies demonstrate that low birth weight is an important 
contributor to the risk of developing diseases later in life. Therefore, the underlying mechanisms 
that mediate the effects of early life environmental determinants of impaired glucose 
homeostasis and T2DM require further investigation so that interventions can be developed.  
 
 
Few studies have examined the effects of IUGR on glucose effectiveness. In young 
adults, glucose effectiveness was increased in males who were light or short at birth but no 
association with size at birth was found in females185. In pre-pubertal children, glucose 
effectiveness was unaltered in short children following IUGR compared to controls186. 
Therefore, these studies suggest that reduced glucose effectiveness is not contributing to 
impaired glucose homeostasis following IUGR, at least in younger cohorts. 
 
 
Many studies to date have utilised the gold standard HEC187-199, minimal model 
techniques185, 199-208, basal plasma insulin to glucose concentrations208, 209, or the ITT210 to 
examine associations between size at birth and insulin sensitivity. Overall, systematic reviews 
have shown that in the majority of studies there is a positive correlation between adult insulin 
sensitivity and size at birth176. In individuals over 50 years of age, the development of obesity 
strengthens the association of size at birth with insulin sensitivity187, 201, 210. In the age group 
from 30-50 years, two studies have shown a reduced insulin sensitivity with decreasing size at 
birth using the minimal model202 and HEC188 techniques. Another study showed no association 
between birth weight and insulin sensitivity in this age group using the minimal model 
approach, however204. Similar associations of impaired insulin action with reduced size at birth 





associations in only females205, or only males185 or have found no effects of size at birth on 
insulin sensitivity in this age group199. Insulin sensitivity in IUGR children is enhanced after 
birth and up to 1 year of age, which may explain in part the increased rates of growth or catch-
up67, 68. After the catch-up period, a positive correlation of insulin sensitivity with size at birth 
following IUGR is also evident as early as four years of age suggesting that there is an early 
switch in insulin sensitivity85, 192, 208, 211, 212. However, one study in Indian neonates showed 
impairment in insulin sensitivity and increased adiposity present at the time of birth rather than 
a switch initiated by catch-up213. Therefore, the variability in the direction of the correlation of 
size at birth with insulin sensitivity depends on the age group of the children tested and 
ethnicity. In IUGR neonates, insulin sensitivity may still be enhanced when insulin sensitivity 
is assessed in the catch-up growth phase67, 68. In contrast when catch-up growth is complete, 
which would be the case in studies of four-year-old children, IUGR consistently predicts 
impaired insulin sensitivity directly using HEC192, 212 or indirectly using HOMA85 or insulin 
and /or glucose to insulin rations208, 211. One longitudinal study in children from birth to three 
years showed that IUGR infants transition from an insulin sensitivity to an insulin resistant state 
in their first three years of life214. This suggests that at birth and in the early catch-up growth 
phase insulin sensitivity is high in IUGR infants; however, in childhood with the effects of 
ageing and other lifestyle events, the associations are reversed such that associations between 
impaired insulin sensitivity and IUGR are enhanced. 
 
 
In young adults to 30 years, six of nine studies185, 205, 207, 215-217 describe a negative 
association between fasting insulin concentrations and size at birth, while one showed no 
relationship199 and two showed a positive relationship206, 218. One study in young adults (20-21 
years) examined males and females separately185 and showed that fasting insulin concentrations 





insulin secretion was negatively correlated with birth weight and length in males but not in 
females suggesting a sex-specific onset of alterations in insulin secretion and action185. Three 
of seven studies directly measuring insulin secretion found no association with size at birth199, 
200, 217, two described a negative association189, 205 and two a positive association206, 218. Most of 
the studies measuring insulin secretion have not measured insulin resistance independently. In 
those studies where insulin sensitivity has also been measured, IUGR predicts impaired insulin 
secretion relative to insulin sensitivity195. Therefore, the variability between these studies may 
reflect changes in insulin resistance and the capacity for compensatory increases in insulin 
secretion between cohorts.  
With ageing the correlations between insulin secretion and size at birth begin to 
become more consistent. In adults with mean ages of 30 to 50 years, all five studies describe a 
negative association between fasting insulin concentrations and size at birth203, 219-222. Four 
studies assessed glucose stimulated insulin secretion in this age group (30 to 50 years) and all 
found negative associations between insulin secretion and size at birth201, 203, 223, 224, suggesting 
that the pancreas is compensating for an impaired insulin sensitivity in this age group. These 
negative associations of size at birth with basal insulin concentrations and insulin secretion after 
a glucose load in the 30 to 50-year-old age group are more consistent with prenatal 
programming of insulin resistance rather than β-cell insufficiency and reduced insulin secretion.  
Many studies have assessed both basal insulin concentrations and insulin secretion 
directly during OGTT/IVGTT to examine the associations with size at birth. In studies of adults 
with mean ages from 50 to 70 years, six of seven studies65, 184, 201, 225-227 described negative 
associations between fasting insulin concentrations and size at birth while only one228 showed 
no association. In studies where the mean age tended to be older (~65 years) the negative 
associations of birth size with fasting insulin were stronger suggesting that the 
hyperinsulinaemia was still present and that IUGR adults maintained hypersecretion of insulin, 





Nevertheless, in IUGR children where insulin-stimulated glucose disposition has 
been measured, insulin secretion relative to insulin sensitivity is reduced, suggesting that the 
ability of the β-cell to compensate for the insulin resistance adds to the risk of T2DM later in 
life212, 214. Therefore, the effects of insulin resistance and relative β-cell secretory capacity 




Skeletal muscle is the major tissue that determines glucose uptake92 and primarily 
utilises glucose by storage to glycogen rather than oxidation to ATP with increased insulin 
stimulus106. The majority of human studies demonstrate a positive correlation between size at 
birth and whole body insulin sensitivity176. However, although IUGR reduces lean tissue, an 
index of skeletal muscle mass229, muscle mass itself does not correlate with insulin 
sensitivity230. This suggests that the effects of small size at birth on insulin sensitivity involve 
intrinsic alterations in insulin responses of skeletal muscle, rather than simply being mediated 
by changes in total muscle mass230.  
In IUGR humans, insulin sensitivity of skeletal muscle is impaired189-191, 194-199 and 
altered expression of insulin signalling genes in skeletal muscle may in part contribute to this 
decline in insulin action190, 196, 198, 229, 231-238. Genes that have reduced expression in human 
skeletal muscle following IUGR include GLUT4, and the post-receptor signalling proteins 
protein kinase C-ζ, and the p85α and p110β subunits of phosphoinositol 3-kinase190, 196, 198, 229, 
231-238. These studies further support a role for intrinsic alterations in skeletal muscle following 
IUGR leading to impaired insulin action in this tissue. 
Increased abdominal fatness in adult men is associated with restricted growth in fetal 
life239. Obesity, especially increases in central or visceral fat, increases circulating FFA, which 





increased central obesity and associated rise in circulating lipids has been hypothesised to be a 
primary cause of the insulin resistance seen in centrally obese adults who were small at birth. 
However, the relationship between insulin sensitivity and size at birth is independent of 
circulating lipid levels in men and women aged 50 years245 and of the amount of visceral or 
subcutaneous fat assessed by computed tomography scanning200. In addition, insulin resistance 
is evident in younger cohorts in their twenties who were IUGR, who still have similar lean 
mass, total fat and abdominal fat mass as controls229. Reduced insulin sensitivity in the liver, 
resulting in increased endogenous glucose output, can also contribute to development of T2DM. 
However, human studies have not consistently shown impairment in insulin-suppression of 
endogenous glucose output following IUGR190, 197, 246. In young adults, endogenous glucose 
production rate was equally suppressed in both IUGR and a control AGA group during HEC 
suggesting that, at this age, reduced insulin sensitivity of liver, and perhaps kidney, are not 
major determinants of whole body insulin resistance observed following IUGR190. Conversely, 
insulin suppression of endogenous glucose production is impaired after IUGR in young 
adults197 and in the Pima Indians, a population genetically-susceptible to T2DM246 
Therefore, impaired insulin sensitivity following IUGR cannot be fully explained by 
effects on mass of the three primary insulin sensitive tissues - skeletal muscle, adipose and liver. 
In addition, the association of impaired glucose tolerance, T2DM or the metabolic syndrome 
with small size at birth is also not fully explained by genetic predisposition, decreased insulin 




Neonatal catch-up growth is also implicated in the programming of impaired insulin 





may also be a mechanism contributing to gender-specific programming by early life factors in 
males as it contributed to more of the total variance in insulin resistance in 49 to 51-year-old 
males compared to females65. Each of the three main mechanisms of the catch-up fat hypothesis 
potentially contribute to insulin resistance following IUGR: compensatory hyperphagic drive, 
re-partitioning of nutrients from lean to fat tissue or alteration to metabolism such that 
thermogenesis is suppressed leading to fuel accumulation72.  
 
 
Obesity is a known risk factor for the development of the metabolic syndrome, 
T2DM, cardiovascular disease, gestational diabetes and reduced life expectancy247-250. There is 
accumulating evidence that small size at birth and catch-up growth are independent risk factors 
for the development of obesity in childhood which persists into adulthood72, 251-259. This 
increased adiposity after IUGR and catch-up growth occurs primarily in visceral deposits which 
contribute greater risk for metabolic dysfunction than subcutaneous depots80. This increase in 
fat deposition may in part be due to perinatal programming of both increased feed intake and 
reduced exercise activity260.  
In addition, others show that muscle mass decreases following IUGR producing a 
“metabolically dangerous”, high adipose:muscle ratio phenotype in later life261, 262. As skeletal 
muscle is the primary tissue of glucose disposal107 and adiposity can impair whole body insulin 
action263 a high adipose to lean tissue mass would be expected to reduce insulin sensitivity. 
Hence, it is important to also consider the role of altered body composition in prenatal 
programming of insulin resistance. 
 
 
Many studies in humans have demonstrated sex-specific programming of cardio-





perinatal programming of cardio-metabolic disease in later life compared to females176, 264, 265. 
Consistent with this, in human studies including both sexes, impaired insulin sensitivity was 
associated with declining size at birth in males but not in females65, 185, 203. Conversely, in a 
large Danish cohort which included 113,801 men and 109,298 women born between 1936-
1983, the associations differed with sex, such that in females the relationship was U-shaped 
with risk of T2DM increased at both the lower and higher birth weight ranges266. In men, the 
relationship between risk of diabetes and birth weight was near inverse throughout the birth 
weight range to 4 kg and then levelled off thereafter266. While associations with risk of T2DM 
at the extremes in birth weight were stronger in females, within any birth weight category the 
percentage risk of T2DM was higher in men compared to women, except in the highest birth 
weight range where percentage risk was comparable between the sexes266. Other studies report 
that impaired insulin action or measures of T2DM correlate with reduced size at birth in males, 
but do not report outcomes in females187, 189, 190, 193-195, 197, 198, 201, 229. When positive correlations 
between insulin sensitivity and size at birth are evident in both males and females the strength 
of the associations are approximately 2.5-fold greater in males than in females suggesting an 
increased impact or susceptibility of males to a sub-optimal intrauterine environment65, 176. In 
50-year-old men and women, both fasting plasma insulin and insulin during an OGTT 
correlated negatively with small size at birth in terms of weight and abdominal 
circumference227. Although the associations between size at birth and insulin concentrations 
were stronger in men than women, when the sexes were analysed separately no significant 
interaction of sex and size at birth was detected in multiple linear regression analyses, hence 
not providing sufficient evidence to support a difference between sexes within that cohort227.  
The increased susceptibility to prenatal programming in males may be due to the 
faster rates of growth earlier in gestation in males with less investment into placental growth 
than females267, 268. This may lead to later adaptations of the placenta to increase its overall size 





metabolic demand of the placenta at the expense of the nutrient supply available to the male 
fetus267, 268. In sheep, the cotyledons of male fetuses are larger in weight and surface area269. 
The faster rates of growth in males in utero and the greater demand for nutrients in later 
gestation may in part put them at higher risk of susceptibility to IUGR if the placental or 
maternal nutrient supply cannot meet their growth potential. Therefore, in the male fetus this 
may increase the risk of programmed future dysfunction such as insulin resistance and cardio-
metabolic disease. 
Another mechanism of the observed sex-specific difference in programmed 
metabolism of glucose homeostasis is via postnatal actions of sex steroids270, 271, however, the 
mechanisms by which sex steroids modulate insulin action are poorly understood272. 
Postnatally, oestrogen deficiency impairs insulin sensitivity and action, and hormone 
replacement therapy improves insulin sensitivity in postmenopausal women270. However, in 
premenopausal women, basal glucose and FFA concentrations do not differ in the follicular and 
luteal phases of the oestrous cycle273. Sex hormones may be acting to alter insulin sensitivity 
via the effect of testosterone to decrease adiponectin secretion, which then increases insulin 
sensitivity and lowers circulating lipids271. Women have higher adiponectin levels compared to 
men with similar body mass index and fat mass271. The absence of female sex hormones appears 
to decrease insulin-mediated whole-body glucose uptake via an impaired insulin-stimulated 
translocation of GLUT4 to the plasma membrane and by decreased protein expression of 
glycogen synthase274. Testosterone treatment further impairs whole-body insulin-mediated 
glucose uptake, presumably by additional impairment of glycogen synthase expression274 or 
testosterone’s inhibition of adiponectin271. Androgen excess in Polycystic Ovarian Syndrome 
is associated with impaired insulin sensitivity, however, IUGR does not raise androgens nor 
does impaired insulin sensitivity following IUGR correlate with androgen concentration in 
females209. Overall, this evidence does not support a role for androgens as a mediator for 





 Need for Animal Models to Investigate Perinatal Programming of 
Glucose Homeostasis 
Human studies have consistently shown a negative relationship of small size at birth 
with insulin resistance, T2DM or metabolic syndrome176-178. Furthermore faster rates of growth 
in the early postnatal period are positively related to these metabolic diseases65. Many human 
studies are based on size at birth as a proxy measure of in utero experience rather than being 
able to look specifically at types of exposures and their timings, however. Furthermore, the 
mechanisms that drive these pathophysiological changes before birth and in the early neonatal 
period and how they are influenced by postnatal life are not fully understood. Therefore, 
experimental models of IUGR are now utilised in a range of species to assess the effects of 
specific perturbations at critical windows of development on fetal development, size at birth, 
growth during the early neonatal period and metabolic outcomes later in life18.  
Assessment of adult outcomes in animal models of IUGR is required to control or 
reduce confounders such as incorrect estimates of gestational age, maternal diets, and other 
lifestyle factors such as smoking. Animal models allow control of maternal factors such as 
parity and maternal phenotype and assessment of insulin sensitivity in models with known size 
at birth measures and accurate postnatal growth data. Species with shorter gestations have the 
advantage of allowing transgenerational effects to be assessed, while species with longer 
gestations allow more accurate assessment of the effects of timing of gestational insults on the 
programming of adult disease18.  
 
 Animal Models of IUGR and Impaired Glucose Homeostasis 
This section focuses on experimental and naturally occurring IUGR in animal models 
that have been used to assess the perinatal programming of glucose homeostasis, and models in 
which relationships of neonatal catch-up growth, appetite and body composition with glucose 







As placental insufficiency is the most common cause of human IUGR and even in 
idiopathic IUGR it is expected that the placenta plays an important part in the reduced size at 
birth31, several animal models have been utilised to investigate the role of placental dysfunction 
in metabolic programming. 
 
 
Occlusion of the uterine arteries in small animal models of IUGR such as the rat275-
282 and the guinea pig283-286 have been achieved either by ligating (suturing)275-282, 286, diathermy 
ablation (burning)283, 284 or clamping (ameroid constrictor)285 placental blood flow and therefore 
placental nutrient supply to the fetus. This is achieved early in pregnancy and the vessels are 
occluded under general anaesthesia. 
In the guinea pig, uterine artery ligation from 30–35 days of gestation, using 
diathermy ablation of the uterine arteries in one horn also reduces size at birth, and leads to a 
disproportionate birth phenotype283. Low birth weight offspring (<80 g) combined from both 
control pregnancies and those with unilateral ablation of the uterine arteries remained smaller 
than normal birth weight offspring (>90 g) to 98 days postnatal age, but the groups did not 
differ in weight by 145 days. Offspring were weaned at day 14 and from day 16 to 60 the low 
birth weight offspring were hyperphagic compared to those of normal birth weight284. Although 
bodyweight did not differ at 145 days of age, low birth weight guinea pigs had a 
disproportionately greater epididymal white adipose tissue mass, fewer adipocytes, greater 
adipocyte diameter, and greater lipid content than the high birth weight offspring284.  
Unilateral uterine artery ligation in the rat at day 18 or 19 of gestation (term ~ 22 
days) is a commonly used model to reduce size at birth (10%-30% compared to controls) via 





control pregnancy or unilateral uterine artery ligation, have an increased brain to body weight 
ratio at 3-4 months of age, suggesting maintenance of an asymmetric IUGR phenotype into 
adult life276. Furthermore, low birth weight was associated with increased blood pressure, 
increased fasting blood glucose, impaired glucose tolerance and reduced insulin secretion 
during an IVGTT at 3-4 months276. Despite the asymmetrical IUGR following unilateral uterine 
artery ligation no postnatal catch-up growth was evident276, unlike that found following IUGR 
in humans22. Furthermore, associations between low birth weight and postnatal blood pressure 
and glucose metabolism were only found in female rat offspring, unlike the majority of human 
studies where males are at greater risk of cardio-metabolic programming65, 185, 203. 
Bilateral uterine artery ligation at 19 days gestation in the rat reduces size at birth to 
a similar degree to that observed following unilateral ligation (reviewed in275) and results in a 
“brain sparing” phenotype in the offspring275, 280-282. Bilateral uterine ligation is often associated 
with a high fetal loss (30% compared to 3% in control or sham operated)282. Some studies report 
comparable body, liver and brain weights by 7 days after birth in IUGR offspring of bilateral 
uterine artery ligated dams and controls282, while others report a delay in the acceleration of 
growth at 7-10 weeks postnatal age280. During the accelerated growth phase these restricted rat 
offspring become hyperglycaemic and hyperinsulinaemic at weeks 15 and 28280 and 
progressively more obese, especially in visceral depots, later in life at 28 weeks280. At birth, β-
cell volume, pancreatic mass and mass/kg body weight are decreased in the IUGR fetuses, and 
this reduction in β-cell number persists to adult life280, 281, 287. In a study where the 6 smallest 
pups from a ligated pregnancy were compared with the heaviest 12 control pups at 15 weeks of 
age, levels of HbA1c% were raised, suggesting poorly controlled glycaemia and by week 25 
offspring from bilaterally-ligated dams were hyperphagic compared to controls277. Therefore, 
in the rat, bilateral uterine artery ligation, which limits supply of oxygen and nutrients to the 
fetus, reduces size at birth, and is associated with accelerated postnatal growth, increased 





This adverse phenotype is further amplified with ageing, perhaps in part via hyperphagia and 
increasing adiposity, leading to progressive β-cell loss, raised HbA1c% and overt T2DM275, 277, 
280-282 resembling that seen in human studies250. Therefore, restricting both oxygen and nutrients 
in gestation via restricting placental function, does produce offspring that are insulin resistant 
and glucose intolerant in this species275, 277, 280-282.  
Another study showed that in fetal life, skeletal muscle mitochondrial mRNA levels 
of NADH ubiquinone-oxidoreductase, subunit C of the F1-F0 ATP synthase and ADP/ATP 
translocator were all reduced in IUGR rats, suggesting impaired glucose utilisation278. In 28-
day old IUGR offspring, the oxidation of NADH/H+ in the electron transport system of skeletal 
muscle remains reduced278. This in turn inhibits the utilisation of glucose via the negative 
feedback of high NADH/H+ on isocitrate dehydrogenase in the citric acid cycle. Therefore, the 
programming of glucose metabolism via placental insufficiency in the rat may be due to 
impaired glucose utilisation in skeletal muscle. 
In addition, GLUT2 protein and mRNA levels are unaltered in the livers of IUGR rat 
offspring generated by maternal unilateral uterine ligation, compared to controls, suggesting 
that IUGR does not alter the capacity of the liver to remove glucose from circulation279. 
 
 
In the rat, reduced uterine placental pressure (RUPP) throughout the entire last 
trimester (day 14, term being 22 days) also induces changes in glucose homeostasis288. RUPP 
involves the clipping of the uterine arteries to reduce blood flow to the uterus. RUPP reduces 
size at birth by 9% and the restricted offspring exhibit accelerated growth post-weaning such 
that their weight does not differ from control by 9 weeks288. At 9 weeks, RUPP progeny had 
higher fasting glucose and insulin concentrations, impaired glucose tolerance (IVGTT) and 







In sheep, surgical removal of the majority of the endometrial caruncles (placental 
attachment sites) prior to pregnancy reduces total placental size and therefore the efficacy of 
oxygen and nutrient transfer269, 289, 290. Surgically induced placental restriction in the ewe 
reduces fetal growth, impairs β-cell function and insulin secretion in late gestation (day 140 of 
~ 147-150 days gestation for term) and reduces size at birth of their offspring291. Placentally 
restricted fetuses have increased abundance of insulin receptor protein in skeletal muscle, but 
reduced abundance of PKC, and GLUT4 protein292. At birth, placentally restricted offspring 
have asymmetrical IUGR with smaller size at birth in terms of weight (-21 to 25%), crown-
rump length (-7 to 9%), abdominal circumference (-10%), and body mass index (-12%), and 
relative sparing of skull width (-5%) and length (-4%)69, 293, resembling the phenotype observed 
with placental insufficiency in human studies22, 23.  
Placental restriction increased fractional growth rates of lambs in terms of weight 
(+24 to 29%) and various growths of long bone lengths (+15 to 23%), increased feed intake to 
45 days of age, increased relative visceral adiposity and reduced muscle mass69, 293. At 30 days 
of age, placentally restricted lambs have high basal glucose, higher fasting insulins, lower post-
prandial insulin secretion, assessed after an IVGTT, and are insulin resistant as assessed by 
HEC69, 294. Expression of GLUT2 is increased in the liver of placentally restricted males while 
expression of insulin receptor, IRS-1, AKT-2, GLUT4, GSK3a and GYS1 are all reduced in 
skeletal muscle of placentally restricted male and female offspring, suggesting that impairment 
to skeletal muscle signalling is the primary defect underlying whole-body insulin resistance in 
these IUGR lambs294. 
 
 
Overnourished adolescent ewes partition nutrients to the growth of the mother and 





embryo transfer into young ewes, followed by overfeeding during gestation. A variable 
response is observed in this model, with approximately 50% of lambs born IUGR, with birth 
weights less than two standard deviations below the mean birth weight of lambs born to control 
pregnancies (<4 kg), and an overall reduction in birth weight in this IUGR group of 
approximately 35%295. IUGR offspring of adolescent pregnancies have increased fasting 
glucose concentration at 48 days and 6 months of age and fasting glucose is negatively 
associated with birth weight at both ages296. IUGR offspring also undergo increased neonatal 
fractional growth, which correlates positively with fasting glucose concentration at 48 days and 
6 months of age. Glucose tolerance, assessed by IVGTT, is not altered in IUGR offspring at 48 
days, but fasting glucose to insulin concentrations and insulin secretion during the first 20 
minutes of the IVGTT were reduced, suggesting attenuated insulin production when compared 
to normal-weight offspring of adolescent pregnancies295. At 6 months of age glucose tolerance 
during the IVGTT was impaired in offspring of adolescent pregnancy, compared to offspring 
of control pregnancies, however, fasting insulin, insulin area under the curve, and insulin 
secretion during the initial phase of the IVGTT did not differ between birth groups296. While 
this model provides evidence for prenatal programming of glucose metabolism, the 
overnutrition model is associated with a preterm delivery295, 296 making it difficult to 
differentiate effects of IUGR and gestational age.  
 
 
Exposing ewes to increased temperature (40°C for 12 h/day, 35°C for 12 h/day) from 
day 40 to typically day 95-120 of gestation redistributes blood away from the placenta and 
induces IUGR in the fetus297. Heat stress, from day 45 to day 120 of gestation, increases 
maternal body temperature to 40°C, 1°C higher than controls297. This reduces fetal and placental 






At approximately 90% of term (131-138 days; term ~ 147-150 days gestation) fetuses 
of heat stressed mothers had a 58% reduction in whole pancreatic β-cell mass, and a 47% 
reduction in β-cell number, with insulin mRNA levels 66% less than controls298. In addition, 
these IUGR fetuses had increased insulin sensitivity of glucose utilisation, partitioning their 
glucose to glucose storage during a hyperglycaemic clamp299. 
Heat-induced placental restriction reduces muscle fibre size and the proportion of 
Type 1 muscle fibres in fetal skeletal muscle near term300. In vitro analysis of M. semitendinosus 
strips showed a lower glucose uptake under insulin-stimulated conditions in muscle from IUGR 
lambs of one month of age compared with controls301. If these changes to muscle fibre types 
persisted into later life the lower percentage of type I fibres in IUGR sheep may lead to insulin 
resistance, as in adult humans the percentage of type I fibres correlates positively with insulin 






Maternal feed restriction has also been utilised in various species, with differing 
timing and magnitude of restrictions, to examine the fetal origins of T2DM and insulin 
resistance in a malnourished models such as rats303-307, guinea pigs308-317, sheep318-321 and 
primates154.  
In baboons, maternal feed restriction to 70% of ad libitum feeding from 30 days 
gestation (term ~184 days) and throughout lactation tended (P<0.06) to reduce birth weight (-
11%)154. At 3.5 years (juveniles), fasting plasma insulin and glucose concentrations were higher 
in the restricted offspring compared to control offspring154, suggesting insulin resistance and 





however, the offspring of feed restricted mothers secreted more insulin to maintain similar 
glucose levels compared to controls154. In feed restricted offspring, the glucose disposal rate 
during the HEC was lower compared to controls suggesting insulin resistance. No sex 
differences were found in any measure of glucose homeostasis in this study154. 
Feed restriction of ewes to 50% ad libitum feeding from early to mid-gestation (day 
28-78, term ~ 147-150 days gestation), followed by ad libitum feeding to lambing did not alter 
birth weight or length of singleton male lambs (females not assessed), compared to ad libitum 
fed controls321. Feed restriction also had no effect on birth weight of twin lambs, although birth 
weight of control and restricted twins was 22% lower than that of singletons overall321. At 63 
days of age, weaned offspring of feed restricted ewes had higher basal glucose, and increased 
AUCglucose and AUCinsulin during an IVGTT compared to controls. At 250 days of age, young 
adult progeny from restricted ewes had a higher AUCglucose compared to controls suggesting 
glucose intolerance321, but AUCinsulin was lower than controls suggesting that insulin 
compensation for any given glucose load was impaired321. In addition, restricted progeny had a 
greater live weight, increased absolute and relative adiposity, and tended to have a reduced 
muscle mass at 280 days of age321. 
In contrast, feed restriction of ewes at 50% ad libitum feeding in twin pregnancies in 
the last 6 weeks of gestation reduces size at birth by 11% compared to non-restricted twins318. 
However, at 6 months of age glucose tolerance did not differ in offspring of feed restricted 
mothers, compared to non-restricted twins319. A more severe feed restriction of 0.3 MJ/d from 
day 105-115 then 0.5 MJ/d until 125 days, compared to controls fed at 13 MJ/d from day 105-
115 then 15 MJ/d until 125 days, followed by a return of both groups to pasture for lambing 
(term ~147-150 days) also reduced size at birth320. In this severe maternal feed restriction 
model, low birth weight and current weight, but not undernutrition per se, impaired glucose 





pathway linking fetal nutritional environment and later adult disease. Contrasting outcomes in 
these studies may come from differences in singleton versus twin pregnancies.  
In rats, maternal feed restriction to 50% ad libitum intake from days 1 to 14 of 
gestation, followed by ad libitum feeding to term, did not alter basal glucose or insulin 
concentrations in male offspring at 15-16 weeks, while female offspring were not studied303. 
Further these male offspring did not have altered glucose tolerance or insulin secretory 
responses following an IVGTT, or impaired glucose production or glucose utilisation during 
HEC303. In contrast, maternal feed restriction to 50% ad libitum from day 15 of gestation to 
weaning reduced glucose tolerance in male rat offspring at 1 year of age compared to 
controls304. This suggests that perturbations occurring during late gestation and early postnatal 
development in the rat may have greater impact on the programming of glucose tolerance than 
those occurring during early-mid gestation. Adult female offspring of rats that were restricted 
to 50% ad libitum feeding during late gestation and throughout lactation had impaired whole 
body insulin sensitivity and impaired suppression of endogenous glucose production but 
peripheral glucose utilisation was not altered305. Therefore, in studies where endogenous 
glucose production and peripheral glucose utilisation were measured, maternal feed restriction 
reduces the insulin sensitivity of liver in female offspring with no change in skeletal muscle 
glucose utilisation305. However, these studies in offspring of maternal feed restriction in the rat 
contrast human observations where insulin resistance of skeletal muscle is the primary defect 
more generally in the pathogenesis of whole body insulin resistance and T2DM92, 236, 322.  
In the pig, unlike many other species, size at birth is not consistently affected by 
various maternal feed restriction magnitudes or timings during gestation (reviewed in323). One 
study, however, did show that reducing feed intake to one-third of ad libitum feeding in the first 
two trimesters results in offspring that tend to have increased rates of growth postnatally 





In the guinea pig, severe maternal feed restriction (50%) from day 30 to term (~67-
70 days) reduced birth weight (-30%), while early feed restriction from conception to day 30 
did not reduce size at birth325. Even at 8 weeks postnatal age, the restricted group remained 
smaller (-22%) than the controls suggesting catch-up had not occurred to restore growth in these 
offspring of severely feed restricted guinea pigs325. Weights of adipose depots were reduced in 
pups of restricted mothers at 8 weeks and for subcutaneous depots such as shoulder fat and 
groin fat, this decrease was proportional to the reduction in body weight325. In contrast, the 
relative weights of the interscapular and retroperitoneal fat depots at 8 weeks of age correlated 
negatively with birth weight325. This suggests that either some fat depots were programmed 
differently in utero by maternal feed restriction or different fat depots are more prone to 
deposition during catch-up following IUGR.  
Moderate global restriction, in guinea pigs, by feeding 70% ad libitum intake to day 
35 gestation followed by 90% ad libitum intake to term, reduces size at birth in male (-12%) 
but not female offspring, however, only limited numbers of female offspring from moderately 
feed-restricted mothers were examined in this study310. Maternal feed restriction did not alter 
neonatal fractional growth rate across the maternal diets or in either sex 310. Moderate feed 
restriction induced hyperphagia, increased visceral (retroperitoneal) adiposity and reduced 
relative M biceps brachii mass in young adult males but not in females. Also in males only, 
moderate feed restriction increased the fasting insulin and fasting insulin:glucose ratio 
compared to controls, but this effect was lost when birth weight was included in statistical 
analyses. This suggests that in the guinea pig growth in utero is a greater determinant of the 
programming of glucose homeostasis than maternal feed restriction treatment itself. When 
outcome data were pooled (sex and treatment) and analysed according to birth weight tertiles, 
the lowest birth weight offspring had the highest food intakes and were hyperinsulinaemic as 





Mild global restriction, induced by feeding pregnant guinea pigs 85% ad libitum 
intake throughout gestation, also decreases size at birth in terms of weight (male -10 to -14%; 
female -8 to -11%), without increasing neonatal fractional growth rates from birth to weaning 
at 28 days310, 312. Young adult males from undernourished mothers had higher cholesterol levels 
prior to and post feeding a high-cholesterol diet for 6 weeks, which was not observed in 
females312. Systolic blood pressure and insulin secretion measured during an IVGTT (as area 
under the insulin profile relative to area under the glucose profile) were both higher in restricted 
male, but not female, offspring compared to controls at 100 days310, 311. This effect on insulin 
secretion was not evident when correcting for litter size or birth weight, again suggesting that 
the effect may be more strongly related to fetal growth rather than the maternal feed restriction 
itself. These studies demonstrate that IUGR induced by maternal feed restriction does in fact 
program many of the features of the metabolic syndrome in the guinea pig and in a sex-specific 
fashion309-312. Males appear to be more at risk of the adverse effects of IUGR and neonatal 
catch-up compared to females in this species, resembling findings reported in systematic 
reviews in humans65, 176-178. 
 
 
Feeding pregnant rats isoenergetic diets containing 0% glucose from day 2 of 
gestation reduces size at birth (-30%) compared to a control diet containing 60% glucose326. In 
contrast, diets containing 12 or 24% glucose did not affect weight at birth. Percentage mortality 
in offspring by postnatal day 1 was 100%, 11% and 4% for the 0%, 12% and 24% glucose diets, 
respectively326. Feeding a 12% glucose diet throughout pregnancy and lactation reduced the 
plasma insulin to glucagon ratio in the first 12-16 hours of postnatal life, due to both a marked 
reduction in insulin and raised glucagon concentration in maternal glucose-restricted offspring. 
Despite the lower insulin levels offspring from mothers whose glucose intake was restricted 





likely due to an impaired activation of glycogen phosphorylase in the maternal glucose-
restricted offspring compared to the control glucose diet. Six-day-old neonates from dams fed 
a 12% glucose diet had higher expression of PEPCK mRNA compared to those from dams fed 
a 24% glucose diet suggesting that maternal diets low in glucose have the potential to increase 
gluconeogenesis in the liver326. However, by day 15 hepatic PEPCK mRNA did not differ 





Restriction of maternal protein intake, by feeding a 5%-8% protein diet, compared to 
15%-20% protein, throughout gestation and lactation does not consistently reduce birth weight 
of the offspring327-336. Some studies do not report size at birth327-330, others report decreases in 
fetal weight at 19 days of gestation331 with a few reporting a reduced size in a least one sex with 
maternal feed restriction332-336.  
Maternal protein restriction at 7% compared to control of 25% in the rat, throughout 
gestation but not during lactation improves glucose tolerance in offspring at 4 months of age337. 
At 9 weeks (young adults), blood glucose was normalised faster, had a smaller rise in maximum 
glucose concentration, and a more rapid glucose clearance to basal levels following an 
intraperitoneal glucose tolerance test (IGTT) in the offspring of protein-restricted dams, 
suggesting glucose tolerance was improved at this age330. In contrast, a more severe maternal 
protein restriction of 5% protein diet, compared to control diets of 15% protein in the last 
trimester of gestation, does not alter glucose tolerance in offspring of protein-restricted dams 
compared to control at 8 weeks of age (only females studied)335.  
However, glucose intolerance does develop with ageing (15-21 months) in offspring 
of protein restricted mothers in some327, 332, 338 but not (44 or 52 weeks) all studies330, 333, 334. 





hyperglycaemia until 21 months332 suggesting males are at greater risk of developing T2DM at 
an earlier age after IUGR. Together these studies suggest that protein restriction does not result 
in an impaired glucose tolerance in young offspring but this develops with ageing in offspring 
of the maternal protein restricted rat327, 332, 338. Supporting this, glucose intolerance did not 
develop until 130 days in female offspring of maternal protein restricted dams suggesting that 
ageing is required to reveal the programmed dysfunction in insulin sensitive organs leading to 
metabolic dysfunction338. 
Severe maternal protein restriction in rats at 5% also reduced fetal pancreas weight, 
islet cell number, and insulin content in the β-cells compared to control at 21 days gestation339. 
This effect on the pancreas was still seen at postnatal 8 weeks suggesting that the impact of 
maternal protein restriction in the rat may be in part via reduced insulin secretory capacity335, 
339. Consistent with this, maternal protein restriction at 8% increased the rate of apoptosis and 
reduced the rate of proliferation of β-cells compared to control in 19.5 to 21.5-day-old fetuses 
(only females examined) which persisted 21 days after birth340. Four-month-old female 
offspring of dams that were protein restricted during pregnancy and lactation have reduced 
pancreatic islet number, islet size and overall β-cell mass, but no effects were observed in male 
offspring338. In four-month-old females, the basal insulin concentration was half that of males, 
showing that impairment in β-cell function in offspring of protein restricted mothers at this age 
is sex-specific338. Overall, insulin secretion in male and female offspring of protein restricted 
mothers also tends to be lower compared to controls at 1 year of age333. 
In the rat, some studies report that maternal protein restriction during gestation337 or 
throughout gestation and lactation331 enhances insulin sensitivity at 4 months of age. In contrast, 
others report that maternal protein restriction during gestation and lactation reduces insulin 
sensitivity in males at 4 months338. Insulin sensitivity measured by GTT in 110-day-old males, 
but not females, is enhanced by maternal protein restriction in gestation and lactation combined 





sensitivity in 110-day-old males, but not females, compared to controls336. Restriction of 
maternal protein to 5% of the total diet, compared to 15%, in the last trimester of gestation, 
does not alter submaximal glucose utilisation or production rates in progeny at 8 weeks (only 
females studied)335.  
Although experimental in vivo studies in the rat have not consistently shown links 
between maternal protein deprivation and altered glucose homeostasis postnatally, some in 
vitro studies do report alterations in the structure and functional development of key tissues for 
insulin action, including skeletal muscle, liver and adipose tissue, in adult offspring following 
maternal protein restriction328, 331, 338, 341-347. In male rats at 130 days of age, phosphorylation of 
AKT in skeletal muscle and visceral adipose tissue increased 4-6 fold with insulin-stimulation 
in controls, but did not change in tissues from male offspring of protein restricted mothers 
suggesting peripheral insulin resistance in the signalling pathway338. Insulin-stimulated 
phosphorylation of AKT in skeletal muscle and visceral adipose tissue did not differ between 
130-day-old female offspring from control and protein restricted mothers, however, implying 
sex-specific effects of maternal protein restriction on insulin sensitivity in the peripheral 
tissues338. In vitro insulin sensitivity of skeletal muscle strips from three-month-old offspring 
of protein restricted mothers is increased in association with increased insulin-stimulated 
glucose uptake, insulin receptor concentration, and GLUT4 protein within plasma membranes 
in skeletal muscle328. These effects of maternal protein restriction differ from those observed 
following uterine artery ligation, where GLUT4 protein concentration in fetal and postnatal 
skeletal muscle were not altered348. Decreased membrane-associated GLUT4 in skeletal muscle 
after maternal protein-restriction328 is however consistent with the finding that 18-week-old 
offspring of dams fed an 8% protein diet during gestation and lactation, compared to 20% 
protein, have impaired glucose turnover and glucose utilisation in M. soleus, a slow twitch 





Protein restriction leads to reduced liver size and increased visceral fat in both 
absolute and relative terms in 130-day-old male rats, compared to controls. However, these 
effects were not observed in females at the same age338. Structural and functional development 
of the liver is altered in adult offspring of protein restricted pregnant rats. In offspring of 
mothers fed diets containing 8% protein, compared to 20% protein, insulin stimulation in vitro 
in isolated perfused liver cells increased glucose output 329. This is in contrast to the expected 
action of insulin in the liver to suppress endogenous glucose output349. This was in conjunction 
with a three-fold increase in the number of insulin receptors, increased insulin uptake and 
increased insulin degradation in the livers of protein-restricted offspring. This suggests that 
protein restriction increases hepatic insulin sensitivity, but alters the post-receptor signalling 
mechanisms 329.  
Many metabolic processes are known to be zoned within specific areas of the liver. 
Glucokinase (GK), the insulin sensitive enzyme that converts glucose to glucose-6-phosphate 
and the rate-limiting step in the glycolytic pathway, is essentially located in the perivenous 
region of liver parenchyma345. Fructose 1,6-bisphosphatase, another glycolytic and insulin 
sensitive enzyme, and phosphoenolpyruvate carboxykinase (PEPCK), an enzyme involved in 
gluconeogenesis, are predominantly located in the periportal regions343, 344. Offspring of rats 
that were protein restricted (6% protein diet) during pregnancy have 50% lower expression of 
GK in the perivenous parenchymal regions of the liver, compared to offspring of control fed 
(20% protein) animals, whereas PEPCK activity was increased by 100% in the periportal 
regions346. Therefore, there is impairment in the ability of the liver to utilise glucose as a fuel 
through glycolysis, and an increase in activity of enzymes, like PEPCK, responsible for glucose 
production, resulting in a net potential to over-produce glucose. Such changes could in part 
account for the hyperglycaemia found in humans who were small at birth. More recently, the 
lobular volume in livers of offspring from 8% protein restricted mothers was shown to be half 





In the rat, adipocytes isolated from offspring from protein-restricted dams have 
significantly higher in vitro basal and insulin-stimulated glucose uptakes than controls, with a 
three-fold increase in insulin receptors and significantly higher basal and insulin-stimulated IRS 
associated PI3K activity341. In contrast, insulin-enhanced glucose uptake and inhibited lipolysis 
in adipocytes from control offspring, but not in offspring of protein-restricted mothers342. 
Chickens have also provided an alternative model in which to study the effects of 
protein restriction, independent of maternal and placental factors, through the in ovo removal 
of albumin163. Albumin removal tends to reduce weight at hatching (p<0.06)350, and reduces 
breast muscle and adipose mass in absolute but not relative terms at 25, 40 and 55 weeks163. At 
10 weeks, plasma glucose remained higher at 30 minutes after an oral glucose bolus in the 
albumin-deprived group compared to control suggesting glucose intolerance163. However, 
glucose tolerance was not altered at later ages in these protein-deprived chickens, and insulin 




In the rat, maternal hypoxia (10% O2 compared to 21% for control) in the last two-
thirds of gestation (day 7-21), reduces size at birth (-12%) and at 28 days of postnatal age, and 
reduces insulin sensitivity as measured by homeostatic model assessment (HOMA) without 
changes in plasma glucose or insulin concentrations351. However, levels of PEPCK protein were 
increased, and levels of GLUT2, AKT and the IRS-2 were reduced in the liver at birth and at 
28 days of age in offspring of hypoxic mothers351. At 11 weeks, triglycerides were increased 
and phosphorylated AKT (p-AKT/AKT) and AMPK (p-AMPK/AMPK) in skeletal muscle 
were reduced in the pups from the hypoxic dams352. Insulin infusion, however, did not alter 
GLUT4 translocation in maternal hypoxia-exposed pups compared to a two-fold increase seen 





A shorter period of maternal hypoxia (10% O2 compared to 21% for control) 
throughout the last third of gestation (day 15-21) reduces size at birth by 12%. At 4 months of 
age, protein expression of IRS-1 and p-AKT, which are involved in glucose metabolism, was 
reduced in the liver of offspring of hypoxic mothers353. Levels of PKC, a kinase involved in 
lipid metabolism, and Akt-1 and Akt-2 were also reduced in the liver of offspring of hypoxic 
mothers, however, similar decreases were observed in offspring of mothers pair-fed during 
pregnancy, to account for the decreased feed intake during hypoxia, suggesting a contribution 
of maternal undernutrition. Protein levels of the insulin signalling molecules IRS-1, p85α, and 
Akt-1 were not altered in skeletal muscle following maternal hypoxia, but levels of Akt-2 were 
reduced. In addition, GLUT4 expression in skeletal muscle was reduced in four-month-old 
offspring of hypoxic mothers to a greater degree that observed in offspring of pair-fed 





Naturally occurring variation in size at birth or spontaneous IUGR due to litter size 
has long been known in the pig with “runt piglets” often born to larger litters354. This natural 
variation can result in 2-3 fold variations in size at birth within the same litter and is partly due 
to the competition for space for implantation and limited growth of placentas and fetuses in 
larger litters354, 355. This reduction in placental growth impairs oxygen and nutrient transfer to 
the fetuses limiting their growth. Overall these IUGR pigs are asymmetrically growth-restricted 
and generally thin at birth354, have reduced muscle mass and fibre number, increased adiposity, 
and decreased lean-to fat-ratio compared to larger litter mates355, 356, consistent with 





Pigs that are categorised as low birth weight grow faster in the first month of age 
compared to the larger littermates suggesting neonatal catch-up growth after spontaneous 
IUGR358. Spontaneous IUGR in pigs, as indicated by thinness at birth, and fractional neonatal 
catch-up in the first month, both independently predicted increased insulin sensitivity at 3 
months in males, while thinness at birth but not fractional neonatal growth rate predicted 
impaired insulin sensitivity in females358. At 12 months of age catch-up growth predicted 
impaired insulin sensitivity in both sexes358. Other components of the metabolic syndrome such 
as raised mean atrial pressure and adiposity are also increased in spontaneous IUGR piglets359, 
360. Hence, natural variation of fetal growth induces programming of several components of the 
metabolic syndrome in this species. 
 
 
Twinning in sheep is relatively common with the majority being dizygotic361. 
Therefore, each placenta is distinct and due to reduced area of placentation the availability of 
nutrient supply is reduced. Twins are often born premature compared to singleton births and 
therefore the combination of nutrient competition and premature delivery may both contribute 
to their fetal growth restriction361. At approximately day 120 of gestation, glucose (-22%) and 
insulin (-20%) are reduced in twins compared to singletons, likely contributing to the reduction 
in fetal weight (-4%)362. In triplet lambs, fetal weight at 120 days is 23% less than that of 
singletons, although not significantly different from that of twins363. By day 140 of gestation 
(term at ~145 days), fetal twins have fewer placentomes (-35%) and reduced weight of the 
caruncular tissues (-28%) and of total placentomes (-33%), compared to singletons364. Together 
this reduces nutrient supply, especially when the demand is increased in late gestation, and 
reduces fetal weight by 16% at 140 days364. Differences in singleton and twin growth trajectory 
in utero appear to be determined early in gestation and may reflect placental capacity362-364. In 





twin suggesting head sparing in the greater restricted of the two365. Birth weight is reduced in 
twins (-17 to 30%) compared to singletons, as are other measures of size at birth such as crown 
rump length (-8 to -10%), chest girth (-7 to -8%) and abdominal circumference (-6%); also 
consistent with asymmetrical IUGR362, 366-369, not unlike that seen in human studies23, 24.  
Despite the differences in size at birth, there is no difference in neonatal growth rates 
(0-3 months) between twin and singleton lambs368. Others show that the growth rates from birth 
to 10 months are stronger predictors of glucose and insulin responsiveness to an IVGTT than 
birth weight, however, these associations were not different in singletons or in twins 
separately367. In addition, glucose or insulin responsiveness after an IVGTT did not differ 
between the lighter and larger twin365. Similarly at 11 months, the expression of p85α and PI3K 
in perirenal fat or skeletal muscle and GLUT4 expression in skeletal muscle do not differ 
between single and twin lambs368.  
Hancock et al (2006) euthanised one twin at 42-43 days gestation (after the period of 
placental attachment in sheep) and allowed the other (“reduced” twin) to birth naturally and 
followed growth to 24 months366. These “reduced” twins had a lower birth weight compared to 
singletons (-13%) but were heavier than control twins (+9%). Growth rates from birth to 
weaning tended to be higher in the reduced twin lambs, compared to both singletons and control 
twins, whereas growth rates from weaning to 12 months were greater in control twins compared 
to singletons and reduced twin progeny366. At 12, 18 and 24 months, body weights were not 
different between the three groups, but control twins and reduced twins had increased fat mass 
(+33%, +40%) and reduced lean mass (-5%, -6%) respectively compared to singletons at 24 
months366. At 3 years of age reduced twins had a greater percentage fat mass and lower lean 
weight than singletons, whereas the control twins were intermediate between the singleton and 
reduced twins for both fat mass and lean weight369. Basal and IVGTT challenged glucose and 
insulin levels did not differ at 11 months and at 3 years between control twins, reduced twins 





However, the insulin responsiveness relative to glucose levels was higher in twins compared to 
singletons suggesting that twins release more insulin for a given plasma glucose concentration 
achieved368. Further, 3-year-old sheep conceived as twins (control and reduction twins 
combined) had a lower insulin sensitivity assessed by HEC compared to singletons369. Overall 
when insulin sensitivity data for female singletons and female control twins were pooled and 
compared to the corresponding pool of males, males had a higher insulin sensitivity than 
females at 3 years of ages. This contrasts with human studies where males appear to be the most 
sensitive to the programming of metabolic disease65, 176-178. However in a more recent study in 
humans, females who were at the extremes of the birth weight range (both low and high) had 
the highest risk of T2DM compared to males perhaps suggesting that females at the ends of the 
birth weight ranges have the highest risk of insulin resistance266. In sheep, insulin sensitivity 
was not different in singletons, reduced twins or control twins at 1 year of age, suggesting that 
the impairment in insulin sensitivity does not become apparent until later life369. The loss in 
insulin sensitivity at 3 years of age was independent of current bodyweight, adiposity and lean 
mass, but was not significant when corrected for birth weight. This suggests that the effect of 
litter size on insulin sensitivity in adult sheep is due to differences in prenatal environment and 
not an indirect consequence of altered adult body composition.  
In ewes selected for their ability to conceive litters of multiple lambs (singletons to 
quintuplets), a series of experiments run by Greenwood et al 1998-2004 examined postnatal 
outcomes in male sheep of low (<2.9 kg) or high (>4.3 kg) birth weight370-373. These low and 
high birth weight male lambs were reared on milk replacer either ad libitum to enable rapid 
postnatal growth (>300 g/d), or at a feeding level sufficient for the maintenance of a slower 
growth rate of 150 g/d. Only males were studied and litter size effects were only reported for 
size at birth370-373. Although not reported, these low birth weight male lambs, appeared to come 
from ewes carrying larger litters, grew faster to 20 kg live weight, and were hyperphagic for 





High birth weight lambs had a greater weight of M. semitendinosus, M. extensor digitorum 
lateralis and M. extensor carpi radialis muscles than offspring of low birth weight at 20 kg live 
weight371. However, the number and proportion of muscle fibre types did not differ between 
the low and high birth weight groups371. Low birth weight lambs reared on the rapid growth 
diet had higher plasma insulins than high birth weight reared slowly372. 
 
 
Small animal models have many logistical advantages for studies into the 
mechanisms that underpin the DOHaD hypothesis. These include rapid development and 
shorter lifespans such that intergenerational and ageing effects can be examined more readily 
than in humans or larger animals. To date, much of the evidence for programming of insulin 
sensitivity has been generated in rodents. These offspring of maternal feed-restricted310-312, 335, 
374 and protein-restricted mothers332, 335, 375-377 display some of the elements of programming of 
glucose homeostasis such as impaired insulin secretion and insulin resistance. However, in 
human populations, much of variance in size at birth is due to placental insufficiency rather 
than malnutrition378, 379. In addition, reducing nutrient intake of the mother does not alter oxygen 
levels, another important determinant of fetal growth46, 47. Placental restriction induced by 
uterine ligation in rats causes IUGR and programs many components of the metabolic 
syndrome276, 280, 380, 381. However, many of these IUGR models in the rat do not exhibit neonatal 
catch-up growth276, 280, 381, which is an important and independent risk factor for the 
development of cardio-metabolic disease in humans83, 382-384.  
Species differences in the timing of development also limit translation of some 
models. In the human, the endocrine pancreas develops in late gestation98. This contrasts with 
pancreatic development in the altricial species commonly used as animal models for 
programming studies, such as the rat and mouse98. In rats and mice, the pancreas continues to 





effects on glucose homeostasis in these altricial species than those observed in the human. 
Therefore, more precocial small animal models in which the timing of organogenesis and 
pancreatic development more closely resemble the human fetus are required. In addition, 
placental restriction/insufficiency accounts for the majority of IUGR, even in under-developed 
countries where malnutrition is common31. Hence, animal models of low birth weight based on 
placental restriction of oxygen and nutrient supply, rather than maternal undernutrition, that 
more closely resemble human IUGR, are required.  
A significant gap in both the studies in IUGR humans and in animal models is that 
in most studies only one sex is assessed, often due to researchers wishing to avoid variation due 
to effects of the hormone cycle of females. There is compelling evidence that there are sex-
specific programming effects for cardiovascular and now for metabolic diseases266, 385, 386, 
indicating that consideration of both sexes is required.  
In litter bearing species, spontaneous fetal growth restriction is commonly observed 
in larger litters. Spontaneous fetal growth restriction based on litter size has advantages as a 
model as it utilises natural variation in litter size without the need for dietary or surgical 
interventions. Surgical models involve the additional stress of surgery, anaesthesia and are often 
associated with increased rates of spontaneous fetal loss (as little as 14% survival)283. Dietary 
restriction models vary in the degree, severity and timing of the restriction and can also impact 
on placental development and function387. These surgical and feed restriction models often have 
abrupt/acute onsets in mid-late pregnancy, which differs from IUGR in humans. In addition, 
animal models with smaller litter sizes have an advantage in that there is no need to cull pups 
postnatally to “standardise” the postnatal environment, which can be associated with variation 







The guinea pig is a precocial species308, with a mean litter size of 3-4 pups388 with 
the IMVS Tri-colour strain used in this thesis having litter sizes of 1-5 pups. The guinea pig has 
a relatively long gestation period compared to other small animals such as the rat and mouse 
therefore several developmental events that occur in utero are similar to that of the human308, 
389. The fat content of guinea pig pups at birth is 10-20%325 similar to that in humans (16%), in 
contrast to other species such as the sheep (2%, in the fetus near term at 140 days), pig (1%), 
rat (2%) and mouse (1%)363, 390. Development of the pancreas, liver, kidney and skeletal muscle 
are mostly complete at, or soon after, birth in the guinea pig308, 388, 389 suggesting this species is 
an appropriate animal in which to investigate prenatal programming of metabolic dysfunction.  
In addition, uteroplacental insufficiency via unilateral uterine artery ligation in the 
guinea pig increases appetite, and increases epididymal (visceral) adiposity in young adult male 
(females not assessed) offspring284. As previously discussed, maternal feed restriction at either 
70% or 85% ad libitum feeding from day 30 to day 60 of gestation impairs cholesterol and 
glucose homeostasis, increases appetite, and increases adiposity in guinea pig progeny, 
primarily in males309-312. Therefore, maternal feed restriction309-312 and uteroplacental 
insufficiency284 in the guinea pig program much of the later dysfunction associated with the 
metabolic syndrome. However, in maternal feed restriction studies size at birth was a stronger 
predictor of many of these adult outcomes than the maternal nutritional treatment suggesting 
that the effects are programmed by size at birth rather than nutrition itself. 
 
 
In the guinea pig, with increasing litter size from one to five pups there is a decrease 





mean birth weight of singleton pups of the same sex391-394. Average placental size is decreased 
by 28% at day 65 gestation (term ~ 70 days) in litters of five compared to litters of one 
suggesting that spontaneous fetal growth restriction due to increased litter size in the guinea pig 
has a substantial placental component391-393. Like IUGR in humans, spontaneous IUGR guinea 
pig offspring from larger litters undergo neonatal catch-up growth with percentage weight gain 
from birth to day 28 (weaning) being 308% and 319% in males and females respectively in 
litters of five, compared to 267% and 247% in males and females from litters of one394. 
Therefore, these larger litters are producing offspring with IUGR with a substantial placental 
component and these offspring undergo catch-up growth in the neonatal period in both sexes391-
394. Thus, the consequences of spontaneous IUGR due to natural variation in litter size provides 
a potential model where catch-up growth and its impact on perinatal programming of glucose 







 Hypothesis and Aims 
 
To address these gaps in knowledge the studies in this thesis were designed to test the following 
general hypothesis:  
 
Spontaneous growth restriction due to increasing litter size in the guinea pig induces neonatal 
catch-up growth, postnatal hyperphagia, and obesity and impaired insulin sensitivity in young 
adults. 
 
To test this hypothesis, studies were conducted to address the following aims: 
 
1/ To characterise the effects of natural variation of litter size on birth phenotype, 
neonatal and postnatal growth, postnatal appetite and adult body composition in male and 
female guinea pigs. (Chapter 2) 
2) To develop and validate methodology for measurement of whole body and tissue 
specific insulin action in male and female guinea pigs. (Chapter 3) 
3) To characterise the effects of natural variation in litter size, birth phenotype and 
catch-up growth on insulin sensitivity and sites of insulin action in adult male and female guinea 










Spontaneous intrauterine growth restriction due to 
increased litter size in the guinea pig programs postnatal 






The following study used 68 pregnant dams to produce the offspring (n=158, males: 
n=78, females: n=80). Of these 158 animals, approximately 20 were from control pregnancies in 
another study investigating the effects of maternal feed restriction on postnatal cholesterol 
metabolism. These animals had size at birth, feed intake and postnatal growth measures recorded, 
but their body composition could not be included in the data analysis for this chapter, as they were 
fed a high-cholesterol diet as adults. I conducted all remaining animal work, including managing 
the mating program, monitoring growth and wellbeing of dams during pregnancy, assessing birth 
parameters, monitoring postnatal growth and feed intake, all tissue dissections and all data 
analysis. This enabled me to assess the first main aim of my thesis to determine the effects of 
spontaneous IUGR due to natural variation in litter size on postnatal growth, appetite and adult 
body composition in the guinea pig. This chapter has been published in the Journal of 
Developmental Origins of Health and Disease (395Appendix 1), and has been reproduced exactly 
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Intrauterine growth restriction (IUGR) and subsequent neonatal catch-up growth are 
implicated in the programming of increased appetite, adiposity and cardiometabolic diseases. 
Guinea pigs provide an alternate small animal model to rodents in which to investigate 
mechanisms underlying prenatal programming, being relatively precocial at birth, with smaller 
litter sizes, and undergoing neonatal catch-up growth after IUGR. The current study therefore 
investigated postnatal consequences of spontaneous IUGR due to varying litter size in this species. 
Size at birth, neonatal, juvenile (post-weaning, 30-60 d) and adolescent (60-90 d) growth, juvenile 
and adolescent food intake and body composition of young adults (120 d) were measured in 158 
male and female guinea pigs from litter sizes of one to five pups. Compared to singleton pups, 
birth weight of pups from litters of five was reduced by 38%. Other birth size measures were 
reduced to lesser degrees with head dimensions being relatively conserved. Pups from larger litters 
had faster fractional neonatal growth and faster absolute and fractional juvenile growth rates 
(P<0.005 for all). Relationships of post-weaning growth, feed intakes and adult body composition 
with size at birth and neonatal growth rate were sex-specific, with neonatal growth rates strongly 
and positively correlated with adiposity in males only. In conclusion, spontaneous IUGR due to 
large litter sizes in the guinea pig causes many of the programmed sequelae of IUGR reported in 
other species, including human. This may therefore be a useful model in which to investigate the 
mechanisms underpinning perinatal programming of hyperphagia, obesity and longer-term 
metabolic consequences.  
 









Small size at birth, following intrauterine growth restriction (IUGR), and/or subsequent 
neonatal catch-up growth are implicated in the initiation of permanent metabolic and/or 
physiological adaptations that persist through adult life. This “programming” may lead to 
increased appetite, adiposity (particularly of visceral depots) and cardiovascular and metabolic 
diseases including insulin resistance and glucose intolerance in adults16, 396. Therefore, animal 
models that mimic human IUGR aetiology, develop cardiovascular and metabolic sequelae with 
ageing after IUGR and/or catch growth and are comparable to the human in their relative maturity 
at birth are required so that underlying mechanisms and intervention strategies can be investigated.  
Small animal models have logistical advantages for such studies, including relatively 
rapid development, and short lifespans facilitating study of the development of progeny with 
ageing and intergenerational effects. Many small animal models of IUGR have used maternal 
feed310-312, 335, 374 or protein restriction332, 335, 375-377 to restrict fetal growth and investigate long-
term outcomes. In developed countries, however, placental insufficiency rather than maternal 
undernutrition accounts for the majority of human IUGR378, 379. Placental restriction induced by 
uterine artery ligation in rats causes IUGR and programs many components of the metabolic 
syndrome276, 280, 380, 381. These IUGR rat models often lack catch-up growth in the early neonatal 
period276, 280, 381, which is an independent risk factor for the development of adult metabolic disease 
in humans83, 382-384. 
Guinea pigs provide an alternate species in which to investigate developmental 
programming of health and disease. The guinea pig has a smaller litter size than the rat280, 374, 392, 
397, is relatively precocial at birth, and resembles the human fetus in having a body fat composition 
of around 10% at term398. In addition, and unlike the rat, the guinea pig spontaneously develops a 
phenotype resembling type 2 diabetes and including hyperglycaemia at 4 months of age399, 400 







metabolic disease with ageing. Maternal feed restriction in the guinea pig at 85% or 70% of ad 
libitum intake reduces fetal and placental weights, increases visceral adiposity in late gestation 
fetuses and alters placental structure impairing function309, 401, 402. Offspring of feed restricted 
mothers do not undergo neonatal catch-up growth, but are hyperphagic post-weaning, and as adults 
have impaired glucose tolerance and cholesterol homoeostasis, increased blood pressure and 
visceral adiposity310-312, demonstrating that prenatal restriction programs metabolic dysfunction in 
this species. These adverse effects are mostly seen in males, suggesting developmental 
programming in the guinea pig is sex-specific as described in other species, including humans385. 
Similarly uterine artery ablation in the mid-gestation guinea pig produces offspring with 
disproportionate IUGR (also known as asymmetrical IUGR), IUGR, and male offspring are 
hyperphagic post-weaning and have increased epididymal adiposity (postnatal outcomes were not 
assessed in females)284, 403. Furthermore, these surgical models impose sudden restriction on 
normal fetal growth at ~0.5 of term, and induce fetal death of between ~50 and 70% of pups283. 
Interestingly, at least in the case of the maternal undernutrition studies where correlation analyses 
were reported, size at birth was a stronger predictor of adult outcomes than was nutritional 
group310-312. In the present study, we therefore chose to investigate the effects of spontaneous fetal 
growth restriction that occurs with variation in litter size in the guinea pig.	
Spontaneous variation in litter size in the guinea pig also restricts fetal and placental 
growth in larger litters391, 392. Importantly, IUGR progeny from large litters undergo neonatal 
catch-up growth394. Consequences of this spontaneous IUGR due to litter size for subsequent 
postnatal growth, appetite and adult body composition have not been assessed. We therefore 
characterized the effects of variation in litter size and hence size at birth on these outcomes in the 
guinea pig. Because developmental programming is sex-specific in other species and in the guinea 









 Materials and Methods 
 
All guinea pigs had ad libitum access to a commercially-prepared guinea pig and rabbit 
ration (diet L102, Milling Industries Stockfeeds, Blair Athol, SA, Australia) containing 2640 
kcal/kg digestible energy, 19.0% crude protein and 2.5% crude fat, and supplemented with an 
increased content of vitamin E (165 mg/kg). All guinea pigs had ad libitum access to tap water 
with added ascorbic acid (400 mg/l, Ace Chemical Company, Camden Park, S.A. Australia). 
Nulliparous female guinea pigs were obtained at 3-4 months of age (Institute of Medical and 
Veterinary Science Tri-coloured, Gilles Plains Resource Centre, Gilles Plains SA, Australia) and 
housed in a 12:12 h day:night cycle throughout the experiment. Females were individually housed 
in wire cages and after 2-4 weeks acclimatisation were weighed three times per week, and checked 
for oestrus daily as indicated by a rupture of the vaginal membrane404. A single male was placed 
with the female during her oestrus (2-3 days of ~15 days cycle) and pregnancy was detected by 
the presence of a copulatory plug on the following morning. Pregnancy was confirmed (n=68) if 
the animal failed to return to oestrus in the subsequent cycle. At day 60 of gestation dams were 
transferred to individual housing in plastic tubs with paper bedding.  
After spontaneous delivery at term (range 65-74 days, mean ± S.E.M. 69.7 ± 0.1 days), 
numbers, sex, weights, abdominal circumference and nose to rump lengths of all liveborn offspring 
were measured and recorded on the day of birth or following morning if delivered overnight 
(n=158 offspring, males: n=78, females: n=80). Head widths (n=148, males: n=71, females: n=77) 
and lengths (n=144, males: n=69, females: n=75) were also measured in a subset of the progeny. 
Each dam was housed with her offspring and provided with ad libitum lucerne chaff in addition to 
the standard diet. Litters were weighed at least five times per week, until weaned at days 28-30 of 







from day 10 until weaning (AGR10-28), with data from birth to day 10 excluded due to non-linear 
growth over this period (Figure 2-2). After weaning all guinea pigs were housed individually and 
were weighed at least three times per week from day 30 until post-mortem at day 115 ± 1. Puberty 
in the guinea pig occurs between day 56-60 in males, and between day 30 and day 134 in females, 
with a mean age at puberty for females of 68 ± 22 days (mean ± SD)404. AGRs were, therefore, also 
calculated for juvenile (weaning - day 60, AGR30-60), and adolescent (days 60-90, AGR60-90) 
periods. Current fractional growth rate (FGR) for weight for each stage was calculated as AGR 
divided by the animal’s weight at the beginning of that stage. Feed intakes were recorded daily 
from day 40 to day 100 (61 males, 58 females) by weighing the filled feed hopper at 9 am, and 
then again before refilling at 9 am the following day. Relative feed intakes were calculated by 
dividing daily feed intake by body weight. Average feed intakes for each animal were then 
calculated for juvenile (days 40-60) and adolescent (days 60-90) periods, and feed efficiency was 




At day 115 ± 1, a subset of animals (n=41, 22 males, 19 females) selected randomly 
within each sex were humanely killed between 2 pm and 4 pm by lethal injection of sodium 
phenobarbitone. Fat depots (interscapular, omental and right side of the neck as well as bilateral 
axillary, retroperitoneal, perirenal, and groin depots) and bilateral skeletal muscles (hindlimb: M. 
biceps femoris, M. semitendinosus, M. gastrocnemius, M. plantaris, and M. tibialis; forelimb: M. 
biceps brachii) were dissected and weighed. Visceral adipose weight was calculated as the sum of 
weights of the left and right perirenal and retroperitoneal fat depots. The omental fat associated 
with the gastrointestinal tract is highly insulin resistant, drains directly into the portal vein and is 







separately. Subcutaneous adipose weight was calculated as the sum of weights of left and right 
axillary and groin fat, right side of the neck fat and interscapular fat depots. Visceral and 
subcutaneous fats were summed to give a measure of combined adiposity. The weights of dissected 
skeletal muscles were summed to obtain combined skeletal muscle mass. A high adiposity to lean 
tissue ratio is a risk factor for many cardiovascular and metabolic diseases406. A ratio of the 
combined adiposity to the combined muscle mass was, therefore, calculated as an index of 
adiposity relative to lean tissue. 
 
 
Data were analysed using SPSS 23.0 for Windows (IBM, Armonk, NY, USA). The 
effects of litter size on weight before mating, weight gain during gestation and change in weight 
during lactation were analysed by repeated-measures ANOVA. Effects of litter size on proportions 
of liveborn and stillborn progeny were analysed by 2 test. The effects of litter size and sex on 
birth phenotype and postnatal outcomes were analysed by mixed models ANOVA, including the 
dam as a random variable to account for effects of a common maternal environment. Bonferroni’s 
post-hoc comparisons were used to compare differences in maternal and offspring outcomes 
between litter sizes. Where effects of litter size differed between sexes, outcomes were analysed 
separately in each sex. Relationships between size at birth and growth rates were examined by 
Pearson’s correlation analysis, separately in each sex. Because birth weight ranges overlapped 
between litter sizes, and in order to assess the effect of catch-up growth on postnatal phenotypes, 
the independent effects of birth weight and neonatal growth rate for weight on post-weaning 
outcomes were examined by multiple linear regression separately in each sex. Gestation length 
was not correlated with outcomes when included in initial models and was, therefore, excluded 
from final multiple linear regression models. A P-value of ⩽ 0.05 was accepted as statistically 









Maternal weight at the oestrus before mating did not differ between the litters, however, 
weight over the 10 days prior to mating differed over time (P<0.001) and differed between the 
litter sizes over time (P=0.048, Figure 2-1). Dam weight on the day of mating (G0) correlated 
positively with subsequent litter size (r=0.280, P=0.025, data not shown).  
Weight increased with time over gestation, and differed between litter size groups, and 
the change in weight with time also differed between litter sizes (P<0.001 for all, Figure 2-1). The 
change in maternal weight in absolute terms from mating to day 60 of gestation (G60) increased 
with litter size (P<0.001, Table 2-1). Dams with litter size of three, four and five gained more 
weight over the first 60 days of gestation than those with litter sizes of one or two (Table 2-1). In 
contrast, change in maternal weight from mating to the day after delivery, reflecting weight of the 
dam herself, was lower in dams that delivered five pups than in all other groups (Table 2-1). 
Maternal feed intakes in mid gestation were greater in dams carrying five fetuses than in those 
with smaller litters (Table 2-1). In late gestation, dams carrying four or five fetuses ate more than 
dams carrying one or two fetuses (Table 2-1).  
Weight during lactation also differed between dams that delivered different litter sizes 
(P=0.036), changed with day (P<0.001), and the change in weight over time differed between the 
litter sizes (P=0.023, Figure 2-1). Dams that gave birth to litters of five gained more weight during 
















Figure 2-1 Maternal weight in pregnancy and lactation according to litter size. 
Maternal weight during the first 60 days of gestation (G) and throughout lactation (L). Dams 
carrying litters of five are shown in downwards triangles, four in upward triangles, three in 
































Table 2-1 Effect of litter size on maternal weights, absolute growth rates and feed intake during pregnancy. 
 
Outcome 
  Litter Size   Significance 
One Two Three Four Five LS 
       
Number of Litters 5 18 25 15 4  
Surviving:stillborn pups at birth 5:0 36:0 71:4 49:11 10:10 <0.001 
Total Pup weight per litter (g) 120 ± 2a 221 ± 5b 295 ± 6c 367 ± 8d 384 ± 31d <0.001 
Gestation length (days) 71 ± 1a 71 ± 0a 70 ± 0 a,b 70 ± 0 a,b 68 ± 1b 0.012 
       
Maternal Weights       
 Pre-mating Weight (g) 589 ± 11 637 ± 19 630 ± 14 651 ± 15 718 ± 41 0.091 
  Weight through gestation, G0-G60 (g) 217 ± 35a 329 ± 16a 408 ± 13b 440 ± 17b 442 ± 20b <0.001 
  Maternal weight, G0-L0 (g) 128 ± 17a,b 165 ± 22a 173 ± 14a 153 ± 19a,b 42 ± 29b 0.025 
  Maternal weight, L0-L30 (g) 26 ± 20a 44 ± 13a 51 ± 7 a 21 ± 14a 117 ± 21b 0.003 
       
Maternal Feed Intake       
 Mid-gestation, G20-G40 (g/day) 31 ± 3a 40 ± 2a 41 ± 1a 43 ± 2a 59 ± 4b <0.001 
 Late-gestation, G40-G60 (g/day) 38 ± 3a 42 ± 1a 46 ± 1a,b 47 ± 1b 50 ± 3b 0.001 
       









Gestation length differed between litter sizes, and was shorter in dams that delivered 
five pups compared to those with one or two (Table 2-1). Gestation length correlated negatively 
with the total pup weight in the litter (r= -0.268, P=0.035, n=67). The proportion of pups born 
alive decreased with increasing litter size (P<0.001), falling from 100% in litter sizes of one 
and two, to 94% in litters of three pups, 82% in litters of four pups, and 50% in litters of five 
pups. Stillbirths were unevenly distributed between litters, and were not consistently smaller 
than liveborn litter mates (data not shown). Total litter weight increased with increasing litter 
size (P<0.001), and was greater than three-fold higher in litters of four or five than in singleton 
litters (Table 2-1).  
 
 
Size at birth of liveborn pups included in later studies in terms of weight, length, 
abdominal circumference and weight:length ratio decreased as litter size increased (Table 2-2). 
Birth weight averaged 97 ± 1 g and ranged from 57 to 134 g across the cohort. Pups from 
singleton litters were all heavier than pups from litters of five, whereas some overlap in the 
range of individual birth weights was seen between pups from other litter sizes (Figure 2-2). 
Average birth weight of pups from a litter size of five was 38% lower than those from litter size 
of one, whereas other birth size measures were reduced to a lesser degree (length 18%; 
abdominal circumference 17%; weight:length 26%, Table 2-2). Head lengths and widths were 
relatively conserved in large litters (Table 2-2). Weight:length ratio and body mass index, 











Table 2-2 Effect of litter size on birth phenotype of live-born pups 
 
Outcome   Litter Size   ANOVA 
One Two Three Four Five LS Sex LS × Sex 
         
Number of litters 5 18 25 15 4    
Number of offspring 5 33 65 46 9    
Male:female Ratio 1:4 18:15 30:35 21:25 3:6    
         
Size at Birth         
 Weight (g) 121 ± 2a 111 ± 2a 96 ± 1b 90 ± 2b 73 ± 6c <0.001 NSD NSD 
 Length (mm) 173 ± 3a 163 ± 2a,b 158 ± 1a,b,c 154 ± 1c 141 ± 4d <0.001 NSD NSD 
 Abdominal circumference (mm) 117 ± 4a 111 ± 2a 104 ± 1b 103 ± 1b 96 ± 2b <0.001 NSD NSD 
 Head length (mm)e 47.1 ± 0.9a 43.8 ± 0.6a 42.2 ± 0.5 a,b 40.4 ± 0.7b 42.7 ± 0.7a,b 0.004 NSD NSD 
 Head width (mm)f 23.5 ± 0.7a 22.0 ± 0.2a,b 22.1 ± 0.2a,b 21.1 ± 0.2b 21.2 ± 0.3a,b 0.024 NSD NSD 
 Weight:length (g/mm) 0.70 ± 0.02a 0.68 ± 0.01a 0.61 ± 0.01b 0.58 ± 0.01b 0.51 ± 0.02c <0.001 NSD NSD 
 Body mass index (kg/m2) 4.05 ± 0.16a,b 4.16 ± 0.08a 3.89 ± 0.04 a,b 3.81 ± 0.06b 3.61 ± 0.13a,b 0.008 NSD NSD 
         
LS × sex, interaction between litter size and sex. NSD: not significantly different, P>0.1 
Data are expressed as actual means ± S.E.M. of offspring in each of the litter sizes (LS) for pups that survived to adulthood and were included in 
growth measures. Statistical models included dam to correct for the common intrauterine environment in multiple birth litters. 
 a,b,c,dMeans with different superscripts differ, P<0.05.  
eHead lengths were not measured in 4 offspring from litter size of three and 10 offspring from litter size of four.  











Figure 2-2 Birth weight distribution and litter size. 
Litter size and birth weights of individual guinea pig pups included in postnatal studies. Each 
symbol indicates an individual pup that survived to young adulthood, lines and whiskers 





















Growth rates were non-linear in the first 10 days of life in both sexes (Figure 2-3A 
and B). In repeated-measures analysis of weight measures during the neonatal period, weight 
decreased with increasing litter size in both sexes, and this difference in weight amplified with 
ageing in males but not females (Figure 2-3A and Figure 2-3B). AGR10-28 did not differ between 
litter sizes. Effects of litter size on neonatal FGR differed between sexes, such that in males 
FGR10-28 increased with each increase in litter size from two to four pups (Table 2-3). In 
females, FGR10-28 was greater in pups from a litter size of four than those from litter sizes of 
two or three (Table 2-3). Neonatal AGR and FGR were higher in males than females (Table 2-
3). AGR10-28 correlated positively with birth weight across the full range of litter sizes (r=0.296, 
P<0.001) and in males and females separately (r=0.323, P=0.003; r=0.303, P=0.001, 
respectively, Figure 4A). FGR10-28 correlated negatively with birth weight overall (r= - 0.525, 
P<0.001) and in males and females separately (r= -0.522, P<0.001; r= -0.701, P<0.001 
respectively, Figure 2-4B). 
 
 
Similar to the neonatal period, body weights during the juvenile period did not differ 
between litter size groups in females (Figure 2-3D). In males, juvenile body weights increased 
more rapidly in those from larger litters during this period (Figure 2-3C). AGR and FGR of 
juvenile guinea pigs were higher in those from litter sizes of four compared to those in litter 
sizes of two, and higher in males than females (Table 2-2). AGR30-60 was not correlated with 
birth weight overall, or in males or females separately. FGR30-60 correlated negatively with birth 







P<0.001) separately. In males, AGR30-60 was independently and positively correlated with 
neonatal FGR, but not with birth weight (Table 2-4). AGR30-60 was not independently correlated 
with birth weight or neonatal FGR in females (Table 2-4). In both males and females, FGR30-60 
was negatively correlated with birth weight but not neonatal FGR (Table 2-4).  
 
 
In adolescents, the change in body weight with age differed between litter sizes in 
males (Figure 2-3E), but litter size did not affect weights in females (Figure 2-3F). During the 
adolescent period, neither AGR nor FGRs differed between litter sizes (Table 2-3). AGR60-90 
was higher in males than females, and FGR60-90 did not differ between sexes. AGR60-90 was not 
correlated with birth weight, in males or in females, and was independently and positively 
correlated with neonatal FGR in females only (Table 2-4). Similarly, FGR60-90 was not 
correlated with birth weight, in males or in females, and was independently and positively 
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Figure 2-3 Growth of progeny as neonates, juveniles and during adolescence 
 
Body weights of male (A, C, E) and female (B, D, F) progeny that survived to adulthood and 
were included in growth measures, from birth to weaning (A, B), during the juvenile period (C, 
D) and during adolescence (E, F). Males are shown in closed symbols and females in open 
symbols with offspring from litters of four in upward triangles, three in circles and two in 








Table 2-3 Effect of litter size and sex on postnatal growth rates and food intake.  
Outcome 
Males from Litter Size Females from Litter Size ANOVA 
Two Three Four Two Three Four LS Sex LS × sex 
Postnatal Growth Rates          
Number of Offspring 18 35 21 15 30 25    
 Neonatal          
 AGR10-28 (g/d) 10.7 ± 0.3 10.7 ± 0.2 10.2 ± 0.2 9.4 ± 0.3 9.0 ± 0.2 8.9 ± 0.2 NSD <0.001 NSD 
 FGR10-28 (%) 5.5 ± 0.1a 6.3 ± 0.1b 6.9 ± 0.2c 5.2 ± 0.2a 5.5 ± 0.1a 6.0 ± 0.1b <0.001 <0.001 <0.0081 
 Juvenile          
 AGR30-60 (g/d) 7.5 ± 0.4a 8.7 ± 0a,b 8.9 ± 0.3b 6.0 ± 0.3a 6.2 ± 0.2a 7.1 ± 0.2b 0.0052 <0.001 NSD 
 FGR30-60 (%) 1.86 ± 0.09a 2.29 ± 0.07b 2.59 ± 0.08c 1.66 ± 0.08a 1.85 ± 0.07b 2.24 ± 0.08c <0.0013 <0.001 NSD 
 Adolescent          
 AGR60-90 (g/d)  5.5 ± 0.3 6.4 ± 0.2 5.6 ± 0.2 4.9 ± 0.3 4.9 ± 0.2 5.1 ± 0.2 NSD <0.001 0.0464 
 FGR60-90 (%) 0.89 ± 0.04 1.01 ± 0.03 0.94 ± 0.04 0.92 ± 0.06 0.95 ± 0.03 0.97 ± 0.04 NSD NSD NSD 
Feed Intakes          
Number of Offspring 15 28 16 12 21 17    
 Juvenile (40-60 days)          
  Absolute (g/day) 40 ± 2 43 ± 1 43 ± 1 34 ± 1 36 ± 1 37 ± 1 NSD <0.001 NSD 
  Relative (g/kg/day) 73 ± 2 78 ± 1 78 ± 1 70 ± 2a 77 ± 2b 79 ± 1b 0.0035 NSD NSD 
 Adolescent (60-90 days)          
 Absolute (g/day) 45 ± 2 50 ± 1 50 ± 2 41 ± 3 40 ± 1 42 ± 2 NSD <0.001 NSD 
 Relative (g/kg/day) 65 ± 2 70 ± 1 72 ± 3 70 ± 3 68 ± 2 69 ± 2 NSD NSD NSD 
Feed Efficiency          
 Juvenile (40-60 days) 0.184 ± 0.008 0.197 ± 0.005 0.204 ± 0.006 0.163 ± 0.008 0.177 ± 0.006 0.186 ± 0.008 0.0606 <0.001 NSD 
 Adolescent (60-90 days) 0.177 ± 0.010 0.189 ± 0.006 0.168 ± 0.008 0.155 ± 0.007a 0.179 ± 0.004b 0.173 ± 0.002a,b 0.0407 NSD NSD 
LS × sex , interaction between litter size and sex; AGR, absolute growth rate; NSD: not significantly different, P>0.1; FGR, fractional growth rate.  
Feed efficiency was calculated as average daily weight gain over each period divided by average daily feed intake. Data are expressed as means ± S.E.M. Statistical models included dam to 
correct for common intrauterine environment in multiple births. a,b,c Means with different superscripts differ, P<0.05.  
1In males, neonatal FGR10-28 differed between all litter sizes (P<0.01 for all), while in females, offspring of litters of four grew faster than litter of two and three only (P<0.02 for both).  
2Overall, juvenile AGR30-60 was greater in offspring from litters of four compared to litters of two (P=0.004) only.  
3Overall, juvenile FGR30-60 differed between all litter sizes (P<0.02 for all). 4Adolescent growth rates did not differ between litter sizes in males or females analysed separately.  
5Relative juvenile feed intake was greater in offspring from litters of three and four than in offspring from litters of two (P<0.02 for both).  
6 Juvenile (40-60 days) feed efficiency did not differ between litter sizes in males or females analysed separately. 7 Adolescent feed efficiency was greater in females, and tended to be greater 
























FIGURE 2-4 RELATIONSHIPS BETWEEN ABSOLUTE AND FRACTIONAL NEONATAL GROWTH 
RATE AND BIRTH WEIGHT IN MALE AND FEMALE GUINEA PIGS. 
 
Relationships between absolute (A) and fractional (B) neonatal growth rates from days 10-28 
and birth weight for male (n=78 closed symbols, solid regression line) and female (n=80, open 
symbols, dashed regression line) guinea pigs. A. Absolute neonatal growth rate correlated 
positively with birth weight in males (r=0.323, P=0.003) and females (r=0.303, P=0.006). B. 
Fractional neonatal growth rate correlated negatively with birth weight in males (r=-0.522, 
P<0.001) and females (r=-0.701, P<0.001). Offspring from litters of five are shown in 
downwards triangles, four in upward triangles, three in circles, litters of two in squares and 









Feed intake in juvenile progeny did not differ between litter sizes, and was greater in 
males than females, in absolute terms (Table 2-3). In contrast, relative feed intake in juveniles 
differed between litter sizes (Table 2-3). Overall, and in females, progeny from litters of three 
or four pups ate more in relative terms than those from litters of two pups (Table 2-3). Feed 
efficiency (weight gain per intake) in juvenile guinea pigs did not differ between litter sizes and 
was higher in males than in females (Table 2-3). In males, absolute juvenile feed intake was 
independently and positively predicted by birth weight and neonatal FGRs; these correlations 
were not significant in females, or for relative feed intake in the juvenile period (Table 2-4). 
Feed efficiency was correlated negatively with birth weight in juveniles of both sexes (Table 2-
4).  
Feed intake of adolescent progeny did not differ between litter size groups, and was 
higher in absolute but not relative terms in males than females (Table 2-3). Feed efficiency 
(weight gain per intake) in adolescent guinea pigs varied with litter size and was higher in 
progeny from litters of three than those from litters of two in females, with a similar trend 
overall, but not in males (Table 2-3). In males, adolescent absolute feed intake was predicted 
independently and positively by neonatal FGR, but not by birth weight (Table 2-4). In females, 
adolescent absolute feed intake was predicted by the overall model and independently and 
positively by both birth weight and neonatal FGR (Table 2-4). Relative adolescent feed intake 
was not correlated with birth weight or neonatal growth rate in males. In females, however, 
relative adolescent feed intake was predicted independently and positively by neonatal FGR, 
but not by birth weight (Table 2-4). Feed efficiency in adolescent males was not correlated with 
either birth weight or neonatal FGR (Table 2-4). Feed efficiency in adolescent females was 







Table 2-4 Relationships between birth weight and neonatal FGR and subsequent postnatal growth rates and food intake 
 
 Overall and Partial Correlation (r, P) 
 Males Females 
Measure Overall Birth Weight FGR10-28 Overall Birth Weight FGR10-28 
       
Postnatal Growth Rates  n=76   n=80  
 Juvenile       
 AGR30-60 (g/day) 0.240, 0.115 0.099, 0.397 0.238, 0.040* 0.128, 0.531 0.008, 0.944 0.097, 0.396 
 FGR30-60 (%) 0.412, 0.001* -0.297, 0.010* 0.114, 0.330 0.452, 0.001* -0.334, 0.003* 0.010, 0.929 
 Adolescent       
 AGR60-90 (g/day)  0.208, 0.204 0.047, 0.693 0.193, 0.093 0.408, 0.001* 0.189, 0.099 0.390, 0.001* 
 FGR60-90 (%) 0.272, 0.063 -0.185, 0.115 0.081, 0.494 0.494, 0.001* -0.052, 0.650 0.344, 0.002* 
       
Feed Intakes  n=61   n=58  
 Juvenile (40-60 days)       
 Absolute (g/day) 0.396, 0.007* 0.350, 0.006* 0.354, 0.006* 0.253, 0.161 0.188, 0.162 0.289, 0.057 
 Relative (g/kg/day) 0.221, 0.234 -0.025, 0.850 0.176, 0.178 0.351, 0.027* -0.159, 0.236 0.127, 0.347 
 Adolescent (60-90 days)       
 Absolute (g/day) 0.344, 0.026* 0.255, 0.055 0.336, 0.009* 0.434, 0.004* 0.327, 0.014* 0.434, 0.001* 
 Relative (g/kg/day) 0.282, 0.090 -0.100, 0.445 0.180, 0.168 0.507, 0.001* 0.124, 0.361 0.445, 0.001* 
       
Feed Efficiency       
 Juvenile (40-60 days) 0.295, 0.072 -0.281, 0.021* -0.072, 0.587 0.323, 0.049* -0.269, 0.043* -0.056, 0.679 
 Adolescent (60-90 days) 0.106, 0.729 -0.021, 0.878 -0.100, 0.457 0.339, 0.037* -0.285, 0.033* -0.063, 0.645 
       
n: Total number of offspring from all litters. FGR10-28, fractional growth rate for weight in neonates from 10-28 days of age. AGR, absolute growth rate 
*Significant correlations (P < 0.05) are shown in bold and trends (P < 0.1) in italics.  









Adult body size did not differ between litter size groups in males or females (Table 
2-5). Males were heavier, longer and had a higher weight:length ratio than females, but body 
mass index did not differ between sexes (Table 2-5). In males, adult body weight and 
weight:length ratio correlated independently and positively with neonatal FGR with similar 
trends for birth weight (Table 2-6). In females, adult body weight correlated independently and 
positively with birth weight with a similar trend for neonatal FGR (Table 2-6). Other measures 




Relative weights of subcutaneous, visceral, omental and total dissected fat depots and 
absolute weight of visceral and omental fat differed between litter sizes overall, with similar 
trends for absolute weights of subcutaneous and total dissected fat depots, and effects of litter 
size were similar in each sex (Table 2-5). Nevertheless, absolute weight of visceral and total 
dissected fat and relative weights of subcutaneous and visceral depots did not differ between 
any two litter sizes. Overall, offspring from litters of three had higher absolute and relative 
omental fat weights (P=0.049 and P=0.013 respectively) and higher relative total dissected fat 
(P=0.038) than those from litters of two; absolute and relative weights of fat depots did not 
differ between litter size pairs in sex-specific analyses. Absolute but not relative weights of 
subcutaneous, visceral and total dissected fat depots were greater in males than females (Table 
2-5). Skeletal muscle weights did not differ between litter sizes, whilst absolute skeletal muscle 
weights were higher in males than females (Table 2-5). The ratio of dissected fat:skeletal 







and relative weights of multiple fat depots, but not absolute or relative skeletal muscle weights, 
were independently and positively correlated with birth weight and neonatal FGR (Table 2-6). 
These correlations were strongest for weights of visceral fats and with the ratio of dissected fat 
to skeletal muscle weights (Table 2-6). In females, in contrast, absolute skeletal muscle weight 
was independently and positively correlated with birth weight but not neonatal FGR, and fat 








Table 2-5 Effect of litter size and sex on adult size and body composition  
 
 Males from Litter Size Females from Litter Size ANOVA 
 Two Three Four Two Three Four LS Sex LS × Sex 
          
Number of litters 6 5 3 2 5 3    
Number of offspring 8 7 7 2 9 3    
          
Adult Phenotype          
 Weight (g) 763 ± 37 838 ± 32 782 ± 34 676 ± 26 679 ± 18 674 ± 41 NSD 0.001 NSD 
 Length (mm) 342 ± 4 344 ± 10 339 ± 3 330 ± 6 318 ± 4 315 ± 7 NSD 0.001 NSD 
 Weight:length (kg/m) 2.2 ± 0.1 2.4 ± 0.1 2.3 ± 0.1 2.1 ± 0.1 2.1 ± 0.1 2.1 ± 0.2 NSD 0.021 NSD 
 Body mass index (kg/m2) 6.5 ± 0.3 7.1 ± 0.3 6.8 ± 0.2 6.2 ± 0.5 6.7 ± 0.2 6.8 ± 0.7 NSD NSD NSD 
          
Adult Body Composition          
 Subcutaneous fat (g) 34 ± 4 42 ± 3 33 ± 5 26 ± 2 32 ± 2 28 ± 4 0.096 0.028 NSD 
 Subcutaneous fat (%) 4.3 ± 0.3 5.1 ± 0.2 4.2 ± 0.4 3.8 ± 0.1 4.6 ± 0.3 4.1 ± 0.4 0.0351 NSD NSD 
 Visceral fat (g) 15 ± 2 19 ± 1 13 ± 2 10 ± 2 14 ± 1 12 ± 3 0.0471 0.026 NSD 
 Visceral fat (%) 1.9 ± 0.1 2.2 ± 0.1 1.7 ± 0.2 1.5 ± 0.2 2.1 ± 0.1 1.7 ± 0.4 0.0261 NSD NSD 
 Omental fat (g) 15 ± 1 17 ± 1 15 ± 1 12 ± 1 16 ± 1 14 ± 2 0.0372 0.098 NSD 
 Omental fat (%) 1.9 ± 0.1 2.1 ± 0.1 2.0 ± 0.1 1.8 ± 0.1 2.3 ± 0.1 2.0 ± 0.1 0.0132 NSD NSD 
 Total dissected fat (g) 63 ± 7 78 ± 4 62 ± 8 48 ± 4 62 ± 4 53 ± 9 0.0501 0.029 NSD 
 Total dissected fat (%) 8.1 ± 0.5 9.5 ± 0.2 7.8 ± 0.7 7.0 ± 0.3 9.1 ± 0.4 7.8 ± 1.0 0.0172 NSD NSD 
 Skeletal muscle (g) 21 ± 1 22 ± 1 21 ± 1 19 ± 3 18 ± 0 19 ± 1 NSD 0.024 NSD 
 Skeletal muscle (%) 2.7 ± 0.1 2.6 ± 0.1 2.7 ± 0.1 2.6 ± 0.0 2.7 ± 0.1 2.9 ± 0.2 NSD NSD NSD 
 Total dissected fat:  
 Skeletal muscle 
3.0 ± 0.2 3.6 ± 0.1 3.0 ± 0.3 2.6 ± 0.2 3.5 ± 0.2 2.8 ± 0.5 0.060 NSD NSD 
          
LS × sex, interaction between litter size and sex. NSD: not significant different, P>0.1.  
Data are expressed as mean ± S.E.M. Mean age ± S.E.M. at post mortem was 115 ± 1 days. Statistical models included dam to correct for common intrauterine 
environment in multiple births.  
1Relative subcutaneous, absolute and relative visceral, and absolute total dissected fat weights did not differ (P>0.05) between any two litter sizes.  







Table 2-6 Relationships between birth weight, neonatal FGR and adult phenotype in the guinea pig. 
 
 Overall and Partial Correlation (r, P) 
 Males n=22 Females n=19 
Measure Overall Birth Weight FGR10-28 Overall Birth Weight FGR10-28 
Adult size       
 Weight (g) 0.542, 0.037* 0.428, 0.053 0.528, 0.014* 0.522, 0.079 0.517, 0.028* 0.444, 0.065 
 Length (mm) 0.244, 0.558 0.186, 0.420 0.234, 0.307 0.119, 0.899 0.051, 0.846 0.112, 0.668 
 Body mass index (kg/m2) 0.405, 0.183 0.308, 0.175 0.392, 0.079 0.370, 0.332 0.369, 0.144 0.255, 0.322 
 Ponderal index (kg/m3) 0.268, 0.493 0.197, 0.391 0.259, 0.256 0.287, 0.526 0.282, 0.273 0.164, 0.528 
 Weight:length (kg/m) 0.524, 0.048* 0.407, 0.067 0.510, 0.018* 0.465, 0.160 0.464, 0.060 0.368, 0.146 
Adult body composition       
 Subcutaneous fat (g) 0.496, 0.079 0.436, 0.054 0.455, 0.044* 0.396, 0.255 0.339, 0.169 0.389, 0.111 
 Subcutaneous fat (%) 0.452, 0.128 0.410, 0.073 0.398, 0.082 0.322, 0.416 0.240, 0.337 0.322, 0.192 
 Visceral fat (g) 0.619, 0.010* 0.571, 0.007* 0.563, 0.008* 0.396, 0.255 0.396, 0.104 0.292, 0.239 
 Visceral fat (%) 0.611, 0.012* 0.579, 0.006* 0.532, 0.013* 0.346, 0.361 0.344, 0.162 0.224, 0.371 
 Omental fat (g) 0.656, 0.005* 0.486, 0.025* 0.652, 0.001* 0.398, 0.252 0.396, 0.103 0.262, 0.293 
 Omental fat (%) 0.620, 0.010* 0.397, 0.078 0.620, 0.002* 0.323, 0.414 0.307, 0.215 0.145, 0.566 
 Total dissected fat (g) 0.564, 0.032* 0.490, 0.028* 0.529, 0.016* 0.397, 0.254 0.384, 0.116 0.351, 0.153 
 Total dissected fat (%) 0.542, 0.044* 0.482, 0.031* 0.497, 0.026* 0.316, 0.431 0.306, 0.216 0.273, 0.267 
 Skeletal muscle (g) 0.217, 0.633 0.112, 0.434 0.198, 0.389 0.657, 0.011* 0.537, 0.022* 0.021, 0.934 
 Skeletal muscle (%) 0.348, 0.294 -0.204, 0.376 -0.348, 0.123 0.477, 0.126 0.452, 0.059 0.212, 0.399 
 Total dissected fat: skeletal muscle 0.604, 0.017* 0.511, 0.021* 0.580, 0.007* 0.323, 0.415 0.203, 0.420 0.320, 0.195 
n, Number of offspring. FGR10-28: fractional growth rate for weight in neonates from 10-28 days of age. 
Adult body composition is expressed as an absolute weight (g) and as a percentage of the body weight at the time of postmortem (%).  







In the current study, increasing litter size in the guinea pig induced disproportionate 
IUGR which was followed by catch-up growth commencing in neonatal life and which 
persisted post-weaning but not into adolescence. Concomitant with this accelerated growth, 
offspring from large litters had increased relative feed intakes as juveniles. Increased neonatal 
growth also predicted hyperphagia in juveniles, which persisted into adolescent life in both 
sexes. Interestingly, perinatal growth was correlated with adult body composition differently in 
males and females, predicting visceral adiposity in males, but not females, and consistent with 
sex-specific relationships between neonatal growth and adiposity in children12. Spontaneous 
fetal growth restriction induced by large litter sizes in the guinea pig, therefore, induces sex-
specific programming of postnatal phenotype. As the guinea pig also develops diabetes mellitus 
spontaneously in adulthood399, 400, this provides a model in which to investigate developmental 
programming of susceptibility to metabolic diseases of ageing. 
 
 
Mothers who were larger at conception tended to have the larger litter sizes, 
consistent with previous reports of a positive relationship between weight and number of 
corpora lutea at conception397, and suggesting that their greater litter sizes reflect higher 
ovulation rates. In the present study, the proportions of stillborn pups increased in large litters, 
particularly in litters of five pups. This may reflect their earlier gestational age at delivery, 
which is negatively correlated with stillbirth rates in this species407. Small size at birth relative 
to gestational age is also a predictor for stillbirth in the guinea pig407. Restricted nutrient supply 
in utero due to competition for maternal nutrients and/or restricted delivery due to placental 
growth and/or function may, therefore, also have contributed to poorer neonatal outcomes in 
large litters in the present study, as these pups were substantially smaller at birth401, 402. Not 





smaller litters. Nevertheless, the change in maternal weight from conception to the start of 
lactation, reflecting growth of the mother herself, was lowest in dams that gestated five pups. 
Guinea pigs give birth to relatively mature pups that account for a significant part of their own 
weight398, and pregnancy appears to reduce maternal energy stores in late gestation, reflected 
in lighter adipose depots408. Together with these previous studies, our results suggest that high 
fetal demand for nutrients plus inability to further increase feed intake in late gestation limits 
maternal growth in dams carrying the largest number of pups. Compensatory hyperphagia may, 
therefore, contribute to the subsequent faster lactation growth rates that we observed in dams 
that gave birth to large litters. It is also likely that nutrient flow to milk production was lower 
in these mothers that gestated litters of five pups than in those that delivered three or four pups 
due to lower perinatal survival of pups and/or earlier weaning. Previous studies have reported 
that although mothers produce higher yields of milk in larger litters the milk yield per pup is 
reduced, suggesting pups in larger litters may be “force” weaned earlier in comparison to those 
from smaller litters409. Interestingly, dams in all litter size groups gained weight in lactation in 
the present study, in contrast to a previous report410.  
 
 
Although there was some overlap in ranges of individual birth weights between litter 
size groups, mean birth weight decreased consistently with increasing litter size and singleton 
pups were 38% heavier than pups from litters of five. This birth weight difference is of a similar 
magnitude as that reported for weights of pups in late gestation in multiparous females391. Most 
measures of size at birth decreased with increasing litter size in the present study, including 
weight to length ratio (an index of thinness), and head width to birth weight ratio (an index of 
head sparing). Thus, spontaneous fetal growth restriction in guinea pigs from large litters 
induces disproportionate IUGR, which in human epidemiological studies is associated with 





proportionate reduction in size at birth210, 411. Asymmetrical growth restriction resulting in a 
thin neonate and characterised by head sparing usually reflects restriction predominantly in late 
gestation26, and is also observed following maternal famine exposure in late gestation in 
humans172 and in experimental models of restricted placental capacity in sheep293. 
Increased litter size may reduce fetal nutrient availability and hence size at birth via 
a reduction in placental size and function and/or competition for maternal nutrients together 
with physical limitations on maternal feed intake392, 394, 397. Fetal weight in guinea pigs diverges 
between litter sizes from ~55 days of gestation391, consistent with progressively increasing 
limitation of nutrient/oxygen supply in large litters through late gestation. Limited maternal 
nutrient intake may also contribute to reduced fetal growth in large litters, with similar mean 
birth weights in litters of four and five in the present study as those induced by feed restriction 
of guinea pigs throughout gestation to either 85% or 70% of ad libitum feed intake310. Shorter 
gestation lengths may also contribute to reduced size at birth. Gestation length is reduced in 
guinea pig litters with high total fetal weights394, which may have contributed to the 3-4 day 
reduction in gestation lengths in litters of five compared to those in litters of one or two pups 
in the present study, and may in turn have contributed at least in part to smaller sizes at birth in 
this group. Weight of fetal guinea pigs increases by ~10% over the last 3-4 days of gestation, 
although interestingly weight gain during this period is markedly lower in large litters than in 
litters with only one or a few pups391. Differences in gestation length are thus unlikely to explain 
the majority of difference in size at birth that we observed in large litters. In recent studies of 
neuroactive steroids in this species, preterm delivery at 62-63 days of gestation (~12% reduction 
in gestation length) reduced birth weight by only 17%412, considerably less than the 38% 
difference in average birth weight between pups from litters of one and five. In the present 
study, the negative relationship between size at birth and litter size in most parameters was 
observed across the full range of litter sizes, further implying that additional factors contribute 







Offspring of larger litters grew faster in fractional terms as neonates, indicating a 
change in partitioning of nutrient intake towards growth in these spontaneous IUGR guinea 
pigs. Increased appetite may also contribute to accelerated neonatal growth after IUGR, as 
occurs in other species including humans79, 293, 413, but neonatal feed intakes have not as yet 
been reported in IUGR guinea pigs. Accelerated neonatal growth may program adverse later 
outcomes in these guinea pigs from large litters, as this is an independent risk factor for the 
development of cardiovascular and metabolic disease in humans83, 382-384. Interestingly, despite 
the more rapid relative neonatal growth in pups from larger litters, these pups exhibited less 
growth check after weaning at 28 days than those from smaller litters (Figures 3C and 3D), 
suggesting that they may have changed their intake from milk to solid feed earlier. This may 
reflect lower milk production per pup, reported previously in large guinea pig litters409, and 
competition between litter mates for the two available teats in this species which only allows 
pups to suckle periodically404. Guinea pigs have been successfully weaned at birth or 8 days of 
age409, indicating that there is not an absolute requirement for suckling in this species. 
 
 
Interestingly, the accelerated relative growth in guinea pigs from large litters 
persisted after the neonatal period, and was also observed in juveniles at 30-60 days of age, but 
this did not continue subsequently to adolescence. The accelerated juvenile growth does appear 
to reflect continued catch-up growth following removal of prenatal constraint, since juvenile 
relative growth rates were negatively correlated with birth weight in both males and females, 
as were relative growth rates in the neonatal period. The relative duration of catch-up in IUGR 
guinea pigs thus appears to be somewhat longer than in IUGR humans, where the majority of 





years of age57, 414-416. Juvenile growth rates in guinea pigs from large litters were greater than 
those from smaller litters, not only in relative, but also in absolute terms. Increased appetite and 
feed intake probably underlies the accelerated juvenile growth rates of these spontaneously 
growth-restricted guinea pigs, at least in part, since we also observed increased food intake 
relative to body size in these animals. This role for increased appetite as a mechanism for early 
catch-up growth after IUGR is further supported by a lack of difference in absolute or relative 
feed intakes between litter sizes during adolescence, when the litter sizes also had similar 
growth rates. Feed efficiency did not differ between litter sizes in the juvenile period in either 
sex, and was improved in female offspring from litters of three compared to two as adolescents. 
Although this may suggest decreased relative fat deposition in these adolescent females, since 
fat has a greater energy content per weight than muscle, this did not reduce fatness in adulthood. 
Juvenile but not adolescent feed efficiency was negatively correlated with birth weight in both 
sexes, indicating improved efficiency of conversion of food to weight gain, and thus suggesting 
greater relative lean tissue deposition in the juvenile period. This pattern of post weaning 
accelerated growth may also lead to adverse health consequences, since accelerated growth 
after IUGR in rats; particularly when allowed increased caloric feed intake or fed Western-style 
diets as adults; is associated with obesity, cardiovascular complications and early death374, 375, 
417, 418. Despite the fact that effects of litter size on growth were similar in both sexes in the 
present study, relationships between perinatal growth and both post-weaning growth and feed 
intake were sex-specific. Relative juvenile growth rates correlated negatively with birth weight 
in both sexes, as discussed above, but absolute juvenile growth rates were not correlated with 
size at birth in either sex, and correlated positively with neonatal growth in males only. Juvenile 
feed intake in absolute terms correlated positively with size at birth and neonatal FGR, but in 
males only, and may reflect effects of perinatal growth on body size, since relative feed intakes 
did not correlate with perinatal growth in either sex. In contrast to these largely male-specific 





growth were observed only in females, where rapid neonatal growth predicted faster growth 
and higher feed intakes in adolescence. These results suggest that programming of postnatal 
appetite and nutrient partitioning by prenatal and early life exposures is sex-specific in guinea 
pig, and furthermore that the sex-specific nature of these effects depend on age. Sex-specific 
programming of later outcomes has been also reported in humans and in animal models, 
particularly for adult metabolic and body composition outcomes385. These results further 
reinforce the need to study progeny of both sexes in future studies investigating developmental 
programming of metabolic and other outcomes in the guinea pig. 
 
 
In the present study, progeny of large litters, despite their smaller size of birth, 
attained similar adult size as those from small litters who were subject to less restriction in 
utero. This is consistent with findings of human studies, where ~85-90% of individuals who 
were born IUGR attain a final height within 2 S.D. of their peers57, 415, 416. Accelerated neonatal 
growth was a major determinant of adult size, particularly in male guinea pigs, again consistent 
with human studies where failure of early catch-up growth is a strong predictor of shorter adult 
height57, 415. Few differences were seen in adult body composition between litter size groups, 
although we were not able to include progeny of litters of one or five pups in these litter size 
comparisons due to low numbers of adult pups of each sex available as young adults. We did 
observe greater weights of omental and total dissected fat in offspring from litters of three than 
in those from either two or four pups. We would have expected greater fatness with increasing 
litter size, given that increasing litter size was associated with progressive decreases in size at 
birth and increases in neonatal growth rates. Interestingly, IUGR induced by chronic maternal 
ethanol consumption throughout guinea pig pregnancy, a model for fetal alcohol syndrome, is 
followed by neonatal catch-up growth and increased visceral and subcutaneous adiposity in 





these causes of IUGR. In male IUGR rats catch-up growth after weaning is followed by 
development of increased visceral adiposity by 7 weeks and obesity by 26 weeks280. IUGR 
induced by uterine artery ablation in guinea pigs is also associated with increased visceral 
adiposity in male offspring, although in this model progeny do not undergo catch-up growth, 
and body composition outcomes in females were not reported284. Small size at birth and catch-
up growth in early life are independent risk factors for obesity in human adults382 and similar 
effects might explain the greater omental and total adiposity we observed in progeny from litters 
of three compared to two male pups. The reason why these effects were not even more 
pronounced in progeny from litters of four pups, which had similar fatness as those from litters 
of two pups, is not clear, given that these pups also experienced catch-up growth and grew faster 
than progeny of litters of two or three pups during the neonatal and juvenile periods. It is 
possible that these progeny of litters of four pups will develop central adiposity with further 
ageing beyond young adulthood, as these animals achieved similar weights to those of pups 
from litters of two nearly a month later than the pups from litters of three, particularly in males. 
Across the entire range of litter sizes, the relationships between size at birth, neonatal 
growth and adult body composition were sex-specific, as also seen for predictors of post-
weaning growth and feed intake. The increased adiposity, particularly visceral adiposity, 
observed in adult male guinea pigs who had grown rapidly as neonates is likely to be associated 
with adverse metabolic outcomes in these animals. Visceral fat is insulin resistant and in 
humans, visceral fat mass is a stronger predictor of cardiovascular and metabolic dysfunction 
than subcutaneous fat405, 406. The association between early life catch-up growth and later 
adiposity seen here in male guinea pigs is consistent with reports in humans and other species239, 
258, 293, 374, 382, 420. Interestingly, our results are consistent with reports from several of these 
studies where the independent associations of small size at birth and neonatal catch-up growth 
with adult adiposity were investigated, and neonatal catch-up growth was more predictive of 







Spontaneous fetal growth restriction due to litter size in the guinea pig gives rise to 
offspring with disproportionate IUGR and these offspring undergo catch-up growth which 
persists from neonatal life post-weaning into the juvenile period. Further programmed adult 
outcomes described here in progeny of large litters whose growth was restricted in utero, such 
as increased visceral adiposity and hyperphagia, are similar to effects of small size at birth 
induced in other models of IUGR in guinea pig310, rat374 and in humans421. The spontaneous 
IUGR guinea pig may, therefore, be a useful model in which to investigate the mechanisms 
underpinning perinatal programming of hyperphagia and obesity. Because many of these 
relationships are sex-specific, it will be critical to include progeny of both sexes in future 
studies. Further studies are required to determine if the spontaneously growth restricted guinea 






Insulin sensitivity of glucose metabolism in young adult 
guinea pigs - validation of the hyperinsulinaemic 
euglycaemic clamp method 
 
 Overview 
The following study was designed to characterise the hyperinsulinaemic-
euglycaemic clamp in the chronically catheterised, non-anaesthetised guinea pig. A dose 
response study for whole body glucose uptake using human insulin was conducted, followed 
by clamp experiments at two insulin infusion rates; 30 mU.min-1.kg-1 (n=53, males: n=31, 
females: n=22) and 7.5 mU.min-1.kg-1 (n=38, males: n=19, females: n=19). Animals studied in 
this chapter were bred and monitored by myself during pregnancy, postnatal growth and post-
surgery for insertion of vascular catheters. I independently performed >80% of the 
hyperinsulinaemic-euglycaemic clamps, performed the majority of the assays for plasma 
human insulin and [3-3H]-glucose 3H2O, was involved in all post-mortems for the collection of 
body composition data, and analysed all of the data.. Dr Arkadi Katsman is acknowledged for 
the dose response studies and Dr Arkadi Katsman and Ms Melissa Walker assisted with 
catheterisation surgeries, post-mortem tissue collection, human insulin and [3-3H]-glucose 
3H2O assays. I would like to acknowledge Prof. C.C. Yip (University of Toronto, Canada) for 
donation of the purified guinea pig insulin and rabbit anti-guinea pig insulin for the 
measurement of guinea pig insulin in a subset of these animals and Ms Patricia Grant for 
performing the assays. 
Since thesis assessment, the data in Chapter 3 has been published in combination with 
comparative data (not described in the thesis) and the first page of this manuscript is shown in 
Appendix 2. The chapter included here is the original version from thesis assessment, with 
minor revisions as suggested by assessors. 
Horton D.M., Saint D.A., Owens J.A., Gatford, K.L. Kind K.L. (2017) Use of the 
hyperinsulinemic euglycemic clamp to assess insulin sensitivity in guinea pigs: dose response, 
partitioned glucose metabolism, and species comparisons. American Journal of Physiology – 











The guinea pig is an alternate small animal model for the study of metabolic disorders 
and for investigating the mechanisms underlying prenatal programming of such disorders, 
including insulin sensitivity. However, only one study to date has reported the use of the 
hyperinsulinaemic-euglycaemic clamp (HEC) to assess glucose metabolism in anaesthetised 
animals in this species, and the dose-response has not been reported. We therefore characterised 
the dose-response curve for whole-body glucose uptake using recombinant human insulin in 
the adult guinea pig. In subsequent studies, we used concomitant D-[3-3H]-glucose infusion to 
characterise insulin sensitivities of whole body glucose uptake, glucose utilisation, production, 
storage and glycolysis in young adult guinea pigs at infusion rates of human insulin that produce 
~half maximal and near maximal whole body responses. Clamps were successfully performed 
in 84% of catheterised guinea pigs. Human insulin infusion at 7.5 mU.min-1.kg-1 increased rates 
of glucose utilisation (P<0.001) and storage (P<0.01), while suppressing that of glucose 
production (P<0.001). Insulin infusion at 30 mU.min-1.kg-1also increased the rate of glycolysis 
in females (P<0.01). Fasting plasma glucose, metabolic clearance of insulin and rates of glucose 
utilisation, storage and production during insulin stimulation were higher in female than male 
guinea pigs (P<0.05), but insulin sensitivity of these and whole body glucose uptake did not 
differ between sexes. This study establishes a method for measuring partitioned glucose 
metabolism in chronically catheterised conscious guinea pigs, providing the basis for further 






Guinea pigs provide an alternate small animal species to rat and mouse in which to 
investigate developmental programming of health and disease. The guinea pig has a smaller 
litter size than the rat280, 374, 392, 397, is relatively precocial at birth, and resembles the human fetus 
in having ~10% body fat at term398. Restriction of fetal growth in the guinea pig by maternal 
feed restriction increases visceral adiposity and blood pressure, impairs glucose tolerance and 
alters cholesterol homoeostasis in adult offspring310-312, indicating that prenatal restriction can 
perturb metabolic function in this species. Size at birth was a stronger predictor of adult 
outcomes than maternal nutritional group in these studies310-312, suggesting the need for further 
study of developmental programming in a model of spontaneous fetal growth restriction in this 
species. Studies described in Chapter 2 demonstrated that increased litter size in the guinea pig 
is associated with decreases in birth weight, and IUGR progeny from these larger litters exhibit 
neonatal catch up growth, as well as increased central adiposity as adults, particularly in 
males395. Hence, fetal growth restriction due to increasing litter size in the guinea pig may be a 
suitable model in which to further study mechanisms underpinning the programming of 
impaired metabolic function. 
In human populations, increased risks of insulin resistance after IUGR have been 
reported in children and in young and older adults187, 189, 190, 192-199, and development of insulin 
resistance in skeletal muscle is suggested as a primary initiating mechanism in the programmed 
development of diabetes126. Animal models enable study of whole body, hepatic and peripheral 
insulin sensitivity, as well as investigation of the specific tissue and molecular changes that may 
underlie altered functionality of insulin action in key target tissues. While impaired glucose 
tolerance has been reported in IUGR guinea pig offspring of feed-restricted mothers310, the 
effects of fetal growth restriction on insulin sensitivity have not been reported in this species. 
The hyperinsulinaemic-euglycaemic clamp (HEC) is the “gold standard” method for 




glucose during the HEC also allows the metabolic fate of glucose and insulin actions in 
individual tissues in vivo to be characterised. This approach has been used extensively in small 
mammalian species, such as the mouse and rat, to investigate the insulin axis under normal and 
pathophysiological conditions143, 144, 147, 422, 423. However, to date, use of the HEC has only been 
reported in a single study in guinea pigs, investigating the effects of the chemotherapeutic agent 
cisplatin on insulin sensitivity424. Only males were used in this study and were assessed at a 
single insulin dose and under general anaesthesia424, which is known to reduce whole body and 
hepatic insulin sensitivity in the rat425. Validation of the methodology for the HEC and 
characterisation of both whole body and partitioned insulin action on glucose metabolism in 
conscious animals of both sexes is required to enable further study of the programming of 
metabolic function in this species. Hence, the aim of this study was to characterise the insulin 
dose-response curve for whole body glucose metabolism in chronically catheterised guinea pigs 
using the HEC. Secondly, we measured whole body glucose utilisation, production, glycolysis 
and storage, and their responsiveness to human insulin in chronically catheterised young adult 
guinea pigs and compared these between males and females. Validation of this methodology 
will provide the basis for further studies into the programming of insulin resistance following 
fetal growth restriction in the guinea pig. 
 
 Materials and Methods 
 
All animal studies were approved by the Animal Ethics Committee of the University 
of Adelaide (Approval number M56/96). Adult male guinea pigs (n=8, 3-4 months of age, 
Institute of Medical and Veterinary Science Tri-coloured, Gilles Plains Resource Centre, Gilles 
Plains South Australia) were used for the initial insulin dose response study. For all additional 
experiments, animal management was as described in Chapter 2395. Nulliparous female guinea 




at 100 days of age. All animals were housed under 12:12 hour light:dark conditions and had ad 
libitum access to a commercial guinea pig/rabbit ration modified with an increased content of 
vitamin E (165 mg.kg-1), except when fasted for HEC studies as described below, and free 
access to tap water supplemented with ascorbic acid (400 mg.L-1). 
 
 
For these studies, a total of 84 guinea pigs underwent surgery for the insertion of 
vascular catheters. Body weight in the males ranged from 678 g to 942 g (Mean  SEM, 806  
11 g, n=45) and in the females from 562 g to 806 g (686  10 g, n=39). Catheters were inserted 
into the right jugular vein (silastic, 0.51 mm ID, 0.94 mm OD, softened in chloroform, sleeved 
onto polyvinyl, 0.5 mm ID, 1.00 mm OD) and right carotid artery (polyvinyl, 0.4 mm ID, 0.8 
mm OD, sleeved into polyvinyl, 0.58 mm ID, 0.96 mm OD) under general anaesthesia induced 
by ketamine (75 mg.kg-1 body weight, intraperitoneal) and xylazine (6 mg.kg-1 body weight, 
intramuscular). Both carotid and jugular catheters were successfully implanted in 80 animals 
(95%). Catheters were maintained by flushing daily with heparinised saline (500 U.ml-1). Patent 
carotid and jugular catheters were present in 78% of the guinea pigs at 5 days after surgery, 
68% at 7 days after surgery, 58% at 10 days after surgery and 40% at 14 days after surgery. 
HECs, which commenced a minimum of 5 days after surgery, were successfully completed in 
66 of the 80 catheterised guinea pigs.  
 
 
Guinea pigs were fasted for 16 h prior to the HEC. Extension lines, made from 
polyvinyl tubing, were attached to the catheters and exteriorised through the top of the cage 
allowing guinea pigs to remained unrestrained during the experiment.  
Recombinant human insulin (Actrapid, Novo Nordisk, A/S, Denmark) was diluted in 




120 minutes. In a subset of eight males, the effect of increasing the rate of insulin infusion was 
examined by performing HECs at insulin infusion rates of 7.5 (n=8), 15 (n=8), 30 (n=3) and 60 
(n=4) mU.min-1.kg-1. At least 3 days recovery was allowed between each HEC. Remaining 
HECs were then performed using insulin infusions of either 7.5 mU.min-1.kg-1 (n=31 male, 
n=22 female) or 30 mU.min-1.kg-1 (n=16 male, n=19 female). Twenty-five of the animals had 
HECs performed at both 7.5 and 30 mU.min-1.kg-1 insulin infusion rates.  
Blood glucose was measured by glucometer (HemoCue AB, Sweden) in fasting 
samples collected 20, 15, 10, 5 and 0 minutes prior to the start of the insulin infusion, and in 
blood samples (50 - 100 l) collected every 5 minutes throughout the HEC. Intravenous 
infusion of glucose (10% glucose, Baxter Healthcare, NSW, Australia) commenced 15 minutes 
after the start of the insulin infusion. The glucose infusion rate (GIR) was adjusted based on the 
blood glucose measurements to restore and maintain euglycaemia, defined as the mean fasting 
blood glucose concentration, using a modified version426 of the algorithm described by De 
Fronzo et al.142.  
A subset of the animals were co-infused with D-[3-3H]-glucose (Amersham 
Pharmacia Biotech, Buckinghamshire, England) to determine insulin sensitivity of individual 
components of whole body glucose metabolism (peripheral glucose utilisation and endogenous 
glucose production). D-[3-3H]-glucose was administered as a priming bolus (14.5 Ci.kg-1) and 
as a continuous intravenous infusion (0.45 Ci.min-1.kg-1) for two hours prior to and during 
clamps at insulin doses of 7.5 (n=19) or 30 (n=19) mU.min-1.kg-1. 
Larger blood samples (500 l) were collected at the -20, -15, -10, -5, 0, 60, 75, 80, 
85, 90, 95, 105 and 120 minutes from the start of the insulin infusion for subsequent analysis 
of radiolabelled metabolites, and human and guinea pig insulin. Blood was centrifuged at 3000 
rpm for 15 minutes and plasma was removed and stored at -20°C. The total blood volume 
removed from each guinea pig during the experiment was approximately 7.5 ml (~12% of blood 









Human insulin concentrations were analysed in samples collected prior to and at 60, 
75, 90, 105 and 120 minutes of the insulin infusion by radioimmunoassay using a commercially 
available kit (Insulin-CT, CIS Bio International, France). Cross-reactivity of guinea pig insulin 
in this assay was <2%. 
Guinea pig insulin concentrations were measured by radioimmunoassay, as described 
previously310, 427. In brief, guinea pig insulin was measured in plasma samples collected prior 
to (-10, -5, 0) and at 60, 75, 90, 105 and 120 minutes of insulin infusion during the dose response 
studies. Purified guinea pig insulin and rabbit anti-guinea pig insulin were provided by 
Professor C.C. Yip (University of Toronto, Canada). Guinea pig insulin was iodinated with Na 
125I (Amersham Pharmacia-Biotech, Sydney, NSW, Australia) and chloramine T to specific 
activities of 35-50 Ci.g-1, and separated from reaction components by chromatography on 
Sephadex G50 (Amersham Pharmacia-Biotech, Sydney, NSW, Australia). Guinea pig insulin 
was measured in duplicate samples of guinea pig plasma and standards (0.1225 to 31.25 ng.ml-
1). The amount of guinea pig insulin that inhibited radioligand binding by 50% averaged 485 
pg, while the CV for the same sample assayed on different occasions was 9.6% within assays, 
and 5.3% between assays. 
 
 
The specific activities of D-[3-3H]-glucose and of 3H2O were measured in plasma 
samples collected prior to and during the HEC (-20, -15, -10, -5, 0, 60, 75, 80, 85, 90, 95, 105, 
120 minutes), using methods based on previous studies in the rat428, 429. To deproteinise the 




followed by 30 minutes incubation on ice, and addition of 100 L of 0.3N ZnSO4 (Sigma 
Aldrich). Samples were incubated on ice for a further 30 minutes, centrifuged at 4C for 15 
minutes at 3500 rpm, and the supernatant removed and weight determined. Forty l was assayed 
in quadruplicate in 10 ml scintillation vials, two samples of which were dried uncovered in an 
oven at 55ºC for 60 minutes. Water, 0.34 ml and 0.3 ml was added to each of the dried and 
undried vials respectively. In addition, to each vial 1 ml of Tissue Solubilizer (NCS-II Tissue 
Solubilizer 0.5N Amersham International Arlington Heights, IL) and 10 ml Ready Organic 
Scintillant (Beckman Coulter Inc., Fullerton CA) was added. Vials were capped and covered 
with aluminium foil, and equilibrated at room temperature overnight before counting for 10 
minutes using a -counter (Beckman Coulter Inc.). The activity of the dried (radioactivity of 
D-[3-3H]-glucose) vials was subtracted from that of the undried vials (radioactivity of D-[3-
3H]-glucose + 3H2O) to give the activity of 3H2O alone.  
 
 
Basal plasma glucose and FFA concentrations were calculated as the mean ± SEM of 
the five samples collected in the last 20 minutes (-20, -15, -10, -5, 0 minutes) of the 2-hour 
saline infusion prior to commencing the HEC. Steady-state plasma concentrations of guinea pig 
and human insulin were calculated as the average of concentrations measured every 15 minutes 
throughout the final hour of the HEC (60-120 minutes). Steady state glucose infusion rate 
(ssGIR) was calculated as the average GIR during the final hour of the clamp. Whole body 
insulin sensitivity was calculated by dividing ssGIR by steady-state plasma concentrations of 
human insulin. The post-hepatic metabolic clearance rate (MCR) of human insulin was 
calculated as the insulin infusion rate during the HEC divided by steady-state plasma 






Plasma D-[3-3H]-glucose specific activity plateaued during the last 20 to 40 minutes 
of D-[3-3H]-glucose infusion in the basal state and during HEC at insulin infusion of 
7.5mU.min-1.kg-1. This is similar to that seen in hyperinsulinaemic-euglycaemic clamp studies 
in the rat145. During this steady-state period, the rate of glucose utilisation or disappearance of 
glucose (Rd) was calculated (Equation 1) by dividing the D-[3-3H]-glucose infusion rate 
(dpm.min-1) by the steady-state plasma D-[3-3H]-glucose specific activity (dpm.mol-1) as 
previously described428, 429. 
 







In the basal state, the rate of glucose appearance (Ra) is equal to the basal rate of 
endogenous whole body glucose production (Rd), which can be calculated as the D-[3-3H]-
glucose infusion rate (dpm.min-1) divided by the steady-state plasma D-[3-3H]-glucose specific 
activity (dpm.mol-1) as previously described 428, 429(Equation 2) 427, 428.  
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In the insulin-stimulated state, the rate of whole body glucose utilisation equals the rate of 
endogenous glucose production plus the exogenous glucose infusion. Therefore, endogenous 
glucose production was calculated as the rate of whole body glucose utilisation minus 
exogenous glucose infusion (Equation 3) 428, 429. 
 






The 3H in the C-3 position of D-[3-3H]-glucose is lost selectively to H2O during 
glycolysis430. Rates of whole body glycolysis were determined from the rate of increase in 3H2O 
(dpm.min-1) multiplied by the total body water mass and divided by the D-[3-3H]-glucose 
specific activity (dpm.mol-1) in both the basal and insulin-stimulated states. Plasma H2O was 
assumed to be 93% of plasma volume, and the mass of H2O in the body was assumed to be 65% 
of total body weight, based on estimates in rodents (Equation 4) 428, 429. The rate of whole body 
glycolysis was determined during the last 15 minutes of D-[3-3H]-glucose infusion in the basal 
state, and the last 60 minutes of insulin infusion. Glucose storage in each state was calculated 
as the difference between total glucose utilisation and glycolysis (Equation 5) 427, 428. 
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Data were analysed using SPSS 24.0 for Windows (IBM, Armonk, USA). For 
comparison between sexes, due to inclusion of different animals in studies at each insulin dose, 
the effect of sex was determined by analysis of variance separately at each dose. The effect of 
recombinant human insulin infusion on fasting plasma guinea pig insulin levels, and on 
components of glucose metabolism was determined using a paired two-tailed t-test. 




Blood glucose levels during the steady state period of insulin infusion were similar 
to the fasting blood glucose levels at all doses of insulin studied (Table 3-1). The coefficient of 
variation of blood glucose during the 60-120 minute period of the clamp ranged from 6.5% to 
10.5% at differing insulin doses (Table 3-1). Circulating human insulin concentration and 
steady state glucose infusion rate increased with increasing infusion rate of human insulin up 
to doses of 30 mU.min-1.kg-1 (Table 3-1, Figure 3-1). Compared to fasting values, the circulating 
concentrations of guinea pig insulin were reduced by infusion of human insulin at doses of 7.5 
and 60 mU.min-1.kg-1 (P<0.05, Table 3-1) and a similar trend was observed at 15 mU.min-1.kg-
1 (P<0.1, Table 3-1). Insufficient samples were available for analysis of guinea pig insulin in 
the animals infused with 30 mU.min-1.kg-1 insulin. Infusion rates of 7.5 and 30 mU.min-1.kg-1 
were chosen for further study to measure insulin responses at around half and near maximal 
human insulin doses. 
Rd  - Rate of Glucose Storage = 
D-[3-
3
H]-glucose infusion rate (dpm.min
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Table 3-1 Metabolic responses to differing infusion rates during the hyperinsulinaemic euglcaemic clamp in young adult guinea pigs 
 
 
 Insulin infusion rate (mU.min-1.kg-1) 
Outcomes 7.5 15 30 60 
Number (n) 8 8 3 4 
Bodyweight (g) 698  27 695  29 795  53 685  25 
Fasting state outcomes (20 min prior to HEC)     
 Fasting whole blood glucose (mmol.l-1) 7.02  0.29 7.51  0.22 7.22  0.48 7.60  0.46 
 Fasting plasma guinea pig insulin (ng.ml-1) 5.91  0.96 6.06  1.51 nd 6.73  0.88 
Steady state outcomes (60-120 min)     
 Blood glucose (mmol.l-1) 7.06  0.34 7.41  0.23 7.15  0.54 7.50  0.45 
 Blood glucose %CV 6.5  1.4 6.4  0.8 10.5  6.0 8.1  1.6 
 Glucose infusion rate (mol.min-1.kg-1) 53.7  3.9 69.4  8.7 82.9  11.1 88.1  12.0 
 Glucose infusion rate %CV 20.3  5.6 19.5  2.6 23.5  13.4 23.3  6.6 
 Plasma human insulin (U.ml-1) 291  33 1419  175 10557  2124 15724  1897 
 Plasma guinea pig insulin (ng.ml-1) 4.16  0.49* 3.60  0.48 nd 3.74  0.29* 
 Whole body insulin sensitivity (mol.ml.U-1.min-1.kg-1) 0.211  0.037 0.064  0.020 0.0086  0.002 0.0057  0.0007 
 
Values are Mean  SEM. Steady state outcomes are averaged from 60-120 minutes of insulin infusion.  
*P<0.05 compared to fasting levels.  






Figure 3-1 Insulin dose response curve for glucose infusion rates during 
hyperinsulinaemic-euglycaemic clamps in the guinea pig.  
Plasma human insulin concentration (log U.ml-1) and glucose infusion rate are mean values 
for 60-120 minutes of insulin infusion, with the insulin infusion dose in mU.min-1.kg-1 shown 
next to each data point. Data are mean ± S.E.M. 
Plasma insulin (log U.ml-1)












































In the cohort of guinea pigs in which whole body insulin sensitivity was assessed at 
7.5 mU.min-1.kg-1 (n=53), fasting plasma glucose was higher in females than males (P<0.05, 
Table 3-2). The co-efficient of variation of blood glucose averaged 5.9% during 60-120 minutes 
of insulin infusion at 7.5 mU.min-1.kg-1. Steady state human insulin concentrations achieved 
during insulin infusion at 7.5 mU.min-1.kg-1 averaged 238 ± 13 U.ml-1 overall, and were higher 
in males than females (P<0.007, Table 3-2), whereas metabolic clearance rate of human insulin 
was higher in females (P<0.02, Table 3-2). Steady state glucose infusion rates averaged 47.8 ± 
2.5 mol.min-1.kg-1 during the HEC and both ssGIR and whole body insulin sensitivity did not 
differ between males and females (Table 3-2). 
In the cohort of animals in which partitioned glucose metabolism was measured at 
7.5 mU.min-1.kg-1 (n=19), fasting blood glucose was similarly higher in females than males 
(P<0.001, Table 3-2), but no sex differences were observed in steady state human insulin 
concentrations or ssGIR (Table 3-2).  
Basal rates of glucose production and utilisation tended to be higher in females 
compared to males prior to the 7.5 mU.min-1.kg-1 clamp (P<0.075 for both). Insulin infusion at 
7.5 mU.min-1.kg-1 suppressed endogenous glucose production (both P<0.001, Table 3-2) and 
enhanced whole body glucose utilisation in both males and females (P<0.001, Table 3-2). The 
insulin-stimulated rates of glucose utilisation at half-maximal insulin dose were higher in 
females than males (P<0.03, Table 3-2), and glucose production under insulin-stimulated 
conditions tended to be higher in females than males (P=0.08, Table 3-2). 
Basal levels of whole body glycolysis and glucose storage did not differ between 
sexes prior to the 7.5 mU.min-1.kg-1 clamps. Insulin infusion at 7.5 mU.min-1.kg-1 tended to 
enhance the rate of whole body glycolysis in males (P<0.08), but did not alter whole body 




infusion in males (P<0.001) and females (P<0.005), and insulin-stimulated rates of glucose 
storage were higher in females than males (P<0.05, Table 3-2). 
Overall, glycolysis accounted for 43 ± 6% (males: 50  9%; females: 35  7%) of 
glucose utilisation in the fasting state and 37 ± 4% (males: 43  7%; females: 32  4%) during 
infusion of human insulin at 7.5 mU.min-1.kg-1 (n=19). Therefore, glucose storage accounted 
for 57 ± 6% (males: 50  9%; females: 65  7%) of glucose utilisation in the fasting state, and 
63 ± 4% (males: 58  7%; females: 68  4%) during infusion of 7.5 mU.min-1.kg-1 human 
insulin. The proportions of glucose utilisation accounted for by glycolysis and glucose storage 
did not differ between males and females. 
 
 
In the cohort of guinea pigs in which whole body insulin sensitivity was assessed at 
30 mU.min-1.kg-1 (n=38), fasting plasma glucose was higher in females than males (P<0.05, 
Table 3-3). The co-efficient of variation of blood glucose averaged 6.7% during 60-120 minutes 
of insulin infusion at 30 mU.min-1.kg-1. Steady state human insulin concentrations achieved 
during insulin infusion at 30 mU.min-1.kg-1 averaged 3199 ± 156 U.ml-1 overall, and were 
higher in males than females (P<0.01, Table 3-3); however, metabolic clearance rate of human 
insulin during near maximal insulin infusion did not differ between sexes. Steady state glucose 
infusion rates averaged 65.4 ± 3.0 mol.min-1.kg-1 during this HEC and both ssGIR and whole 
body insulin sensitivity did not differ between males and females (Table 3-3). 
In the animals in which partitioned glucose metabolism was measured at 30 mU.min-
1.kg-1 (n=19), fasting blood glucose was also higher in females (P<0.05, Table 3-3), but no 
differences were observed in steady state human insulin concentrations or glucose infusion rate 




Table 3-2 Whole body insulin sensitivity and partitioned glucose metabolism at half-
maximal insulin dose in the guinea pig (7.5 mU.min-1.kg-1). 
 
 Male Female 
Whole body insulin sensitivity measures   
Number 31 22 
Bodyweight (g) 796  15 661  12*** 
Fasting blood glucose (mmol.l-1) 6.77  0.13 7.31  0.19* 
Glucose infusion rate (60-120 min) (mol.min-1.kg-1) 48.7  3.6 46.6  3.2 
Plasma human insulin (60-120 min) (U.ml-1) 266  18 195  14** 
Whole body insulin sensitivity (mol.ml.U-1.min-1.kg-1) 0.204  0.019 0.261  0.031 
MCR human insulin (60-120 min) (ml.min-1.kg-1) 32.9  2.7 43.7  3.9* 
   
Partitioned glucose metabolism   
Number 10 9 
Glucose infusion rate (60-120 min) (mol.min-1.kg-1) 36.6  3.4 40.2  4.3 
Fasting blood glucose (mmol.l-1) 6.41  0.22 7.52  0.18** 
Plasma human insulin (60-120 min) (U.ml-1) 203  21 162  11 
Whole body glucose production   
Basal (mol.min-1.kg-1) 53.7  5.9 69.3  5.7§ 
Insulin stimulated (mol.min-1.kg-1) 39.6  5.7††† 55.2  6.3††† § 
Insulin-stimulated decrease (mol.min-1.kg-1) 14.1  2.4 14.1  2.6 
Whole body glucose utilisation   
Basal (mol.min-1.kg-1) 53.7  5.9 69.3  5.7§ 
Insulin stimulated (mol.min-1.kg-1) 74.7  7.3††† 96.3  5.3††† * 
Insulin-stimulated increase (mol.min-1.kg-1) 21.0  4.3 27.0  6.3 
Whole body glycolysis   
Basal (mol.min-1.kg-1) 23.5  3.7 25.7  4.9 
Insulin stimulated (mol.min-1.kg-1) 29.9  4.4 30.1  3.6 
Insulin-stimulated increase (mol.min-1.kg-1) 6.3  3.3 4.4  4.9 
Whole body glucose storage   
Basal (mol.min-1.kg-1) 30.2  7.3 43.6  4.6 
Insulin stimulated (mol.min-1.kg-1) 44.8  8.2††† 66.2  5.4†† * 
Insulin-stimulated increase (mol.min-1.kg-1) 14.6  3.2 22.6  6.0 
 
Values are mean  SEM. Glucose infusion rate, human insulin and metabolic clearance rates 
(MCR) are averaged from 60-120 minutes of insulin infusion. For whole body insulin 
sensitivity, human insulin concentrations were available for n=30 males and 20 females.  
§P<0.10, *P<0.05, **P<0.01, ***P<0.001 compared to males.  




Insulin infusion at 30 mU.min-1.kg-1 suppressed endogenous glucose production in 
males (P<0.001, Table 3-3) and females (P<0.05, Table 3-3) and enhanced whole body glucose 
utilisation to a similar degree in both sexes (P<0.001 for both, Table 3-3). Glucose production 
during insulin stimulation at 30 mU.min-1.kg-1 was higher in females than males (P<0.04), but 
there was no difference in the insulin-stimulated decrease in endogenous glucose production 
between the sexes. 
Insulin infusion at 30 mU.min-1.kg-1 did not alter whole body glycolysis in males, but 
enhanced glycolysis in females (P<0.01, Table 3-3), and therefore the insulin-stimulated change 
in glycolysis from basal levels was higher in females (P<0.04, Table 3-3). Insulin-stimulated 
rates of glycolysis during the clamp also tended to be higher in females than males (P<0.06, 
Table 3-3). Prior to the 30 mU.min-1.kg-1 HEC, basal rates of glucose storage were higher in 
females than males (P=0.05). Insulin infusion at 30 mU.min-1.kg-1 increased whole body 
glucose storage in males (P<0.001) and females (P<0.04, Table 3-3), and insulin-stimulated 
glucose storage was similar in males and females.  
In the fasting state, prior to insulin infusion at 30 mU.min-1.kg-1, glycolysis accounted 
for 43  6% of glucose utilisation and glucose storage accounted for 57 ± 6%. Glycolysis 
accounted for a higher percentage of glucose utilisation in males than females (males: 54  9%; 
females: 31  6%, P<0.04) and conversely glucose storage accounted for a lower percentage of 
utilisation in males (males: 46  9%; females: 69  6%, P<0.04). In the insulin infused state, at 
30 mU.min-1.kg-1 insulin, glycolysis accounted for 38 ± 3% of glucose utilisation (males: 36  
4%; females: 40  5%) and glucose storage accounted for 62 ± 3% (males: 64  4%; females: 





Table 3-3 Whole body insulin sensitivity and partitioned glucose metabolism at 
maximal insulin dose in the guinea pig (30 mU.min-1.kg-1). 
 
 Male Female 
Whole body insulin sensitivity measures   
Number 19 19 
Bodyweight (g) 785  19 658  15*** 
Fasting blood glucose (mmol.l-1) 6.7  0.2 7.3  0.2* 
Glucose infusion rate (60-120 min) (mol.min-1.kg-1) 66.7  4.3 63.9  3.7 
Plasma human insulin (60-120 min) (U.ml-1) 3644  289 2878  128** 
Whole body insulin sensitivity (mol.ml.U-1.min-1.kg-1)  0.022  0.0044 0.023  0.0019 
MCR Human insulin (60-120 min) (ml.min-1.kg-1) 9.4  1.3 10.8  0.5 
   
Partitioned glucose metabolism   
Number 10 9 
Glucose infusion rate (60-120 min) (mol.min-1.kg-1) 66.0  6.3 61.5  4.5 
Fasting whole blood glucose (mmol.l-1) 6.3  0.3 7.0  0.2* 
Plasma human insulin (60-120 min) (U.ml-1) 3679  451 3008  205 
Whole body glucose production   
Basal (mol.min-1.kg-1) 51.9  5.8 65.1  6.0 
Insulin stimulated (mol.min-1.kg-1) 24.3  6.1††† 50.2  9.9† * 
Insulin-stimulated decrease (mol.min-1.kg-1) 27.6  5.5 14.9  6.1 
Whole body glucose utilisation   
Basal (mol.min-1.kg-1) 51.9  5.8 65.1  6.0 
Insulin stimulated (mol.min-1.kg-1) 89.7  7.0††† 109.3  9.9††† 
Insulin-stimulated increase (mol.min-1.kg-1) 37.8  8.0 44.2  8.2 
Whole body glycolysis   
Basal (mol.min-1.kg-1) 25.6  2.5 19.6  4.0 
Insulin stimulated (mol.min-1.kg-1) 30.7  3.1 41.6  4.5†† § 
Insulin-stimulated increase (mol.min-1.kg-1) 5.1  3.9 22.0  6.7* 
Whole body glucose storage   
Basal (mol.min-1.kg-1) 26.3  6.7 45.5  6.3* 
Insulin stimulated (mol.min-1.kg-1) 59.1  7.2††† 67.7  9.4† 
Insulin-stimulated increase (mol.min-1.kg-1) 32.7  6.2 22.2  8.7 
 
Values are mean  sem. Glucose infusion rate, human insulin and metabolic clearance rates are 
averaged from 60-120 minutes of insulin infusion. For whole body insulin sensitivity, human 
insulin concentrations were available for n=13 males and 18 females. For partitioned glucose 
metabolism, human insulin concentrations were available for n=6 males and 5 females.  
§P<0.10, *P<0.05, **P<0.01, ***P<0.001 compared to males.  






This study has characterised whole body glucose metabolism and its response to 
insulin in the euglycaemic state in the chronically catheterised guinea pig. Human insulin 
increased glucose utilisation and suppressed endogenous glucose production in the guinea pig, 
although sensitivity to the actions of human insulin particularly for suppression of endogenous 
glucose production was lower in the guinea pig than reported previously in human431-434, or in 
other small experimental species, such as rats and mice143, 144, 147, 422, 423. Nevertheless, these 
studies have demonstrated that HEC using human insulin can be used for quantitative assessment 
of insulin sensitivity in the guinea pig. As the guinea pig resembles the human in its susceptibility 
to diabetes435, 436, atherosclerosis and in aspects of cholesterol homeostasis312, 437, this establishes 
methodology that will allow this species to be used for further investigation of the mechanistic 
basis underlying perturbations of glucose metabolism and insulin action. 
Perturbations of fetal growth and development in the guinea pig impair postnatal 
growth, visceral adiposity (Section 2.5.6), and feed intake (Section 2.5.5)395, and cholesterol312 
and glucose metabolism310, therefore also establishing it as an excellent animal model for further 
investigations into the underlying causes of the developmental origins of metabolic disease. 
While the HEC is well established and used in rats and mice143, 144, 147, 422, 423, the volume of blood 
that can be sampled, and the number of experiments and analyses possible is limited in these 
species, particularly in younger animals. The guinea pig, in contrast, ranges in weight from 60 to 
140 g at birth and attains a body weight of 400 g by 3-4 weeks of age, thus avoiding some of the 
limitations related to size and body weight in other small animal models. In particular, in the 
present study, we have demonstrated the capacity to perform repeat HEC studies in the 
chronically catheterised young adult guinea pig.  
Glucose concentrations were successfully clamped during the last hour of the HEC in 
the guinea pig with a covariance of blood glucose of 5.9%  0.3% and 6.7%  0.7% during the 




variability seen during HEC in rats (5-8%;143-145), young lambs (2.6%;69), dogs (7%;438), baboons 
(~5%;154) and humans (4-6%;142). In the guinea pig, circulating insulin concentrations and GIR 
required to maintain glycaemia increased with increasing insulin dose up to 30 mU.min-1.kg-1, 
but were similar at insulin doses of 30 and 60 mU.min-1.kg-1. At near-maximal insulin dose (30 
mU.min-1.kg-1), plasma human insulin concentrations averaged 3199 U.ml-1 and required a 
ssGIR of 65 mol.min-1.kg-1 for maintenance of euglycaemia. In contrast, in young adult humans, 
dose response studies of whole body insulin sensitivity indicate an insulin ED50 of 54U.ml-1 
and near maximal actions at >500 U.ml-1 insulin, with glucose infusion rates of 62 and 65 
mol.min-1.kg-1 required to maintain euglycaemia at plasma insulin concentrations of 168 and 
666 U.ml-1 respectively439. In the rat, ssGIRs of 22 and 68 mol.min-1.kg-1 are required to 
maintain glycaemia at human insulin concentrations of 39 and 120U.ml-1 during HEC440, and 
similar results are observed with porcine insulin (ssGIRs of 74 mol.min-1.kg-1at plasma insulin 
of 100U.ml-1)143, 144. The mouse is more sensitive to insulin compared to these species, as an 
ssGIR of 227 mol.min-1.kg-1 is required to maintain euglycaemia in mice at a human plateau 
insulin concentration of only 37U.ml-1 146. Furthermore, circulating insulin concentrations 
reported during HEC in other species represent combined levels of infused and endogenous 
insulin, due to strong cross-reactivity between insulins from different species. In the current 
study, it was possible to specifically analyse human insulin concentrations, exclusive of the 
endogenously produced guinea pig insulin, since the assays do not cross-react between these 
species. These observations in the present study suggest that the insulin responsiveness of the 
guinea pig to human insulin is low, in comparison with the human, and to other small 
experimental species, particularly the mouse. However, one other study that utilised HEC in male 
guinea pigs, with infusion of human insulin at 3 mU.kg-1, required glucose infusion rates of 
approximately 72-83 mol.min-1.kg-1 to maintain euglycaemia at a plateau plasma insulin 




65.4 mol.min-1.kg-1 required to maintain glycaemia at human insulin concentrations of ~3200 
U.ml-1 in the current study. A number of factors may have contributed to the discrepancies in 
apparent insulin sensitivity between these two studies. Guinea pigs were anaesthetised during the 
HEC in the previous study424; however, in rats anaesthesia reduces insulin sensitivity425, 
suggesting that anaesthesia may not explain the differences. In the previous study, although 
control groups did not receive the treatments (capsaicin or cisplatin) they were treated with the 
solvent used to administer these drugs (75 mg.kg-1 mannitol i.p) for 9 days prior to HEC 
testing424. In addition, body weight of animals studied by Szilvassy et al (2006)424 ranged from 
350-400 g, a considerably lighter weight than the male guinea pigs in the current study, and 
animals were fasted for 24 hours, compared to 16 hours used in this study. In mice, fasting time 
can influence insulin sensitivity assessed by HEC, with insulin sensitivity increasing following 
an 18 hour compared to a 5 hour fast146. This is consistent with the greater insulin sensitivity of 
muscle but not in liver following a 16 hour compared to a 5 hour fast using HEC with D-[14C]-
glucose and 2-deoxy-D-[3H]-glucose reported in mice441. Insulin sensitivity similarly increases 
following an overnight fast in humans442. Therefore, the use of a 24 h fast by Szilvássy424, 
compared to a 16 h fast in our study, may contribute to the higher insulin sensitivity that they 
observed. The effects of mannitol on insulin sensitivity have not been reported, however the 
sugar-alcohol is poorly absorbed through the gut443 so mannitol per se is unlikely to act 
systemically to alter insulin sensitivity. Similarly, although repeated i.p. injections for 8 d prior 
to HEC may induce mild chronic stress, this is associated with decreased rather than increased 
insulin sensitivity in rats444, and therefore also seems unlikely to contribute to the greater insulin 
sensitivity of guinea pigs reported by Szilvássy424,  compared to the present study. Furthermore, 
details of the assay used to measure plasma insulin in the previous study were not provided424. It 
is therefore not clear why a higher ssGIR at a lower steady-state insulin concentration was 




Guinea pig insulin has a low affinity for many mammalian insulin receptors, including 
its own, and also has lower affinity for its own receptor when compared to insulins of other 
species445. Previous studies have reported that guinea pig insulin is not as potent as bovine insulin 
in lowering blood glucose in the guinea pig446. The guinea pig appears to compensate for this 
through an increased plasma insulin concentration310, 427, 445-447 and possibly an increased tissue 
abundance of insulin receptors445. This study provides evidence that human insulin can bind and 
act through the guinea pig insulin receptor, as previously reported for insulins from several other 
species, including bovine and porcine445.  
Use of concomitant radioactively labelled glucose infusion during HEC allows 
determination of basal and insulin-stimulated rates of glucose utilisation, production, storage and 
glycolysis. In the guinea pig, as in other species, glucose is utilised for oxidative purposes and 
carbon dioxide production, with much of the remainder directed to hepatic glycogen storage in 
the fasted state or to lipid storage in adipose tissue in the fed state448. Basal rates of endogenous 
glucose production in the guinea pig were high (e.g. average of 61 mol.min-1.kg-1 prior to the 
7.5 mU.min-1.kg-1clamps) when compared to rates reported for healthy adult humans (11-12 
mol.min-1.kg-1)431-434 and rats (27-38 mol.min-1.kg-1)428, 449, 450. Infusion of human insulin 
suppressed glucose production and stimulated glucose utilisation and storage in the guinea pig, 
consistent with actions on both hepatic and peripheral glucose metabolism. Overall, human 
insulin infusion at 7.5 mU.min-1.kg-1 suppressed glucose production by 20% and stimulated 
glucose utilisation by 39% in the guinea pig and infusion of human insulin at 30 mU.min-1.kg-1 
suppressed glucose production by an average of 23% and increased glucose utilisation by 68%. 
In contrast, in humans, maximal suppression of endogenous production is achieved at lower 
insulin concentrations than those required to stimulate maximal rates of glucose utilisation. In 
humans, dose response studies using porcine insulin 433 show that the plateau insulin 
concentrations required to achieve half-maximal effects are lower for hepatic glucose production 




the rat, with lower plasma insulin concentrations required to achieve maximal suppression of 
hepatic glucose production, compared to those required for stimulation of glucose utilisation 428, 
434. Furthermore, in rats, hepatic glucose production is suppressed by >90% and glucose uptake 
is stimulated ~5-fold at insulin concentrations of 124 U.ml-1 during HEC with porcine insulin434. 
Similarly, in humans, maximal and complete suppression of glucose production occurs at an 
insulin concentration of 57 U.ml-1 and a ~5-fold increase in glucose utilisation occurs at plateau 
plasma insulin levels of 678 U.ml-1 433. In the guinea pig, a 37% suppression of glucose 
production and 68% increase in glucose utilisation during the 30 mU.min-1.kg-1 HEC were 
observed at human insulin concentrations of >3000U.ml-1, suggestive of lower activity of 
human insulin in guinea pig liver and peripheral tissues, when compared to its actions in human 
tissues. 
Sex-specific differences in glucose metabolism were observed in the current study. 
Compared to males, female guinea pigs had higher fasting plasma glucose, metabolic clearance 
of insulin and rates of glucose utilisation, storage and production during insulin stimulation. 
Whole body insulin sensitivity and the insulin sensitivity of glucose production and utilisation 
did not differ between the sexes, although the insulin-stimulated increase in glycolysis was 
greater in females than males at high-dose insulin. Numerous studies have examined sex-specific 
differences in insulin sensitivity in humans273, 451-455. Metabolic clearance of insulin is greater in 
women than men456, in agreement with the sex-differences observed in guinea pigs. Greater 
endogenous glucose production in women than men, per kilogram body weight, has been 
reported in some studies273, 454, however, others report no differences in glucose production 
between sexes273, 453. Suppression of endogenous glucose production is greater in women than 
men at low, but not at high, doses of insulin273, 454. This contrasts with the results seen here in 
guinea pigs, where glucose production was higher in females than males during insulin 
stimulation at the high insulin dose. Greater skeletal muscle sensitivity to insulin has also been 




the potential actions of steroid hormones are suggested as potential factors contributing to the 
sex-specific differences in insulin sensitivity and glucose metabolism271, 273, 455. Although insulin 
sensitivity, measured as the change from basal to insulin-stimulated states, did not differ between 
young adult male and female guinea pigs in the current study, some measures of glucose 
metabolism in the fasting and insulin-stimulated states did differ between sexes. The potential 
for sex-specific effects should be therefore considered in studies investigating perturbations of 
insulin sensitivity of glucose metabolism in the guinea pig. 
 
 Conclusion 
In conclusion, this study has validated the HEC in chronically catheterised male and 
female guinea pigs, and has confirmed that concomitant tracer infusions can also be utilised to 
investigate partitioned glucose metabolism in an unanaethetised guinea pig model. Human 
insulin stimulated glucose utilisation and suppressed endogenous glucose production in the 
guinea pig, although the relative magnitude of these changes differed from those reported during 
HEC in the human and rat. Nevertheless, this study demonstrates that quantitative assessment of 
insulin action is possible in the guinea pig, indicating the guinea pig as a useful model species in 








Sex-specific perinatal programming of insulin sensitivity in 





The following study aimed to characterise the effects of natural variation in litter size, 
birth phenotype and catch-up growth on insulin sensitivity and sites of insulin action in adult 
male and female guinea pigs. This utilised the same cohort of animals as described in Chapter 3, 






Fetal growth restriction and subsequent neonatal catch-up growth have been 
implicated in the programming of insulin resistance later in life. Spontaneous fetal growth 
restriction due to litter size in the guinea pig gives rise to offspring with disproportionate IUGR 
and these offspring undergo catch-up growth. We therefore hypothesised that spontaneous IUGR 
due to natural varying litter size and subsequent fractional neonatal growth (FGR10-28) or catch-
up growth would impair insulin sensitivity in young adult male and female guinea pigs. Insulin 
sensitivity of glucose metabolism was determined by hyperinsulinaemic-euglycaemic clamp 
(HEC) in 38 (male=21, female=17) young adult guinea pigs from litter sizes of two to four pups. 
A subset (male=10, female=8) were infused with D-[3-3H]-glucose two hours prior to and 
throughout the HEC to determine rates of basal and insulin-stimulated glucose utilisation, 
storage, glycolysis, and endogenous glucose production. In males, the insulin sensitivities of 
whole body glucose uptake (r=0.657, P=0.002) and glucose utilisation (r=0.884, P=0.004) 
correlated positively and independently with birth weight, and a similar trend was observed with 
the insulin sensitivity of endogenous glucose production (r=0.621, P=0.074), whereas no 
associations were observed with FGR10-28. In females, whole body glucose uptake and partitioned 
glucose metabolism were not related to birth weight, but the insulin sensitivity of endogenous 
glucose production correlated negatively (r= -0.815, P=0.025) and independently with FGR10-28. 
Effects of perinatal growth on whole body and partitioned glucose metabolism in the guinea pig 
are sex-specific, with evidence of impaired insulin action including of glucose utilisation after 
IUGR in males, and for impaired hepatic insulin sensitivity after rapid neonatal growth in 
females. Therefore both small size at birth and rapid neonatal growth are independent and sex-
specific risk factors for the development of insulin resistance in the guinea pig. 
 
Keywords: guinea pig, insulin sensitivity, glucose uptake, glycolysis, endogenous glucose 






Numerous epidemiological studies have implicated intrauterine growth restriction 
(IUGR), as indicated by being light, short or thin at birth, in the initiation of permanent 
physiological and/or metabolic adaptations2. These adaptations induced by sub-optimal 
conditions in utero result in “programmed” changes in determinants of insulin action at the tissue 
and molecular level, which may alter metabolic signalling, leading to insulin resistance, 
particularly in skeletal muscle189, 190, 196, 198, 229, 231, 234, 236. A mismatch between the environmental 
conditions experienced in utero and those experienced later in the individual’s life course may 
expose these programmed changes and lead to the development of type 2 diabetes mellitus 
(T2DM) and the metabolic syndrome2, 13, 65, 176, 457. Human studies using the hyperinsulinaemic-
euglycaemic clamp (HEC), the “gold standard” method to assess insulin sensitivity, have directly 
demonstrated increased risks of insulin resistance after IUGR, in children and in young and older 
adult males187, 189, 190, 192-199.  
In human infants, IUGR is often followed by accelerated, or catch-up, growth in the 
first few months of life57. Neonatal catch-up growth following IUGR has been identified as an 
additional risk factor for the development of insulin resistance65, 82 Poor growth in utero and 
catch-up growth are independently associated with adverse cardio-metabolic outcomes in 
adulthood83-89, including insulin resistance 65, 90. Catch-up growth often occurs when restricted 
nutrient availability, as occurs in IUGR, is followed by hyperphagia in a relatively nutrient-rich 
environment80, 374. Down-regulation of thermogenesis, and a redistribution of glucose towards 
adipose tissue, associated with limited uptake of glucose and growth of skeletal muscle, are also 
suggested as potential mechanisms contributing to increased risk of obesity and T2DM following 
catch-up growth72, 73, 76.  
Insulin sensitivity, assessed using the HEC, is variably affected by IUGR in rodent 




461. Maternal feed restriction in rodents has been associated with impaired 305, 417, unchanged303 
or even improved306 insulin sensitivity. Similarly, maternal protein restriction in the rat appears 
to induce variable changes in insulin sensitivity of the offspring, with studies reporting no 
change459 or improved insulin sensitivity460, 461. 
Evidence from studies of T2DM in humans suggest skeletal muscle as the key site of 
adult insulin resistance432, 462. The increase in glucose uptake in skeletal muscle accounts for 
approximately 70% of total whole body glucose disposal in the insulin-stimulated state, and the 
primary fate of this increased muscle glucose uptake is for storage as glycogen106. Studies in 
IUGR humans and animal models of IUGR demonstrate altered tissue development and gene 
expression which may impair insulin action within skeletal muscle190, 196, 198, 229, 231-238. The liver 
is also involved, as in rats, experimental IUGR permanently reduces its growth and programs 
reduced hepatic expression of genes in the insulin signalling pathway232, 326, 377, 463. In adipose 
tissue, insulin receptor numbers and glucose uptake are increased after IUGR in humans and in 
progeny of undernourished rats, suggesting a mechanism for increased adiposity, in turn 
contributing to increased risks of T2DM following IUGR189, 341. This suggests that these tissues 
are plausible targets for perinatal programming of altered insulin sensitivity later in life. 
Guinea pigs provide an alternate species in which to investigate developmental 
programming of insulin resistance. After spontaneous growth restriction due to increasing litter 
size, pups are smaller at birth391, 392 and these IUGR progeny from large litters undergo neonatal 
catch-up growth394 (Chapter 2)395. Previously we have shown that spontaneous growth restriction 
in the guinea pig also induces catch-up growth in both absolute and fractional terms that persists 
post weaning, as well as increased central adiposity in adults (Chapter 2)395. In addition, and 
unlike the rat, the guinea pig can develop a phenotype resembling T2DM and including 
hyperglycaemia at 4 months of age399, 400 making it a good species in which to investigate whether 
IUGR accelerates the risk of development of metabolic disease. Restricted fetal growth in the 




tolerance, increased blood pressure and altered cholesterol homoeostasis in adult offspring310-312. 
These studies demonstrate that prenatal restriction can perturb metabolic function in the guinea 
pig; however, insulin sensitivity was not assessed. Furthermore, size at birth was suggested as a 
stronger predictor of adult outcomes than was maternal nutritional group310-312, suggesting that 
further studies should focus on a model of spontaneous fetal growth restriction. In addition, 
adverse effects of exposure to maternal nutrient restriction were mostly seen in males, suggesting 
developmental programming of metabolic dysfunction in the guinea pig is sex-specific as 
described in other species, including humans65, 185, 336, 464-466.  
We therefore hypothesised firstly that small size at birth and spontaneous IUGR due 
to natural variation in litter size would be associated with reduced whole body, peripheral and 
hepatic insulin sensitivity. Our secondary hypothesis was that accelerated neonatal growth in 
terms of weight would independently predict impaired whole body, peripheral and hepatic insulin 
sensitivity. We therefore measured these outcomes in chronically catheterised young adult guinea 
pigs from litters of two, three or four pups by HEC with concomitant infusion of D-[3-3H]-
glucose tracer. Because developmental programming of glucose metabolism is sex-specific in 
IUGR humans185, and other species including the guinea pig310, 464, we investigated outcomes in 
both male and female progeny. 
 
 Materials and Methods 
 
 
The Animal Ethics Committee of The University of Adelaide approved all animal 
studies (Approval number M56/96). Animal management was as described previously; the 
present cohort with insulin sensitivity measures are a subset of the animals described previously 
(Section 2.4.1)395. In brief, the present cohort were progeny of ad libitum–fed nulliparous female 




three of four pups at term (range 67-71 days, mean ± S.E.M: 69.5 ± 0.3 days). Litter size, sex, 
weights, abdominal circumference, nose to rump lengths and head dimensions of all offspring 
were measured and recorded on the day of birth or following morning if delivered overnight. The 
cohort in which insulin sensitivity was measured in adulthood consisted of 38 pups (males: n=21, 
females: n=17). Each dam was housed with her offspring and provided with ad libitum lucerne 
chaff in addition to the standard diet. Litters were weighed at least 5 times per week until weaning 
at days 28-30 of age and absolute and fractional growth rates from day 10 until weaning (AGR10-
28, FGR10-28), were calculated as described previously (Section 2.4.1, 395.  
 
 
A total of 38 guinea pigs underwent surgery at 100.1  0.4 days of age for the insertion 
of vascular catheters. Catheters were inserted into the right jugular vein and carotid artery, as 
described in Section 3.4.2, under general anaesthesia induced by ketamine (75 mg.kg-1 body 
weight, intraperitoneal) and xylazine (6 mg.kg-1 body weight, intramuscular)312. Catheters were 
kept patent by daily flushing with heparinised saline, with patency success as described in the 
larger cohort (Section 3.4.2). 
 
 
Six days post-surgery animals were fasted for 16 hours and a HEC was performed to 
determine whole body insulin sensitivity of glucose metabolism in conscious, unrestrained 
guinea pigs as previously described (Section 3.4.3). In brief, human insulin was continuously 
infused at 7.5 mU.min-1.kg-1, for 2 hours. Prior to insulin infusion, blood samples (800 l) were 
collected at -20, -15, -10, -5 and 0 minutes to determine basal glucose concentration in whole 
blood measured by glucometer (HemoCue AB, Sweden). These samples were also collected for 
basal concentrations of free fatty acids (FFA). Blood samples (50-100 l) were taken every 5 




solution) commenced 15 minutes after the start of the insulin infusion. The glucose infusion rate 
(GIR) was adjusted, based on the blood glucose measurements, to restore and maintain 
euglycaemia, defined as the mean fasting blood glucose concentration, using a modified 
version426 of the algorithm described previously142. The mean blood glucose concentration 
achieved during the last 60 minutes of the HEC was 6.69 ± 0.12 mmol.l-1 with co-efficient of 
variation of 5.9 ± 0.3%.  
A subset of the animals (n = 18, males = 10; females = 8) were infused with D-[3-3H]-
glucose (Amersham Pharmacia Biotech, Buchinghamshire, England) as a priming bolus (14.5 
Ci.kg-1) followed by a continuous infusion (0.45 Ci.min-1.kg-1) for 2 hours prior to and then 
throughout the HEC in order to determine rates of glucose utilisation, storage, glycolysis, and 
endogenous glucose production, in the fasting and insulin-stimulated states428, 429. Larger blood 
samples were collected (800 l) at 60, 75, 80, 85, 90, 95, 105 and 120 minutes after the start of 
the insulin infusion, centrifuged and plasma stored at -20C for analysis of radiolabelled 
metabolites and human insulin. 
 
 
Plasma concentrations of glucose (Glucose HK, Roche) and free fatty acids (FFA C, 
Wako Pure Chemical Industries, Japan) were measured by colorimetric enzymatic analysis on a 
COBAS Mira automated centrifugal analyser. Human insulin concentrations were analysed by 
radioimmunoassay using a commercially available assay with <2% cross-reactivity with guinea 
pig insulin (Insulin-CT, CIS Bio International, France).  
 
 
The specific activity of D-[3-3H]-glucose and of 3H2O was measured exactly as 
described in Section 3.4.5. In brief, samples were deproteinised using 0.3N Ba(OH)2 and 0.3N 




scintillation counting. The DPM of the dried (radioactivity of D-[3-3H]-glucose) vials was 
subtracted from that of the undried vials (radioactivity of D-[3-3H]-glucose + 3H2O) to give the 
DPM of 3H2O alone.  
 
 
Steady-state plasma concentrations of human insulin were calculated as the average of 
concentrations every 15 minutes throughout the final hour of the HEC. Steady state glucose 
infusion rate (ssGIR) was calculated as the average GIR during the final hour of the clamp. Whole 
body insulin sensitivity was calculated by dividing ssGIR by steady-state plasma concentrations 
of human insulin. The post-hepatic metabolic clearance rate (MCR) of human insulin was 
calculated as the insulin infusion rate during the HEC divided by steady-state plasma 
concentrations of human insulin. Rates of partitioned components of glucose metabolism in 
fasting and insulin-stimulated states (endogenous glucose production, glucose utilisation, 
glucose storage and glycolysis) were calculated based on kinetics of D-[3-3H]-glucose 
metabolism in the steady-state (last 20-40 minutes) for each condition, as described in detail 
previously Section 3.4.6, 428, 429. 
 
 
The subset of animals that underwent tracer studies (n=18, 10 male, 8 female) were 
humanely killed between 2 pm and 4 pm by lethal injection of sodium phenobarbitone 
immediately after the HEC and a post mortem was performed (age: 115 ± 2 days). Fat depots 
(interscapular, omental, right side of the neck and bilateral axillary, retroperitoneal, perirenal, 
and groin depots) and bilateral skeletal muscles (hindlimb: M. biceps femoris, M. semitendinosus, 
M. gastrocnemius, M. plantaris, and M. tibialis; forelimb: M. biceps brachii) were dissected and 
weighed as described previously Section 2.4.2, 395. Visceral adipose weight was calculated as the 




weight was calculated as the sum of weights of left and right axillary and groin fat, right side of 
the neck fat and interscapular fat depots. Visceral and subcutaneous fats were summed to give a 
measure of combined adiposity. The weights of dissected skeletal muscles were summed to 
obtain combined skeletal muscle mass. The ratio of the combined adiposity to the combined 
muscle mass was calculated as an index of relative adiposity. 
 
 
Data were analysed using SPSS 23.0 for Windows (IBM, Armonk, USA). The effect 
of litter size on total pup weight and gestational length was assessed by ANOVA. Effects of litter 
size on proportions of liveborn and stillborn progeny were analysed by chi-squared test. The 
effects of litter size and sex on birth phenotype, neonatal growth and whole body insulin 
sensitivity and postnatal outcomes were analysed by mixed models ANOVA, including the dam 
as a random variable to account for effects of a common maternal environment. Bonferroni’s 
post-hoc comparisons were used to compare differences in maternal and offspring outcomes 
between litter sizes. Insulin sensitivity had not been measured previously by HEC in the guinea 
pig nor was tracer analysis to determine the partitioned glucose metabolism assessed therefore a 
priori power analysis was not possible in this instance. Where effects of litter size differed 
between sexes, outcomes were analysed separately in each sex. Due to limited numbers of 
animals and therefore power for tracer studies of components of glucose metabolism and post-
mortem body composition measures within each litter size group and sex, mixed models analyses 
could not be performed for these outcomes. The independent effects of birth weight and neonatal 
growth rate for weight on outcomes were assessed by multiple linear regression separately in 
each sex for both whole body and partitioned glucose metabolism. As neonatal growth did not 
affect the insulin sensitivity of whole body glucose uptake, effects of birth weight on this outcome 




sex. A P-value of < 0.05 was accepted as statistically significant. All results are expressed as 





In the litters that generated the animals in which insulin sensitivity was measured, 
gestation length did not differ between litter sizes (overall mean 69.4 ± 0.2 days, Table 4-1). The 
proportion of pups born alive tended (P=0.054) to decrease as litter size increased from 2 (100% 
survival) to three (97% survival) or four (82% survival), and total litter weight increased with 
increasing litter size (P<0.001, Table 4-1).  
 
 
Table 4-1 Effect of litter size on litter outcomes 
 
Outcome  Litter Size  Significance 
Two Three Four LS 
     
Number of litters 5 13 7 - 
Surviving:Stillborn pups at birth 10:0 35:1 23:5 0.054 
Total pup weight per litter (g) 230 ± 7a 286 ± 5b 374 ± 11c <0.001 
Gestation length (days) 69.6 ± 0.7 69.5 ± 0.3 69.6 ± 0.6 NSD 
     
Data expressed as means ± SEM of dams carrying each of the litter sizes (LS).  
a,b,cMeans with different superscripts differ, P<0.05. NSD: not significantly different, P>0.1.  
 
 
Average birth weight of pups from a litter size of four was 17% lower than those from 
litter size of two, while other measures of size at birth were reduced to a lesser degree (Table 4-
2). Birth weight and length were higher in males from litters of two when compared to males 
from litters of three or four pups (P=0.001 for both, Table 4-2). In females, birth weight, length 
and head length did not differ between litter sizes. Abdominal circumference was higher in males 




compared to litters of three pups (P=0.051). Abdominal circumference was higher in females 
from litters of two compared to litters of three pups (P=0.039), but not compared to offspring of 
litters of four pups. The weight:length ratio was higher in males of litters of two pups compared 
to litters of three and four pups (P=0.004 and P=0.003 respectively). Weight:length ratio did not 
differ with litter size in females. Body mass index at birth was not altered by litter size overall or 
within each sex.  
Neonatal absolute growth rates (AGR10-28) were higher in males (10.5 ± 0.2 g.day-1) 
than females (8.9 ± 0.2 g.day-1) (P<0.001) but did not differ with litter size (Table 4-2). Neonatal 
fractional growth rates (FGR10-28) were also higher in males (6.3 ± 0.2%) than females (5.4 ± 
0.1%), whilst effects of litter size on FGR10-28 differed between sexes (P=0.027, Table 4-2). In 
males, FGR10-28 differed between litter sizes (P=0.002), with litters of four growing faster than 
litters of two (P=0.003) or three (P=0.011) pups. In females, FGR10-28 did not differ between litter 
sizes. AGR10-28 tended to correlate positively with birth weight overall (r=0.292, P=0.068, n=38), 
and in males alone (r=0.431, P=0.051, n=21), but not in females. FGR10-28 correlated negatively 
with birth weight overall (r= -0.431, P=0.007, n=38) and in males (r= -0.578, P=0.006, n=21) 







Table 4-2 Effect of litter size and sex on birth phenotype and neonatal growth rates 
Outcome Males from Litter Size Females from Litter Size Significance 
 Two Three Four Two Three Four LS Sex LS × sex 
          
Number of Offspring 4 10 7 2 11 4    
          
Size at Birth          
 Weight (g) 119 ± 3a 94 ± 3b 91 ± 4b 106 ± 22 94 ± 2 101 ± 5 0.008 NSD 0.0701 
 Length (mm) 172 ± 3a 156 ± 3b 155 ± 2b 155 ± 16 157 ± 2 161 ± 5 NSD NSD 0.0492 
 Abdominal circumference (mm) 114 ± 5a 103 ± 2a,b 101 ± 2b 118 ± 7a 100 ± 2b 111 ± 3a,b 0.007 NSD NSD 
 Head-length (mm)† 47 ± 1a 40 ± 2a,b 39 ± 2b 42 ± 1 40 ± 1 41 ± 3 NSD NSD 0.0163 
 Head-width (mm)‡ 23 ± 1 21 ± 1 21 ± 1 22 ± 2 22 ± 0 21 ± 0 NSD NSD NSD 
 Weight:length (g.mm-1) 0.69 ± 0.01a 0.60 ± 0.01b 0.59 ± 0.02b 0.67 ± 0.07 0.60 ± 0.02 0.63 ± 0.03 0.028 NSD NSD 
 Body mass index (kg.m-2) 4.0 ± 0.1 3.9 ± 0.1 3.8 ± 0.2 4.3 ± 0 3.8 ± 0.1 3.9 ± 0.3 NSD NSD NSD 
          
Neonatal Growth Rates          
 AGR10-28 (g.day-1) 11.1 ± 0.4 10.2 ± 0.2 10.6 ± 0.3 8.8 ± 0.3 8.8 ± 0.3 9.2 ± 0.3 NSD <0.001 NSD 
 FGR10-28 (%) 5.7 ± 0.1a 6.1 ± 0.2a 7.0 ± 0.2b 5.3 ± 0.8 5.5 ± 0.2 5.3 ± 0.1 NSD <0.001 0.0274 
          
Data expressed as actual means ± SEM of offspring in each of the litter sizes (LS).  
a,b,c,Means with different superscripts differ, P<0.05. NSD: not significantly different, P>0.1.  
LS × sex = interaction between litter size and sex. Statistical models included dam to correct for common intrauterine environment in multiple births.  
†Head lengths were not measured in 1 male from litter size of three and 2 males and 1 female from litter size of four. 
‡Head widths were not measured in 1 male from litter size of three.  
1In males, birth weight differed across the litter sizes (P=0.001) with litters of two being larger than litters of three and four (P=0.001 for both) while birth weights of 
offspring of litters three and four were not significantly different. In females, there were no differences in birth weight found across the litters.  
2In males, birth length differed across the litter sizes (P=0.029) with litters of two being larger than litters of three and four (P<0.05 for both) while birth lengths of 
offspring of litters three and four did not differ. In females, there were no differences in birth length found across the litters.  
3In males, birth head-length tended to differ across the litters (P=0.066), with litters of two tending to have larger head-length than litters of three (P=0.097) while 
birth head-lengths of offspring of litters three and four did not differ. In females, there were no differences in birth head-length found across the litters.  
4In males, fractional neonatal growth rate differed between litter sizes (P=0.002) with litters of four growing faster than litters of two (P=0.003) and three (P=0.011), 





Fasting plasma glucose and FFA were not altered by litter size or sex (Table 4-3). 
Effects of litter size on steady-state plasma concentrations of human insulin differed between 
sexes, with males (255 ± 23 U.ml-1) having a higher steady state plasma insulin than females 
(212 ± 15 U.ml-1) overall (Table 4-3). Nevertheless, when the sexes were analysed separately 
steady-state plasma concentrations of human insulin did not differ between litter sizes in either 
sex. The MCR for human insulin was ~13% lower in males (34 ± 3 ml.kg-1.min-1) than females 
(39 ± 3 ml.kg-1.min-1, P=0.011), and effects of litter size differed between sexes (Table 4-3). In 
males, the MCR of human insulin differed between litter sizes (P=0.036) with males from litters 
of two pups having a higher MCR than those from litters of three pups (P=0.036), whereas in 
females MCR was not affected by litter size (Table 4-3). Although effects of litter size on insulin 
sensitivity of whole-body glucose metabolism differed between sexes (P=0.021), the effects of 







Table 4-3 Effect of litter size and sex on whole body glucose metabolism.  
Outcome 
Males from Litter Size Females from Litter Size Significance 
Two Three Four Two Three Four LS Sex LS × Sex 
          
Number of Offspring 4 10 7 2 11 4    
 Weight (g) 829 ± 29 801 ± 16 790 ± 27 670 ± 20 652 ± 17 692 ± 21 NSD <0.001 NSD 
          
Fasting Plasma Concentrations          
 Glucose (mmol.l-1) 6.7 ± 0.2 6.7 ± 0.2 6.7 ± 0.4 6.6 ± 1.1 7.3 ± 0.2 7.2 ± 0.2 NSD NSD NSD 
 Free fatty acids (meq.l-1) 2.5 ± 0.1 2.1 ± 0.2 2.5 ± 0.2 1.8 ± 0.3 2.3 ± 0.1 2.4 ± 0.4 NSD NSD NSD 
          
Steady State Outcomes          
 Glucose infusion rate (mol.min-1.kg-1) 41.1 ± 3.9 41.5 ± 5.1 47.4 ± 9.3 33.9 ± 7.9 43.9 ± 3.9 45.7 ± 6.0 NSD NSD NSD 
 Plasma human insulin (U.ml-1) 155 ± 22 297 ± 40 252 ± 18 273 ± 2 199 ± 20 216 ± 23 NSD NSD 0.0031 
 MCR human insulin (ml.kg-1.min-1) 52 ± 8a 30 ± 4b 30 ± 2ab 28 ± 0 42 ± 5 36 ± 4 NSD 0.011 <0.0012 
 Whole body insulin sensitivity 
 (mol.ml.U-1.min-1.kg-1) 
0.29 ± 0.06 0.15 ± 0.02 0.20 ± 0.04 0.12 ± 0.03 0.24 ± 0.03 0.22 ± 0.03 NSD NSD 0.0213 
          
Data expressed as actual means ± SEM of offspring in each of the litter sizes (LS). a,b,cMeans with different superscripts differ, P<0.05. NSD: not significantly different, 
P>0.1. LS × Sex = interaction between litter size and sex. Statistical models included dam to correct for common intrauterine environment in multiple births.  
1Plasma human insulin during steady state in the last hour of the HEC did not differ between litter sizes in males or females analysed separately.  
2In males, the metabolic clearance rate (MCR) of human insulin differed between litter sizes (P=0.036) with litters of two having a higher MCR than litters of three 
(P=0.045) and tending to have a higher MCR than litters of four (P=0.090), whereas in females, MCR did not differ between litter sizes.  
3In males, whole body insulin sensitivity tended to differ between litter sizes (P=0.083) with litters of three tending to have a lower insulin sensitivity of whole body 




In multiple linear regression analyses, fasting plasma glucose concentrations did not 
correlate with birth weight or FGR10-28 in males or females separately. In males, fasting plasma 
FFA concentrations did not correlate with FGR10-28 or birth weight, whereas in females FFA 
levels tended to correlate negatively with FGR10-28, but not with birth weight (Table 4-4).  
In males, birth weight was independently and positively associated with the MCR of 
insulin and with whole body insulin sensitivity, and tended to correlate negatively with plasma 
human insulin concentrations (P<0.07), while FGR10-28 was not associated with any of these 
measures (Table 4-4).  The ssGIR60-120, in contrast was positively associated with FGR10-28, but 
not with birth weight, in males (Table 4-4). In females, whole body insulin sensitivity, ssGIR, 
plasma human insulin and MCR insulin did not correlate with birth weight or FGR10-28 (Table 
4-4). These relationships were also evident in simple correlation analyses, such that the whole-
body insulin sensitivity of glucose uptake (Figure 4-1) correlated positively with birth weight 
overall (r=0.417, P=0.007, n=38), and in males (r=0.606, P=0.004, n=21) but not in females 











Table 4-4 Whole body metabolic outcomes before and during HEC at 7.5 mU insulin.min-1.kg-1 in the guinea pig  
 
 Overall and Partial Correlation (r, P) 
 Males n=21 Females n=17 
Whole Body Measure Overall Birth weight FGR10-28 Overall Birth weight FGR10-28 
Fasting Plasma Concentrations       
 Glucose (mmol.l-1) 0.057, 0.972 0.048, 0.841 0.051, 0.832 0.234, 0.674 0.112, 0.680 -0.079, 0.770 
 Free fatty acids (meq.l-1) 0.246, 0.607 0.023, 0.927 -0.199, 0.429 0.476, 0.165 0.338, 0.200 0.476, 0.062 
       
Steady State Outcomes       
 Glucose infusion rate (mol.min-1.kg-1) 0.479, 0.096 0.359, 0.120 0.465, 0.037* 0.491, 0.145 -0.086, 0.769 -0.423, 0.102 
 Plasma human insulin (U.ml-1) 0.554, 0.037* -0.413, 0.070 0.175, 0.460 0.466, 0.180 -0.296, 0.266 -0.462, 0.071 
 MCR human insulin (ml.kg-1.min-1) 0.646, 0.008* 0.544, 0.013* 0.126, 0.598 0.362, 0.374 0.185, 0.494 0.353, 0.180 
 Whole body insulin sensitivity 
(mol.ml.U-1.min-1.kg-1) 
0.661, 0.006* 0.657, 0.002* 0.332, 0.152 0.130, 0.888 0.080, 0.769 -0.022, 0.937 
       
n, Number of offspring. FGR10-28: fractional growth rate for weight in neonates from 10-28 days of age. 



















Figure 4-1 Correlation between whole body insulin sensitivity and birth weight in male and female guinea pigs 
Relationship of the insulin sensitivity of whole body glucose metabolism and birth weight in males, closed symbols, solid regression 
line (r=0.606, P=0.004, n=21) and females in open symbols (r=0.128, NS, n=17). Offspring of (■ males = 4; □ females = 2) litters of 







 Endogenous glucose production 
In males, basal and insulin-stimulated rates of endogenous glucose production were 
not associated with birth weight or FGR10-28 (Table 4-5), but the insulin sensitivity of 
endogenous glucose production tended to correlate positively with birth weight, but not with 
FGR10-28, in males (Table 4-5). In females, basal endogenous glucose production was not related 
to birth weight or neonatal growth rates. However, the insulin-stimulated rate, the insulin 
stimulated decrease and the insulin sensitivity of endogenous glucose production were all 
positively and independently correlated with FGR10-28 in females (Table 4-5). Birth weight was 
not associated with the insulin stimulated decrease or insulin sensitivity of glucose production 
in females, but did tend to correlate positively with the insulin stimulated rate of endogenous 
glucose production (Table 4-5).  
 
 Glucose utilisation 
In males, the basal and insulin-stimulated rates of whole-body glucose utilisation and 
the insulin-stimulated increase in whole-body glucose utilisation did not independently 
correlate with birth weight or FGR10-28 (Table 4-5), whereas the insulin sensitivity of whole-
body glucose utilisation correlated independently and positively with birth weight, but not with 
FGR10-28 (Table 4-5). In females, basal and insulin-stimulated rates of whole body glucose 
utilisation and its insulin sensitivity were not related to birth weight or neonatal FGR (Table 4-
5). 
 
 Glucose storage 
Basal and insulin-stimulated rates of whole-body glucose storage and its insulin 





In males, basal and insulin-stimulated rates of whole body glycolysis and its insulin 
sensitivity did not independently correlate with birth weight nor with FGR10-28 (Table 4-5). In 
females, the basal rate of glycolysis correlated independently and positively with birth weight 
and with FGR10-28 (Table 4-5), whereas the insulin-stimulated rate of glycolysis correlated 
positively with FGR10-28, but not with birth weight (Table 4-5). In females, the insulin-
stimulated increase and the insulin sensitivity of the rate of glycolysis did not independently 





Table 4-5 Relationships of perinatal growth and partitioned glucose metabolism at 7.5 mU insulin.min-1.kg-1 insulin infusion in the guinea pig. 
 Overall and Partial Correlation (r, P) 
Partitioned Glucose Metabolism Measure  Males n=10   Females n=8  
Overall Birth weight FGR10-28 Overall Birth weight FGR10-28 
Endogenous glucose production       
 Basal (mol.min-1.kg-1) 0.153, 0.920 0.084, 0.830 -0.067, 0.864 0.621, 0.296 0.604, 0.151 0.564, 0.187 
 Insulin stimulated (mol.min-1.kg-1) 0.260, 0.783 -0.170, 0.662 0.086, 0.826 0.813, 0.067 0.750, 0.052 0.807, 0.028* 
 Insulin-stimulated decrease (mol.min-1.kg-1) 0.332, 0.152 0.130, 0.888 0.080, 0.769 0.948, 0.003* -0.556, 0.195 -0.941, 0.002* 
 Insulin sensitivity (mol.ml.U-1.min-1.kg-1) 0.746, 0.058 0.621, 0.074 -0.198, 0.610 0.821, 0.061 -0.597, 0.157 -0.815, 0.025* 
       
Whole body glucose utilisation       
 Basal (mol.min-1.kg-1) 0.153, 0.920 0.084, 0.830 -0.067, 0.864 0.621, 0.296 0.604, 0.151 0.564, 0.187 
 Insulin stimulated (mol.min-1.kg-1) 0.396, 0.550 0.233, 0.546 -0.176, 0.647 0.598, 0.330 0.598, 0.156 0.433, 0.331 
 Insulin-stimulated increase (mol.min-1.kg-1) 0.604, 0.205 0.393, 0.295 -0.296, 0.439 0.473, 0.530 0.254, 0.582 -0.163, 0.727 
 Insulin sensitivity (mol.ml.U-1.min-1.kg-1)  0.918, 0.002* 0.884, 0.004* -0.537, 0.136 0.459, 0.554 0.320, 0.483 -0.057, 0.904 
       
Whole body glycolysis       
 Basal (mol.min-1.kg-1) 0.234, 0.821 0.050, 0.898 -0.172, 0.659 0.834, 0.051 0.770, 0.043* 0.830, 0.021* 
 Insulin stimulated (mol.min-1.kg-1) 0.184, 0.886 0.165, 0.672 0.014, 0.971 0.904, 0.013* 0.454, 0.306 0.883, 0.009* 
 Insulin-stimulated increase (mol.min-1.kg-1) 0.305, 0.710 0.259, 0.502 0.278, 0.278 0.533, 0.433 -0.461, 0.297 -0.091, 0.846 
 Insulin sensitivity (mol.ml.U-1.min-1.kg-1)  0.228, 0.830 0.198, 0.610 0.202, 0.602 0.539, 0.424 -0.516, 0.235 -0.244, 0.598 
       
Whole body glucose storage       
 Basal (mol.min-1.kg-1) 0.075, 0.980 -0.014, 0.972 0.056, 0.886 0.228, 0.875 0.201, 0.666 0.056, 0.905 
 Insulin stimulated (mol.min-1.kg-1) 0.227, 0.756 0.075, 0.848 -0.195, 0.616 0.649, 0.255 0.543, 0.208 0.031, 0.948 
 Insulin-stimulated increase (mol.min-1.kg-1) 0.587, 0.228 0.173, 0.656 -0.453, 0.221 0.644, 0.262 0.508, 0.245 -0.041, 0.930 
 Insulin sensitivity (mol.ml.U-1.min-1.kg-1)  0.737, 0.064 0.503, 0.168 -0.435, 0.242 0.670, 0.225 0.594, 0.159 0.120, 0.798 
       
n, Number of offspring. FGR10-28: fractional growth rate for weight in neonates from 10-28 days of age. Age at HEC was 115 ± 1 days.  
*Significant correlations (P < 0.05) are shown in bold and trends (P < 0.1) in italics.  
Basal: prior to insulin infusion, Insulin-stimulated: during insulin infusion, insulin stimulated decrease/increase: change between the basal and insulin-





Overall males had a greater adult weight, longer length and a greater weight:length 
than females, while body mass index was not different between the sexes (Table 4-6). Absolute 
weights of subcutaneous, visceral and total dissected fat were greater in males compared to 
females (P<0.007 for all), while the absolute weight of omental fat did not differ between sexes 
(Table 4-6). The relative weight of subcutaneous fat tended to be greater in males compared to 
females, however, all other measures of adiposity in relative terms did not differ between the 
sexes. 
In males, fasting plasma metabolites were not correlated with adult body weight or 
body composition. In females, fasting plasma glucose concentration correlated positively with 
the relative weight of omental fat (r=0.727, P=0.041), but was not related to any other measures 
of body composition. In males, insulin sensitivity of whole body glucose metabolism was not 
correlated with adult body weight or body composition. In females, the insulin sensitivity of 
whole body glucose metabolism correlated positively with the relative weight of omental fat 
(r=0.731, P=0.039) but was not related to any other measures of body composition. In males, 
basal rates of glucose utilisation and endogenous glucose production correlated negatively with 
relative omental fat mass (r= -0.699, P=0.024 for both). In males, the insulin sensitivity of the 
endogenous glucose production tended to correlate negatively with the relative omental fat mass 
(r= -0.601, P=0.066) and the total dissected fat to muscle ratio (r= -0.630, P=0.051). In females, 
the insulin sensitivity of glucose utilisation correlated positively with both the absolute and 
relative mass of omental and of total dissected fat (P<0.05 for all). Similarly, in females, the 
insulin sensitivity of glucose storage correlated positively with both the absolute and relative 
omental fat mass (P<0.025 for both). No correlations were found between the insulin sensitivity 
of glucose utilisation or of storage and adult weight or body composition in males. No 
correlations were found between the insulin sensitivity of the rate of glycolysis and adult weight 




Table 4-6 Effect of sex on adult size and body composition 
 
Outcome   Significance 
Males (n=10) Females (n=8) Sex 
    
Age at Post Mortem 116 ± 3 113 ± 1 NSD 
    
Adult Size    
 Weight (g) 840 ± 28 680 ± 22 <0.001 
 Length (mm)§ 349 ± 6 320 ± 5 0.002 
 Weight:Length (g.mm-1) § 2.41 ± 0.07 2.13 ± 0.08 0.021 
 Body Mass Index (kg.m-2) § 6.9 ± 0.2 6.7 ± 0.3 NSD 
    
Adult Body Composition    
 Subcutaneous fat (g) 43 ± 3 30 ± 3 0.002 
 Subcutaneous fat (%) 5.1 ± 0.2 4.4 ± 0.3 0.079 
 Visceral fat (g) 19 ± 1 13 ± 1 0.007 
 Visceral fat (%) 2.2 ± 0.1 1.9 ± 0.2 NSD 
 Omental fat (g) 17 ± 1 15 ± 1 NSD 
 Omental fat (%) 2.05 ± 0.05 2.22 ± 0.09 NSD 
 Total dissected fat (g) 79 ± 4 58 ± 5 0.006 
 Total dissected fat (%) 9.3 ± 0.3 8.5 ± 0.5 NSD 
 Skeletal muscle (g) 22 ± 1 18 ± 1 0.01 
 Skeletal muscle (%) 2.64 ± 0.08 2.74 ± 0.09 NSD 
 Total dissected fat: skeletal muscle 3.5 ± 0.1 3.2 ± 0.2 NSD 
    
Data expressed as means ± SEM of dams carrying each of the litter sizes (LS). NSD: not significantly different, P>0.1.  
Weights of all measures of adult body composition are expressed in absolute terms (g) and as a percentage of adult body weight (%). 






We have found for the first time that spontaneous IUGR due to variable litter size in 
the guinea pig is associated with impaired whole body insulin sensitivity in young adult males. 
This is consistent with sex-specific programming of insulin sensitivity following IUGR in 
young adult human males in their twenties185, 194, 195, 198, 229, 328. This impaired whole body insulin 
sensitivity in the spontaneously IUGR male guinea pig appears to reflect primarily impaired 
insulin sensitivity of glucose utilisation, which decreased with decreasing size at birth. These 
observations are also consistent with findings in IUGR humans and animal models of IUGR 
demonstrating impaired insulin signalling in skeletal muscle primarily of glucose uptake190, 231, 
237, 328, 329, 467-469. The insulin sensitivity of glycolysis, in contrast, was not related to size at birth 
in young adult guinea pigs of either sex.  
While effects of birth weight on whole body insulin sensitivity were not observed in 
female offspring, rapid neonatal growth predicted impaired hepatic insulin sensitivity but 
improved basal and insulin-stimulated rates of glycolysis in young adult females only. Thus, in 
the guinea pig, spontaneous IUGR impairs whole body and peripheral insulin sensitivity in 
young adult males, with similar trends for hepatic insulin sensitivity, which may lead to overt 
diabetes and other cardio-metabolic pathology with ageing in this species.  
 
 Perinatal Growth and Whole Body Insulin Sensitivity 
In the present study, small size at birth was associated with impaired whole body 
insulin sensitivity in young adult male guinea pigs. Consistent with this relationship, insulin 
sensitivity tended to be lower in males from litters of three, compared to two pups. In contrast 
to the larger cohort described in Chapter 2395, males from litters of three and four pups were of 
similar weight and size at birth within the subset of animals in which insulin sensitivity was 




association between insulin sensitivity in young adult guinea pigs and their size at birth is 
consistent with studies in the IUGR human and in other species measured using the HEC154, 187, 
189, 194, 464. In contrast, IUGR induced by maternal protein restriction in the rat does not 
consistently impair insulin sensitivity of young adult offspring, also measured by HEC335, 460. 
We found that fasting glucose levels in adult guinea pig offspring were not related to size at 
birth, and did not differ between litter sizes, in either sex. These observations suggest that the 
impairment in insulin sensitivity in male guinea pigs who were small at birth precedes any 
impairment of glucose tolerance or hyperglycaemia. This is consistent with previous reports of 
insulin resistance without hyperglycaemia in young adulthood in humans after small size at 
birth or IUGR185, 189, 217. Previously we have shown that catch-up following spontaneous IUGR 
is associated with increased adiposity in visceral compartments in young adult guinea pigs, 
primarily in males (Chapter 2, 395). Neonatal growth rates did not predict whole-body insulin 
sensitivity in young adult guinea pigs. We hypothesise that with further ageing a progressive 
increase in visceral adiposity, particularly in males after IUGR and rapid neonatal growth, 
would exacerbate impaired insulin sensitivity, leading to compensatory failure, glucose 
intolerance and hyperglycaemia. Consistent with this, many studies in humans only report 
correlations between IUGR and impaired glucose tolerance and overt diabetes in aged 
cohorts187, 201, 202. 
 
 Perinatal Growth and Components of Glucose Metabolism 
Insulin resistance in the male guinea pig of low birth weight was apparent for whole-
body glucose utilisation with a tendency for impairment in endogenous glucose production. 
Impaired glucose utilisation and storage largely reflect impaired insulin action in skeletal 
muscle106. In humans, skeletal muscle is the primary tissue for glucose disposal in the insulin-
stimulated state, accounting for approximately 70% of the increase in glucose uptake106. 




the physiological importance of this tissue432. Our findings in guinea pig are consistent with 
those of previous studies in humans where small size at birth reduces expression of key targets 
in the insulin signalling pathway leading to insulin resistance in young adults. This includes 
reduced expression of GLUT4 and reduced glucose uptake, as well as decreased expression of 
the post-receptor signalling protein kinase C-ζ and p85α and p110β subunits of phosphoinositol 
3-kinase190, 196, 198, 229, 231-238.  
In the current study, we also observed a tendency for a positive independent 
correlation between the insulin sensitivity of endogenous glucose production and birth weight 
in males only. This suggests that both skeletal muscle and liver contribute to the whole-body 
insulin resistance associated with small size at birth in males in this species. This hepatic 
contribution is also consistent with studies in humans where insulin suppression of endogenous 
glucose production is impaired after IUGR197, 246. Similarly, insulin signalling in liver is 
impaired in several animal models of IUGR326, 329, 346, 463, 470. Additional studies will be required 
to determine the underlying mechanisms for insulin resistance in muscle and liver in the 
prenatally growth restricted guinea pig.  
In contrast to previous reports in humans and other species358, neonatal catch-up 
growth was not associated with impaired insulin sensitivity of whole-body glucose uptake in 
either sex in the young adult guinea pig. This lack of relationship is consistent, however, with 
previous reports in the control and placentally-restricted sheep, where measures of neonatal 
growth were not correlated with adult insulin sensitivity of whole-body glucose uptake in either 
sex464. The lack of correlation between neonatal growth and insulin sensitivity in the young 
adult male guinea pigs is particularly interesting given the positive correlations observed 
between neonatal growth and visceral adiposity (Chapter 2, 395).  
Intriguingly, the insulin sensitivity of endogenous glucose production was correlated 
negatively with neonatal fractional growth rate but not with birth weight in female guinea pigs 




contribute to the sequelae of insulin resistance later in life. Females in this species also tend to 
have a higher basal endogenous glucose production rates than males (Section 3.5.2), consistent 
with reports of higher basal endogenous glucose production rates in women than men of similar 
age, and suggesting a sex-specific hepatic handling of glucose454. Fast neonatal growth also 
correlated with high circulating FFA in adult female guinea pigs, and elevated FFAs are known 
to impair insulin action in the liver which leads to increased hepatic glucose production471. This 
suggests that elevated FFA might contribute to the impaired suppression of endogenous glucose 
production under HEC conditions after accelerated neonatal growth in the female guinea pig.  
In females, basal rates of glycolysis correlated positively with birth weight perhaps 
suggesting a reduced capacity for glycolysis in low birth weight female guinea pigs. The rates 
of basal and insulin-stimulated glycolysis increased with increasing neonatal fractional growth 
rate without an increase in the insulin sensitivity of glycolysis with neonatal catch-up. This 
suggests that neonatal catch-up may enhance the rate limiting step in glycolysis but does not 
alter the overall insulin sensitivity of the entire pathway. In humans, IUGR indicated by thinness 
at birth is associated with reduced rates of glycolysis during exercise, measured by 31P magnetic 
resonance spectroscopy234. In these IUGR humans, there was no association between insulin 
sensitivity and thinness at birth and previous findings suggest insulin mediated glucose uptake 
into muscle is not the rate limiting step of glycolysis 472. The observation of reduced glycolytic 
potential during exercise in IUGR humans did not report effects of sex. Hence, further 
investigation is required to determine if the impaired rate of basal glycolysis following IUGR 
is sex-specific in a larger cohort in guinea pigs, other animal models of IUGR and in humans. 
 
 Impaired Insulin Sensitivity in the Low Birth Weight Male is not 
Related to Body Composition 
Insulin sensitivity was not correlated with adult body composition in young adult 
male guinea pigs, suggesting that the insulin resistance in male guinea pigs who were small at 




young adult humans showing that adiposity does not explain reductions in insulin sensitivity 
with small size at birth200, 206. In turn, these findings suggest that impaired insulin sensitivity is 
due to changes in the function of insulin sensitive tissues, rather than the absolute or relative 
amounts of these.  
 
 Sex Differences 
In the current study, prenatal programming of insulin resistance was evident 
primarily in male guinea pigs. This male-specific programming by IUGR was of whole body 
insulin sensitivity and glucose utilisation, with a similar trend for the suppression of endogenous 
glucose production. Consistent with this, studies in humans report impaired insulin sensitivity 
in males but not in females after IUGR65, 185. Others report that impaired insulin action or 
measures of T2DM correlate positively with size at birth in males and do not report outcomes 
in females187, 194, 195, 201, 229. Systematic reviews of the literature suggest that when positive 
correlations between insulin sensitivity and size at birth are evident in both males and females 
the strength of the associations are approximately 2.5-fold greater in males than in females 
suggesting an increased impact or susceptibility of males to a sub-optimal intrauterine 
environment65, 176. In contrast, other studies in humans have not shown sex-specific 
programming of insulin sensitivity of glucose metabolism154, 227. It is possible that greater 
numbers of progeny and inclusion of the full range of litter sizes, including progeny of the less 
common extreme litter sizes of one and five pups, might allow us to observe subtler effects of 
prenatal restriction on insulin sensitivity in female as well as male guinea pigs. In the rat, insulin 
sensitivity is impaired in male but not female offspring of maternal protein restricted dams305, 
336, 465, 466. Conversely another study using the same model did report reduced insulin sensitivity 
in both male and female offspring305. One limitation to this study is that because females were 
age matched, they were not all measured at a specific stage of the oestrous cycle. In rats, glucose 




and oestrus (~15%) where oestrogen is the major circulating steroid hormone and lower at 
diestrus where progesterone from the corpus luteum is the dominant steroid hormone 473. In 
humans, insulin sensitivity derived from the tolbutamide-modified intravenous glucose 
tolerance test (IVGTT) is higher in the follicular phase when circulating 17-oestradiol is high 
compared to the luteal phase474, and consistent with this, glucose uptake during hyperglycaemic 
clamp is also higher in the follicular than luteal phase, despite similar circulating insulin 
concentrations475. Direct measures of whole-body and hepatic insulin sensitivity by HEC in 
women did not, however, differ between follicular and luteal phases in another study476. 
Glucose tolerance measured by oral glucose tolerance test also did not differ between follicular 
and luteal phases in healthy, non-obese, regularly menstruating women477. Effects of the 
oestrous cycle on glucose tolerance and insulin sensitivity have not, as yet, been reported in 
guinea pig, but could potentially have added variability to these outcome measures in the 
females in this study. Our results do however suggest that sex differences in the impact of 
prenatal restriction on insulin sensitivity are probably not due to postnatal effects of sex steroids 
acting indirectly via altered body composition, since fat and lean tissue proportions were not 
correlated with insulin sensitivity in these animals. Nevertheless, sex steroids may contribute 
to sex differences in programming and may protect female offspring from insulin resistance, as 
oestrogen replacement in postmenopausal women increases insulin clearance and sensitivity270. 
 
 Conclusion 
Spontaneous IUGR in the guinea pig provides a model for investigating the causal 
mechanisms for insulin resistance in muscle and in liver. The associations between spontaneous 
IUGR and impaired insulin sensitivity of whole body glucose metabolism and utilisation, are 
sex-specific occurring primarily in males, which is consistent with studies in humans and other 
animal models. We suggest that further studies in ageing adults are merited, to determine 
whether the impairments in insulin sensitivity observed in low birth weight young adults, lead 












Studies in humans have shown that small size at birth is associated with NCD 
including metabolic diseases such as insulin resistance, T2DM and the metabolic syndrome in 
later life2-4. A fast rate of growth or catch-up growth that often follow times of constraint or 
nutrient deprivation, as occurs in IUGR, is also an independent risk factor for the development 
of these NCD later in life2, 3, 14. This has brought about the hypothesis of the Developmental 
Origins of Health and Disease or DOHaD8-13. Several small animal models of IUGR have been 
utilised to investigate the mechanisms underlying the perinatal programming of metabolic 
disease, however, many models do not undergo catch-up growth immediately after birth or do 
not induce all the programmed adult outcomes seen in human studies. Therefore, the studies 
described in this thesis were designed to investigate spontaneous IUGR due to natural variation 
in litter size in the guinea pig as a potential model of perinatal programming of insulin 
resistance.  
Firstly, I investigated the birth phenotype to determine if guinea pigs of larger litters 
are disproportionately growth restricted (Chapter 2)395. Secondly, we examined their postnatal 
growth to determine if guinea pigs from larger litter sizes undergo catch-up as both IUGR and 
neonatal catch-up are independent risks for insulin resistance later in life in humans (Chapter 
2)395. We also examined if these spontaneous IUGR guinea pigs became hyperphagic and had 
increased adiposity as young adults (Chapter 2)395, the latter being a known contributor to 
T2DM in humans 123, 127. Both hyperphagia and increased adiposity are early events following 
IUGR and/or catch-up growth in SGA humans and some experimental animal models of IUGR. 




3H]-glucose tracer to determine partitioned glucose metabolism, in unanaesthetised, 
unrestrained male and female guinea pigs (Chapter 3). Finally, I used an insulin infusion rate 
of 7.5 mU.kg-1.min-1 that was an approximately half maximal insulin doses, determined through 
a dose response study in Chapter 3, to determine whole body and partitioned insulin sensitivities 
of male and female guinea pigs of known size at birth and neonatal growth rates (Chapter 4) to 
determine if these measures of insulin sensitivity are programmed in early life.  
In addition to comparisons between groups based on litter size, all outcomes in 
Chapters 2, 3 and 4 were assessed by multiple linear regression against size at birth and neonatal 
fractional growth rate to determine independent contributions of pre- and early postnatal 
growth. These dual approaches allowed me to examine both effects of litter size and how 
perinatal growth predicts adverse outcome across the entire spectrum. This is important as 
systematic reviews in humans show the relationship of insulin resistance, the primary defect in 
syndrome X, with size at birth, is U- or J-shaped177, 178. This suggests that both ends of the birth 
weight spectrum may have risks for the development of metabolic disease via different 
mechanisms.  Others have investigated effects of IUGR in litter-bearing species such as pigs 
and in sheep selected for variable litter size by comparing outcomes in growth-restricted (runt) 
or low birth weight littermates to those of littermates in the normal birth weight range 359, 360, 
370-373, 478. These approaches select a more extreme IUGR phenotype, but only allows inclusion 
of a limited subset of progeny per litter, and does not permit analyses across the birth weight 
range as used throughout this thesis.  
This final chapter summarises the context of the key findings of these studies, 
discusses the strengths and weakness of the studies conducted as well as the future directions 






 Effects of Litter Size, Spontaneous IUGR and Neonatal Growth on 
Postnatal Phenotype (Chapters 2 and 4) 
Pups from larger litter size were not only of low weight at birth, but also exhibited 
disproportionate growth restriction. This is consistent with multiple births in human42 and other 
spontaneous IUGR animal models due to multiple births in sheep362, 366-369 and pigs358-360, 479. 
Spontaneous IUGR in the guinea pig gave a large natural variation in birth weight where 
animals from larger litters are thin at birth and have relative sparing of head/brain size and 
length in relation to soft tissue mass (Section 2.7.3)395. This was indicated by a conserved head 
width across the litter sizes and low birth weight to length ratio an index of thinness at birth 
(Section 2.7.3)395. Disproportionate size at birth is a known risk factor for metabolic disease 
later in life in human studies66, 252, 253. Spontaneous growth restriction in the guinea pig due to 
larger litter size has a substantial contribution originating from placental insufficiency391-394. It 
is also possible that intrinsic maternal differences that contribute to differences in ovulation and 
conception rates contribute to differences in progeny phenotypes associated with litter size. 
Heavier maternal weight rather than age or parity at conception is the greatest predictor for 
large litter sizes in the guinea pig 397. Litter size was similarly associated with maternal size in 
guinea pigs in the present study (Chapter 2)395, creating the possibility that dams with larger 
litters also have greater potential food intake and/or maternal nutrient reserves, potentially 
increasing lactational capacity. Consistent with this hypothesis, in goats, litter size is positively 
associated with total milk production, nevertheless volume per kid is lower in large litters480. 
We suggest that pups in large litters in the present study may have responded to limited milk 
availability by earlier commencement of solid feeding on pellets available within the dam’s 
cage, explaining the smaller “check” in their growth trajectories at weaning, compared to guinea 
pig pups from small litters (Chapter 2)395. Altered feed composition in early postnatal life may 
therefore also have contributed to programming effects associated with litter size. Litter size 
also increases with maternal age and parity in guinea pig 397, but as all dams were of similar age 




Other animal models that specifically induce placental restriction, such as uni- or bi-lateral 
uterine artery ligation in the rat275, 276, 280-282, surgical carunclectomy in the sheep69, 293, and heat-
induced placental restriction300 also produce offspring with disproportionate IUGR. We expect 
that in IUGR due to large litter size in guinea pigs, relative placental insufficiency will worsen 
with advancing gestation as fetal size increases rapidly and demand exceeds placental capacity 
for nutrient supply391. In larger litters although fetal weight gain is slower compared to that of 
smaller litters in late gestation the gain in length is comparable481 which gives rise the greater 
weight to length ratio at birth in larger litters compared to smaller litters in this species (Chapter 
2)395. 
In late gestation when nutrient requirement for the fetuses is high, dams carrying litters 
of three and four pups increased their feed intake in late gestation (40-60 days) compared to 
mid gestation (20 to 40 days) with no changes in maternal intake over gestation in dams 
pregnant with one or two pups (Chapter 2)395. Paradoxically, litters of five pups had a 15% 
reduction (ns) in feed intake in late gestation compared to mid-gestation. This suggests that 
total pup volume in these largest litters interferes with maternal feeding and gastric filling and 
emptying, and may further reduce nutrient supply to the growing fetuses especially in late 
gestation. In feed-restricted dams, 60-day-old offspring have reduced liver and muscle weights 
with heavier adipose tissue deposits compared with progeny of ad libitum-fed dams 309, 
demonstrating programming via maternal feed intake. 
Guinea pigs from larger litter sizes were IUGR and underwent neonatal catch-up which 
persisted after weaning into the juvenile period in both sexes. Catch-up growth is a phenomenon 
observed in IUGR humans57-59 and animal models of IUGR in sheep69, 293, 295, pigs358, rats77, 282, 
288 and guinea pigs394 where faster rates of growth occur soon after birth. The IUGR male and 
female guinea pig offspring were hyperphagic after weaning suggesting that altered appetite 




seen in IUGR sheep293 and following maternal feed restriction in the guinea pig310 and in the 
rat77, 374. 
 Both neonatal catch-up growth and larger size at birth in males independently predicted 
increased adiposity, especially in visceral depots, and increased the fat to muscle ratio in 
adolescence which was not evident in females. Catch-up growth in early life has been associated 
with increased adiposity in many human studies covered in systematic reviews66, 252, 253 and this 
increase in adiposity with catch-up growth is replicated in many IUGR animal models259, 482, 
483. 
Small size at birth predicted insulin resistance of whole body glucose uptake 
independent of neonatal catch-up growth, adiposity and muscle mass in males but not in females 
in the young adult (Section 4.5.3 and 4.5.4). Many in vivo studies in humans have shown, using 
the HEC, that insulin sensitivity is positively associated with size at birth187-199. In the studies 
described in this thesis programming of insulin resistance due to small size at birth was sex-
specific, occurring in males and not in females. This is consistent with reports in young adult 
humans, where insulin sensitivity correlated positively with birth weight in males but not 
females65, 185. In humans, impaired insulin action or measures of T2DM also correlate positively 
with size at birth in males; however, outcomes in females are often not reported187, 194, 195, 201, 
229. In animal models, IUGR in sheep295, 464, maternal protein restriction in the rat336, 465, 466 and 
maternal feed restriction in the guinea pig also program impaired glucose homeostasis in a sex-
specific manner, and primarily in males. 
Here we have shown for the first time that glucose utilisation was positively 
correlated with birth weight, independent of neonatal fractional growth rate, adult adiposity and 
muscle mass in males, while a similar trend was observed for endogenous glucose production. 
In contrast, no associations of insulin sensitivity of whole body glucose uptake or partitioned 
glucose metabolism with birth weight were found in young adult females. The impaired insulin 




muscle. Skeletal muscle is responsible for approximately 70% of the glucose disposal under 
insulin stimulation92 and primarily utilises glucose by storage to glycogen rather than oxidation 
to ATP with increased insulin stimulus106. This relationship is consistent with the majority of 
in vivo and in vitro studies in LBW/IUGR humans which show impaired skeletal muscle 
uptake189-191, 194-199, and altered expression of components of the insulin signalling pathway in 
skeletal muscle that would be expected to result in reduced insulin action in this tissue190, 196, 
198, 229, 231-238. Consistent with this, IUGR in sheep and in rats, altered the expression of insulin 
signalling proteins such as PKC, IRS-1, AKT-2, GSK3a and GYS1 and GLUT4 in skeletal 
muscle, explaining impairing insulin action in this tissue231, 292, 294, 328, 338, 353.  
The current studies also provided evidence of perinatal programming of hepatic 
insulin sensitivity. Although human studies197, 246 and other animal models have shown there is 
programming of the liver in terms of growth377, insulin sensitivity329 and insulin signalling326, 
329, 346, 463, 470, 484 these studies either examined one sex only, did not report differences between 
males and females, or did not find differences between the sexes. In the young adult guinea pig, 
perinatal programming of hepatic insulin sensitivity, as indicated by the impaired suppression 
of endogenous glucose production during HEC was sex-specific. Insulin sensitivity of 
endogenous glucose production tended to correlate positively with birth weight in males, but 
not in females, as young adults. In contrast, in females the insulin sensitivity of endogenous 
glucose production correlated negatively with neonatal fractional growth rate. This impaired 
responsiveness to insulin in the liver after IUGR or neonatal catch-up growth may also add to 
the risk of hyperglycaemia and overt T2DM later in life, as observed in both LBW/IUGR 
humans and animal models of IUGR.  
Although we showed that spontaneous IUGR and/or neonatal catch-up growth were 
associated with increased adiposity, reduced muscle mass or a metabolically adverse high 
adipose to muscle weight ratio, we did not find consistent associations between insulin 




body composition. This suggests that in male guinea pigs of small size at birth, impaired insulin 
sensitivity is due to intrinsic alterations in the structure or protein expression within insulin 
sensitive tissues, particularly skeletal muscle and liver. This is consistent with numerous studies 
in humans and animal models where IUGR alters, mostly down-regulating, the expression of 
insulin signalling proteins in liver197, 246, 326, 329, 346, 463, 470, skeletal muscle190, 196, 198, 229, 231-238, 278, 
294, 485, and in adipose tissue332, 341, 342, 486, 487 which may ultimately lead to impaired insulin 
action.  
 
 Sex-Specific Outcomes (Chapters 2, 3 and 4) 
The numerous sex-specific programmed outcomes demonstrated in the current thesis 
highlights the need for both sexes to be assessed in future studies of metabolic programming. 
It has long been established that there are sex differences in size at birth with males generally 
having higher birth weights but higher neonatal mortality and morbidity488. The very fact that 
the fetal placenta is derived from the trophoblast cells of the blastocyst which carries the XY or 
XX sex chromosomes gives the placenta a degree of “sex” and this may induce differing 
responses to a suboptimal environment 488, 489  
Sex-specific programming by in utero events may result from differential adaptations 
and plasticity at the timing of insult at conception, the placenta and how the fetal and therefore 
early postnatal growth responds to acute or chronic perturbations of maternal nutrient 
deprivation, oxidative stress, overnutrition, glucocorticoid and sex steroid supplementation15, 
467, 488-492.   
Male embryos are more likely to form at the extremes of the fertility window of the 
ova than female embryos490. This may account for the higher incidence in spontaneous 
abortions in males suggesting lower viability and notion of the “fragile male embryo” 490. This 
may explain the fact that the 5 of 10 surviving guinea pigs in the litters of five were all female 




Recent reviews suggest that the placentas of each sex have differing biochemistry 
which may alter growth in utero in sub-optimal conditions488, 489. The male fetus continues to 
grow despite a sub-optimal uterine environment as the male-specific placenta is glucocorticoid 
resistant and therefore does not allow elevated glucocorticoids, which usually inhibit glucose 
uptake and fetal growth during maternal or fetal stress, to activate the expression of genes of 
the glucocorticoid-sensitive IGF axis488. Therefore, male fetuses continue to grow and develop 
during periods of environmental insult in utero such as undernutrition and hypoxia through 
signalling of increased placental growth allowing increased blood flow489. During times of sub-
optimal nutrient supply, a male fetus ensures short-term survival by increasing placental size 
and therefore supply of nutrients to the fetus. In later gestation when growth is accelerated the 
increased placental size of males results in increased competition for nutrients resulting in an 
asymmetric phenotype at birth489. In contrast, the placenta of a female fetus is responsive to 
glucocorticoid changes in the mother and therefore the IGF-axis, glucose metabolism and 
growth is inhibited leading to a slowing down of growth in sub-optimal conditions. This ensures 
in late pregnancy that the placental:fetal ratio is optimal for survival in the female fetus488. 
Nevertheless, in the current study (Chapter 2)395 we did not see any effect of sex on birth 
phenotype in the guinea pig. Therefore, the contributions of the uterine environment on the sex-
specific programming in this species remains unclear.  
Reduced maternal nutrient intake, oxidative stress in utero or paternal obesity at the 
time of conception, can lead to sex-specific alterations in expression of genes postnatally or 
epigenetic programming, which leads to greater susceptibility to perturbations in males than in 
female fetuses 15, 467, 488, 489, 491. This does not alter the overall DNA base sequence itself but can 
silence the expression of genes in early and in postnatal life. Offspring from obese fathers have 
hypomethylation, or the loss of suppression of the IGF-2 gene which results in increased 
growth, insulin secretion and obesity in these offspring491. Similarly DNA methylation of 




metabolises glucocorticoids from the placenta and therefore the fetus can be silenced by 
methylation in the placenta467. This	decreased	 clearance	 of	 glucocorticoids	may	 also	 act	 as	 a	
mechanism	 for	metabolic	 dysfunction	 in	 later	 life467.	There is increasing evidence that DNA 
methylation accounts for a significant proportion of sex-specific programmed events in utero 
15, 489. Based on these studies, approaches to increase fetal nutrition and oxygenation, such as 
maternal nutrient supplementation, development of anti-epigenetic therapeutics or epigenetic 
markers to determine fetuses at risk may merit investigation as intervention approaches.  
Programming of the HPA axis is also an important mechanism likely contributing to 
sex-specific disease outcomes in later life. Hypercortisolaemia is associated with increased 
risks of development of cardio-metabolic disease in later life493. In fetal sheep males have a 
higher cortisol response, despite similar adrenocorticotrophic hormone responses to an acute 
hypoxic stress compared to females 494. Consistent with this, in humans, adult males have a 
higher cortisol release response to psychological stress compared to females 495.  This suggests 
that sensitivity of the HPA to the environment differs between sexes.  
In rats, maternal feed restriction causes IUGR and when ad libitum feeding is allowed 
postnatally rapid catch-up occurs which can be normalised if nutrients are restricted 496, 497. 
Further rapid catch-up growth in these studies resulted in impaired metabolic function which 
was rectified in females but not males when postnatal growth was slowed with undernutrition 
following IUGR496, 497.  In the guinea pigs studies reported in Chapter 2, adult adiposity was 
strongly positively correlated with neonatal FGR in males, but not females. Together, this 
suggests that catch-up growth in males has more serious consequences in males than females.  
Many of the programmed adult outcomes observed in IUGR guinea pigs in the 
current study, such as adiposity, whole body, peripheral (skeletal muscle: glucose utilisation) 
and central (liver: endogenous glucose production) insulin resistance, occurred in males but not 
in females. This is consistent with systematic reviews, where males are at greater risk of 




assessed insulin sensitivity in males only and shown strong associations between size at birth 
and insulin resistance later in life65, 185. In sheep models of IUGR based on surgical placental 
restriction or adolescent mothers, male but not female offspring exhibit impaired glucose 
homeostasis in later life295, 464. This male-specific insulin resistance after IUGR in guinea pigs 
is also consistent with observations following protein-restriction during gestation and lactation 
in the rat. Protein-restricted male but not female rat offspring were insulin resistant as assessed 
by IVGTT and HOMA338. The insulin-stimulated activation of phosphorylation of AKT was 
impaired in skeletal muscle and adipose tissue of male offspring of protein-restricted mothers, 
males compared to controls, however the phosphorylation of AKT did not differ between the 
protein-restricted or control female progeny338. Therefore, in males only both spontaneous 
IUGR in guinea pigs (Section 4.5.3) and protein-restriction during gestation and lactation in the 
rat338, leads to peripheral insulin resistance. In the current thesis, several sex-specific postnatal 
programmed outcomes were also found such as an association of increased obesity with 
neonatal catch-up in males, but not females, and reduced muscle mass in IUGR females. 
 Early postnatal factors that may contribute to altered homeostasis later in life either via 
prenatal events or as independent factors require further investigation. In females, rapid 
neonatal growth predicted impaired insulin sensitivity of endogenous glucose production but 
higher rates of basal and insulin-stimulated rates of glycolysis. In females, rapid neonatal 
growth also tended to predict raised plasma FFAs (Section 4.5.2), suggesting that circulating 
concentrations of FFA may contribute to the sex-specific association of neonatal growth with 
hepatic insulin sensitivity. In males, faster rates of neonatal growth although predicting 
increased adiposity especially in visceral deposits (Section 2.7.6.2)395 did not predict higher 
FFAs or impaired insulin sensitivity of the liver or skeletal muscle (Sections 4.5.2 and 4.5.3). 
Investigation of the insulin sensitivity of FFAs in male and female guinea pigs following IUGR 
and neonatal catch-up growth is required to assess this further. However, the combined 




on metabolic insulin resistance and overt T2DM needs to be elucidated in this species as in 
older humans catch-up growth accounted for a large variance in insulin sensitivity in males but 
not in females65.  
These data demonstrate that spontaneous IUGR and neonatal catch-up growth 
programmed glucose metabolism in a sex-specific manner. Therefore, could be utilised as a 
model but to assess the sex-specific mechanisms of insulin resistance and it’s cardio-metabolic 
sequalae known to be programmed by perinatal growth in humans. 
 
 Strengths and Limitations 
The spontaneous growth restricted guinea pig is a small animal model of IUGR which 
has logistical advantages over larger species, such as the sheep and pigs. The guinea pig has 
smaller litter sizes than rodents but still has a significant spread of mean birth weight across the 
litter sizes of one (121 ± 2 g) to five (73 ± 6 g) pups and here had a range 57 g to 134 g or a 
235% difference between the lightest to the heaviest pup within the total cohort (Chapter 2) 
allowing for sufficient power to detect programming effects of variable prenatal growth. The 
guinea pig is also a precocial species, therefore, unlike altricial species like the rat and mouse, 
most of the development of fat, pancreas, muscle and liver have already occurred at the time of 
birth when measures of IUGR are assessed325, 388. In addition, nutrient gain during lactation 
impacts the growth and development of organs in species where organogenesis continues 
through early life. Most of the studies to date in rats have restricted food or protein during both 
pregnancy and lactation, therefore impacting the early neonatal period which is known to be a 
contributor to later disease via catch-up growth12, 65. 
We have characterised the HEC in the chronically catheterised, un-anesthetised 
guinea pig using human insulin (Chapter 3) and demonstrated that the guinea pig responds to 
human insulin, albeit with lower sensitivity compared to human, rat and mouse, thus validating 




infusates for at least 20 minutes prior to each clamp commencing, and new lines were used for 
each clamp. Although it is possible that some insulin may not reach the animal due to adsorption 
of insulin to the PVC infusion line, this would not affect results, as calculations of insulin 
sensitivity were based on circulating concentrations of human insulin measured in guinea pig 
plasma throughout the clamp. Insulin sensitivity of whole body, glucose utilisation and 
endogenous glucose production was sex-specific such that the associations with birth weight 
only occurred in males (Chapter 4). In contrast in females, rapid neonatal growth rates predicted 
impaired endogenous glucose production independent of birth weight. Therefore, the HEC 
could be used in this model of spontaneous IUGR and subsequent neonatal catch-up for further 
investigations into the perinatal programming of metabolic disease such as the sequelae of 
insulin resistance, T2DM and the metabolic syndrome. 
One of the limitations of the studies described in Chapter 4 that assessed the 
associations of size at birth and insulin sensitivity was a smaller range in birth weights in 
females compared to males. This may not have allowed a significant enough birth weight 
spectrum to detect changes in insulin sensitivity in this cohort. Additional studies including the 
full range of birth weights in both sexes are required to confirm the sexual dimorphism in the 
programming of insulin resistance in this model. In addition, the subset of females in this group 
did not undergo catch-up growth in the larger litters of four pups. This again may have reduced 
power at the extremes of birth weight and postnatal growth. Due to the significant restriction in 
the larger litters, especially that of litters of five, still births were more common than in smaller 
litters. Therefore, in some of the larger litters the postnatal environment was changed with 
mothers that had carried larger litter feeding smaller litters during lactation. Whether this 
impacted our results may need further investigation.  
Because insulin sensitivity in the guinea pig using HEC with or without D-[3-3H]-
glucose tracer had not been assessed before the studies reported in this thesis, an a priori power 




partitioned glucose metabolism in Chapter 4 (10 males, 8 females) may not have been sufficient 
to detect with enough power other sex-specific programming effect of prenatal and postnatal 
growth on partitioned glucose metabolism. Nevertheless, the observed sex-specific outcomes 
in this cohort were consistent with the fact that impaired insulin sensitivity of whole-body 
glucose uptake in individuals of low birth weight was only seen in males and not females in the 
larger cohort (21 males,18 females). Another potential contributing factor to the lack of 
observed effects of litter size or size at birth on insulin sensitivity in females may be variability 
due to different oestrous stages when insulin sensitivity was measured. Because outcomes were 
measured at a set age, females were likely at variable points in their cycles, and there is some 
evidence from human studies that glucose tolerance and insulin sensitivity vary throughout the 
cycle by up to 2-fold 474, 475, although these outcomes do not differ with cycle stage in all studies 
476, 477, as discussed in Chapter 4. 
Guinea pig insulin differs from other mammalian insulins in various key amino acid 
sequences in the chain which allow dimerisation of the insulin molecule441, 478. These changes 
in the amino acid structure impair the cross reactivity of guinea pig insulin with the insulin 
receptor of other species and guinea pig insulin also binds with low affinity to its own 
receptor446, 498. Guinea pig insulin has a lower efficacy to reduce blood glucose compared to 
other mammalian insulins such as bovine insulin446. The guinea pig appears to compensate for 
this through an increased secretion310, 427, 445-447 and therefore insulin abundance at the receptors 
on the target tissues or increased tissue abundance of insulin receptors themselves445. Despite 
the unique differences in guinea pig insulin and its receptor and the lower affinity of the guinea 
pig receptor for most mammalian insulins, this study provides evidence that human insulin can 
bind and act through the guinea pig insulin receptor. Human insulin increased whole body 
glucose disposal and glucose utilisation and enhanced the rate of glycolysis when used at a near 
maximal dose. Human insulin also suppressed endogenous glucose production in the guinea 




In conclusion, despite guinea pig insulin and its receptor having unique pharmacokinetics to 
many other small animal models, human insulin still increased glucose disposal, utilisation and 
glycolysis and therefore is a viable model for HEC studies using human insulin. 
 
 Future Directions 
The findings from this thesis suggest that the spontaneous growth restricted guinea 
pig due to natural variation in litter size is a potential model for future studies into the metabolic 
programming of insulin resistance and its sequelae in the development of the metabolic 
syndrome with ageing. The sex-specific findings highlight the need for all animal model studies 
to assess programming events in both sexes. The spontaneous growth restricted guinea pig 
should be further investigated as a model with significant merit to determine the underlying 
perinatal programmed mechanisms for altered appetite regulation, obesity and insulin resistance 
in muscle and liver.  
Glucose utilisation was impaired in low birth weight male but not female guinea pigs, 
and endogenous glucose production also tended to be reduced impaired in these IUGR males. 
Therefore, this would be a good model to investigate insulin signalling pathways in muscle, 
liver and adipose tissue in both sexes to determine if sex-specific dimorphisms exist in the 
programming of expression of key proteins in these pathways. Glucose transporters in liver and 
pancreas, and specifically GLUT4 in skeletal muscle and adipose tissue and its insulin 
stimulated translocation to the membrane, need to be measured in the spontaneous IUGR guinea 
pig as this is a feature of many molecular defects associated with small size at birth in humans190, 
198, 231 and other IUGR models231, 292, 294, 353. Other signalling proteins such as the insulin 
receptor, PKC, and the p85α and p110β subunits of phosphoinositol 3-kinase, and the 
phosphorylation of AKT, AMPK and IRS should also be determined for comparisons with the 
human 190, 196, 198, 229, 231-238 and other animal models of IUGR 294, 328, 331, 338, 346, 347, 351, 352. This 




these specific pathways can be trialled. Ideally, the effects of 17-oestradiol and oestrous 
cycling would need to be controlled as expression and activation of many of these insulin 
signalling proteins are positively regulated by oestrogen 473, 499. 
Once glucose has entered the muscle cell it essentially has two fates: storage as 
glycogen or the synthesis of ATP with the first pathway that of glycolysis. The accumulation 
of a tracer of 3H-glucose into glycogen can also be determined in specific muscles of differing 
fibre composition. Similarly, the accumulation of 3H-glucose and conversion to glycogen in 
specific zones of the liver could also be examined. This would give detailed measures of 
glycogenesis in muscles of differing composition to determine if skeletal muscle fibre types or 
liver zones are programmed differently in utero. IUGR lambs due to maternal heat-induced 
placental restriction have reduced insulin sensitive Type 1 muscle fibres which may predispose 
to insulin resistance later in life300 consistent with the muscle fibre changes seen in humans with 
T2DM and those with metabolic syndrome302. In animal models of IUGR the intralobular 
distribution of periportal enzyme, PEPCK (gluconeogenesis) is increased while perivenous 
enzyme glucokinase is suppressed following IUGR such that the liver tends to become more 
proficient at producing rather than storing glucose347, 500, 501. In humans, FFA concentrations are 
known to impair hepatic insulin sensitivity and are a risk factor in the pathogenesis of T2DM471. 
In the current thesis, rapid neonatal growth tended to predict higher fasting FFA in females but 
not males (Section 4.5.3). The assessment of accumulated fat in the livers of both male and 
female guinea pigs that were small at birth and/or underwent neonatal catch-up may help 
determine if hepatic insulin resistance is mediated via increased visceral adiposity, circulating 
FFAs and/or intrinsic changes to enzyme activity in the lobes of the liver itself. Therefore, the 
mechanisms by which rapid neonatal or catch-up growth impairs the insulin sensitivity of the 
liver also requires further investigation. 
Studies using 2-deoxy-D-[1-14C]-glucose should also be done in this model to 




[1-14C]-glucose is a non-metabolisable analogue of glucose that can be taken up by muscle, 
liver and fat, but cannot be utilised as an energy source502. Therefore, a dose of 2-deoxy-D-[1-
14C]-glucose during the fasting (no clamp) or insulin stimulated-state during HEC would enable 
measurement of glucose uptake in specific skeletal muscles, adipose depots and the liver in the 
basal or insulin-stimulate state. Glucose uptake is one of the rate limiting steps of the signalling 
pathway so direct measurement with 2-deoxy-D-[1-14C]-glucose will assist in determining 
location of the site of impairment in these low birth weight males from larger litters. 
Cross fostering experiments to control litter size during lactation could help to 
address any effects of potential differences in feed availability during lactation due to varying 
litter sizes and stillbirths, as this may also impact on growth rates during the immediate neonatal 
period. This may be a useful intervention in this model to determine the independent effects of 




Intervention studies are the primary goal of future research into the field of DOHaD 
with increasing placental function a major target503. Several interventions in both humans and 
animal models of IUGR have already investigated possible pharmaceutical agents to increase 
placental blood flow via increased placental growth, angiogenesis and/or vasodilation to 
alleviate IUGR. These include the use of maternal IGF-1 and IGF-2 504-506, VEGF antagonists, 
Sidenefil 507, 508 and similar PDE5A specific antagonists which block the breakdown of cGMP 
reducing the clearance of nitric oxide, and L-arginine infusion to increase nitric oxide synthesis 
507 in the placenta. 
Studies utilising leptin509, the glucagon-like peptide 1 (GLP-1) analogue exendin-




interventions as possible counter-measures for the cardiometabolic consequences of IUGR in 
animal models.  
These interventions could also be examined in the spontaneous growth restricted 
guinea pig to determine if insulin resistance can be alleviated in this model of IUGR. Studies 
manipulating individual aspects of the intra-uterine environment suggest that maternal nutrient 
deprivation or specific nutrient deficiency, oxidative stress with hypoxia (via experimental 
uteroplacental insufficiency) and exposure to excess glucocorticoids may each impact fetal 
tissue development directly467, 514-516 or via epigenetic pathways15, 467, 488, 489, 491. Many of these 
perturbations disrupt placental development especially when severe and chronic, therefore 
interventions to enhance placental growth and blood flow would be a prime target to elevate 
programmed metabolic disease. Given sex-specific outcomes after prenatal adversity, efficacy 
of interventions is likely to differ between sexes and it will be important to include both males 
and females in such studies. 
 
 Conclusion 
In conclusion, spontaneous IUGR due to larger litters in the guinea pig produces a 
disproportionate fetal growth restriction, which is followed by catch-up growth in the neonatal 
and juvenile periods in both male and females. Pups from larger litters or with low birth weights 
exhibit increased feed intake, obesity, and insulin resistance of whole body glucose disposal, 
utilisation and endogenous glucose production as young adults. This programming due to low 
birth weight is sex-specific with adverse adult outcomes primarily in male offspring. In contrast, 
in females, neonatal catch-up growth predicted impaired insulin sensitivity of endogenous 
glucose production. The primary dysfunction of insulin resistance in young adult guinea pigs 
that were IUGR and/or underwent rapid growth postnatally may lead to overt T2DM and the 
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